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Abstract
Damage to cartilage from general wear, disease, or injury can lead to joint pain and tissue degeneration.
With its limited ability for self-repair, cartilage has become a target for tissue engineering (TE). As current
treatments have yet to provide long-term functional cartilage repair, this dissertation introduces the
development and use of photopolymerizable hyaluronic acid (HA) based hydrogels for TE to optimize
cellular interactions and neocartilage formation. By altering hydrogel design parameters (e.g., molecular
weight and macromer concentration), a wide range of hydrogel properties were obtained. These
hydrogels all preserved the rounded morphology of chondrocytes, but cell viability and neocartilage
formation were dependent on hydrogel design, where increased crosslinking resulted in cell death and
increased macromer molecular weight yielded inhomogeneities in cell and ECM distribution within the
hydrogel. These variables also influenced the formed neocartilage properties.
The ability of HA hydrogels to promote neocartilage formation was also dependent on cell source and
culture. The expansion of chondrocytes in 2D in vitro affected neocartilage formation in HA hydrogels
after the second passage, as construct properties further decreased with continued passage.
Chondrocytes from different tissue sources also behaved variably in the hydrogels; auricular
chondrocytes excelled in static culture and subcutaneous culture over articular chondrocytes, while
articular chondrocytes were stimulated in a mechanically loaded environment.
As the use of chondrocytes for cartilage TE is limited clinically, we turned to mesenchymal stem cells
(MSCs). In vitro culture of MSC-laden HA hydrogels demonstrated that these HA hydrogels not only
supported, but enhanced chondrogenesis when compared to relatively inert hydrogels, potentially due to
receptor interactions with HA. However, in these hydrogels, ECM was localized to pericellular regions. To
accelerate the diffusion and distribution of ECM proteins, hydrolytically degradable HA macromers were
synthesized to create a dynamic environment. When degradation complemented ECM deposition, ECM
distribution and ultimately the functional maturation of the construct were improved.
While this dissertation focused on material development to improve cartilage regeneration, growth factor
delivery optimization and successful implementation of these hydrogels in cartilage defect models
remain, towards our goal of a successful long-term repair solution to cartilage damage.
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ABSTRACT

DEVELOPMENT AND CHARACTERIZATION OF
PHOTOCROSSLINKABLE HYALURONIC ACID HYDROGELS FOR CARTILAGE
REGENERATION

Cindy Chung

Advisor: Jason A. Burdick, Ph.D.

Damage to cartilage from general wear, disease, or injury can lead to joint pain and
tissue degeneration. With its limited ability for self-repair, cartilage has become a target for tissue
engineering (TE). As current treatments have yet to provide long-term functional cartilage repair,
this dissertation introduces the development and use of photopolymerizable hyaluronic acid (HA)
based hydrogels for TE to optimize cellular interactions and neocartilage formation. By altering
hydrogel design parameters (e.g., molecular weight and macromer concentration), a wide range
of hydrogel properties were obtained. These hydrogels all preserved the rounded morphology of
chondrocytes, but cell viability and neocartilage formation were dependent on hydrogel design,
where increased crosslinking resulted in cell death and increased macromer molecular weight
yielded inhomogeneities in cell and ECM distribution within the hydrogel. These variables also
influenced the formed neocartilage properties.
The ability of HA hydrogels to promote neocartilage formation was also dependent on cell
source and culture. The expansion of chondrocytes in 2D in vitro affected neocartilage formation
in HA hydrogels after the second passage, as construct properties further decreased with
continued passage. Chondrocytes from different tissue sources also behaved variably in the
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hydrogels; auricular chondrocytes excelled in static culture and subcutaneous culture over
articular chondrocytes, while articular chondrocytes were stimulated in a mechanically loaded
environment.
As the use of chondrocytes for cartilage TE is limited clinically, we turned to
mesenchymal stem cells (MSCs). In vitro culture of MSC-laden HA hydrogels demonstrated that
these HA hydrogels not only supported, but enhanced chondrogenesis when compared to
relatively inert hydrogels, potentially due to receptor interactions with HA. However, in these
hydrogels, ECM was localized to pericellular regions. To accelerate the diffusion and distribution
of ECM proteins, hydrolytically degradable HA macromers were synthesized to create a dynamic
environment. When degradation complemented ECM deposition, ECM distribution and ultimately
the functional maturation of the construct were improved.
While this dissertation focused on material development to improve cartilage
regeneration, growth factor delivery optimization and successful implementation of these
hydrogels in cartilage defect models remain, towards our goal of a successful long-term repair
solution to cartilage damage.

iv

TABLE OF CONTENTS
CHAPTER 1 Introduction .......................................................................................................................1
1.1 Cartilage..................................................................................................................................... 1
1.2 The Cartilage Problem: Clinical Aspects.................................................................................... 1
1.3 Developing a Cartilage Solution: Cartilage Tissue Engineering ................................................ 3
References:...................................................................................................................................... 6

CHAPTER 2 Research Overview...........................................................................................................8
2.1 Specific Aims & Hypotheses ...................................................................................................... 8
2.2 Research Summary ................................................................................................................... 9

CHAPTER 3 Engineering Cartilage Tissue: A Review .........................................................................12
3.1 Introduction .............................................................................................................................. 12
3.2 Cell Source............................................................................................................................... 13
3.2.1 Chondrocytes ............................................................................................................... 14
3.2.2 Fibroblasts .................................................................................................................... 20
3.2.3 Stem Cells .................................................................................................................... 21
3.3 Scaffolds .................................................................................................................................. 25
3.3.1 Hydrogels ..................................................................................................................... 28
3.3.2 Sponges ....................................................................................................................... 32
3.3.3 Meshes ......................................................................................................................... 34
3.4 Stimulating Factors .................................................................................................................. 36
3.4.1 Growth Factors and Additives ...................................................................................... 36
3.4.2 Gene Therapy .............................................................................................................. 38
v

3.4.3 Hydrostatic Pressure .................................................................................................... 39
3.4.4 Dynamic Compression ................................................................................................. 40
3.4.5 Bioreactors ................................................................................................................... 41
3.5 Conclusions.............................................................................................................................. 42
References:.................................................................................................................................... 43

SECTION I.
ENZYMATICALLY DEGRADABLE HYALURONIC ACID HYDROGELS
CHAPTER 4 Synthesis and Characterization of Methacrylated Hyaluronic Acid Hydrogels................73
4.1 Introduction .............................................................................................................................. 73
4.2 Materials & Methodology ......................................................................................................... 74
4.2.1 Macromer Synthesis and Polymerization..................................................................... 74
4.2.2 Hydrogel Characterization............................................................................................ 76
4.2.3 Cell Viability .................................................................................................................. 78
4.2.4 Statistical Analysis........................................................................................................ 78
4.3 Results & Discussion ............................................................................................................... 79
4.3.1 Network Synthesis........................................................................................................ 79
4.3.2 Network Swelling, Mechanics, and Degradation.......................................................... 80
4.3.3 Cell Encapsulation and Viability ................................................................................... 84
4.4 Conclusions.............................................................................................................................. 85
References:.................................................................................................................................... 86

CHAPTER 5 Optimization of Methacrylated HA Hydrogel Properties for Neocartilage
Formation by Auricular Chondrocytes .............................................................................88
5.1 Introduction .............................................................................................................................. 88
vi

5.2 Materials & Methodology ......................................................................................................... 90
5.2.1 Macromer Synthesis and Polymerization..................................................................... 90
5.2.2 Chondrocyte Isolation and Photoencapsulation........................................................... 90
5.2.3 Implantation in Nude Mice............................................................................................ 91
5.2.4 Biochemical Analysis.................................................................................................... 91
5.2.5 Histological Analysis..................................................................................................... 92
5.2.6 Statistical Analysis........................................................................................................ 93
5.3 Results & Discussion ............................................................................................................... 93
5.3.1 Macroscopic Appearance............................................................................................. 94
5.3.2 Biochemical Analysis.................................................................................................... 94
5.3.3 Histological Analysis..................................................................................................... 98
5.4 Conclusions............................................................................................................................ 100
References:.................................................................................................................................. 101

SECTION II.
EXPLORATION OF CELL SOURCE AND CELL BEHAVIOR
CHAPTER 6 Effects of Chondrocyte Expansion on Neocartilage Formation
in Hyaluronic Acid Hydrogels ........................................................................................104
6.1 Introduction ............................................................................................................................ 104
6.2 Materials & Methodology ....................................................................................................... 105
6.2.1 Macromer Synthesis and Polymerization................................................................... 105
6.2.2 Chondrocyte Isolation, Expansion, and Photoencapsulation..................................... 106
6.2.3 Implantation in Nude Mice.......................................................................................... 107
6.2.4 Mechanical Testing .................................................................................................... 107
6.2.5 Biochemical Analysis.................................................................................................. 108
vii

6.2.6 Histological Analysis................................................................................................... 109
6.2.7 Statistical Analysis...................................................................................................... 110
6.3 Results & Discussion ............................................................................................................. 110
6.3.1 Mechanical Behavior .................................................................................................. 110
6.3.2 Biochemical Analysis.................................................................................................. 112
6.3.3 Immunohistochemical Analysis .................................................................................. 115
6.4 Conclusions............................................................................................................................ 117
References:.................................................................................................................................. 118

CHAPTER 7 Auricular and Articular Cartilage:
How do chondrocytes differ in Hyaluronic Acid Hydrogels?..........................................121
7.1 Introduction ............................................................................................................................ 121
7.2 Materials & Methodology ....................................................................................................... 123
7.2.1 Macromer Synthesis and Polymerization................................................................... 123
7.2.2 Chondrocyte Isolation and Photoencapsulation......................................................... 123
7.2.3 In Vivo and In Vitro Culture Methods ......................................................................... 123
7.2.4 Mechanical Stimulation .............................................................................................. 124
7.2.5 Mechanical Testing .................................................................................................... 125
7.2.6 Biochemical Analysis.................................................................................................. 126
7.2.7 Viability ....................................................................................................................... 126
7.2.8 Gene Expression Analysis ......................................................................................... 126
7.2.9 Histological Analysis................................................................................................... 127
7.2.10 Statistical Analysis....................................................................................................128
7.3. Results & Discussion ............................................................................................................ 128
7.3.1 In Vivo Culture............................................................................................................ 128
7.3.2 In Vitro Culture ........................................................................................................... 134
viii

7.3.3 Mechanical Stimulation .............................................................................................. 137
7.4 Conclusions............................................................................................................................ 139
References:.................................................................................................................................. 140

CHAPTER 8 Mesenchymal Stem Cell Chondrogenesis in Hyaluronic Acid Hydrogels .....................144
8.1 Introduction ............................................................................................................................ 144
8.2 Materials & Methodology ....................................................................................................... 145
8.2.1 CD44 Staining and Flow Cytometry ........................................................................... 145
8.2.2 Macromer Syntheses ................................................................................................. 145
8.2.3 Mechanical Characterization ...................................................................................... 146
8.2.4 MSC Photoencapsulation and Culture ....................................................................... 147
8.2.5 Viability ....................................................................................................................... 147
8.2.6 Gene Expression Analysis ......................................................................................... 148
8.2.7 Microarray Assay........................................................................................................ 149
8.2.8 Histological Analysis................................................................................................... 149
8.2.9 Statistical Analysis...................................................................................................... 149
8.3 Results & Discussion ............................................................................................................. 150
8.3.1 MSC interactions with HA........................................................................................... 150
8.3.2 MSC Chondrogenesis ................................................................................................ 151
8.3.3 Comparison between HA and PEG hydrogels ........................................................... 157
8.4 Conclusions............................................................................................................................ 164
References:.................................................................................................................................. 165

ix

SECTION III.
DYNAMIC HYALURONIC ACID HYDROGELS
CHAPTER 9 Synthesis of Hydrolytically Degradable Hyaluronic Acid Hydrogels..............................169
9.1 Introduction ............................................................................................................................ 169
9.2 Materials & Methodology ....................................................................................................... 170
9.2.1 Methacrylated HA (MeHA) Macromer Synthesis ....................................................... 170
9.2.2 Methacrylated Lactic Acid HA (MeLAHA) Macromer Synthesis ................................ 170
9.2.3 Methacrylated Caprolactone HA (MeCLHA) Macromer Synthesis ............................ 172
9.2.4 Hydroxyethyl Methacrylated HA (Hema-HA) Macromer Synthesis............................ 174
9.2.5 Hydrogel Formation and Acellular Characterization .................................................. 174
9.2.6 Short-Term Cell Viability and Matrix Elaboration In Vitro........................................... 175
9.3 Results & Discussion ............................................................................................................. 176
9.3.1 Synthesis of MeLAHA Macromer ............................................................................... 176
9.3.2 Synthesis of MeCLHA and Hema-HA Macromers ..................................................... 181
9.3.3 Characterization of Hydrolytically Degradable HA Hydrogels.................................... 183
9.3.4 Cell Viability and Matrix Elaboration........................................................................... 185
9.4 Conclusions............................................................................................................................ 185
References:.................................................................................................................................. 187

CHAPTER 10 Influence of Temporal Degradation on
Matrix Deposition in Hyaluronic Acid Hydrogels ...........................................................191
10.1 Introduction .......................................................................................................................... 191
10.2 Materials & Methodology ..................................................................................................... 192
10.2.1 Macromer Syntheses ............................................................................................... 192
x

10.2.2 Acellular Characterization ........................................................................................ 193
10.2.3 MSC Photoencapsulation and Culture ..................................................................... 193
10.2.4 Cellular Characterization .......................................................................................... 194
10.2.5 Statistical Analysis....................................................................................................196
10.3 Results & Discussion ........................................................................................................... 196
10.3.1 Acellular Characterization ........................................................................................ 196
10.3.2 Cellular Characterization .......................................................................................... 198
10.3.3 Gene Expression Analysis ....................................................................................... 200
10.3.4 Long-Term In Vitro Culture....................................................................................... 202
10.3.5 Mechanical Properties.............................................................................................. 204
10.3.6 DNA and Biochemical Content................................................................................. 206
10.3.7 Immunohistochemical Analysis ................................................................................ 208
10.3.8 Importance of Degradation Rate .............................................................................. 209
10.3.9 Importance of a Dynamic Hydrogel.......................................................................... 209
10.4 Conclusions.......................................................................................................................... 212
References:.................................................................................................................................. 213

CHAPTER 11 Conclusions, Limitations, and Future Directions ...........................................................217
11.1 Conclusions.......................................................................................................................... 217
11.2 Limitations ............................................................................................................................ 221
11.3 Future Directions.................................................................................................................. 223
11.3.1 TGF-β3 Delivery ....................................................................................................... 223
11.3.2 In Vivo Defect Model ................................................................................................ 227
References:.................................................................................................................................. 229

xi

LIST OF TABLES
Table 3.1 Cell sources used in the regeneration of cartilage tissues............................................ 14
Table 3.2 Types of biomaterials used in cartilage tissue engineering........................................... 27
Table 4.1 MeHA hydrogel compositions........................................................................................ 79
Table 4.2 MeHA hydrogel mesh size............................................................................................. 80
Table 7.1 Porcine primer & probe sequences for real-time PCR ................................................ 127
Table 8.1 Human quantitative PCR primers and probes............................................................. 148
Table 10.1 MeHA:MeCLHA hydrogel compositions .................................................................... 194
Table 10.2 Volumetric swelling ratios of MeHA:MeCLHA hydrogels .......................................... 198

xii

LIST OF FIGURES
Figure 3.1 Schematic of cartilage tissue engineering approaches ............................................... 13
Figure 3.2 Scaffold architectures used in engineered cartilage tissues........................................ 26
Figure 4.1 Synthetic scheme and 1H NMR of MeHA .................................................................... 75
Figure 4.2 Schematic of free radical polymerization of MeHA ...................................................... 76
Figure 4.3 Volumetric swelling ratios of MeHA hydrogels............................................................. 80
Figure 4.4 Mechanical properties of MeHA hydrogels .................................................................. 81
Figure 4.5 Degradation of MeHA hydrogels by exogenous hyaluronidase................................... 82
Figure 4.6 Viability of 3T3-fibroblasts in MeHA hydrogels ............................................................ 84
Figure 5.1 Schematic of photoencapsulation and subsequent analysis ....................................... 91
Figure 5.2 Macroscopic appearances of explanted MeHA constructs cultured in vivo ................ 94
Figure 5.3 Water content of MeHA constructs after in vivo culture............................................... 95
Figure 5.4 DNA content of MeHA constructs after in vivo culture................................................. 96
Figure 5.5 Glycosaminoglycan content of MeHA constructs after in vivo culture ......................... 97
Figure 5.6 Collagen content of MeHA constructs after in vivo culture .......................................... 98
Figure 5.7 Histological stains for ECM in MeHA constructs after in vivo culture .......................... 99
Figure 6.1 Schematic of chondrocyte expansion, encapsulation, and subsequent analysis...... 106
Figure 6.2 Uniaxial confined compression testing setup............................................................. 108
Figure 6.3 Macroscopic image of explanted MeHA constructs with passaged chondrocytes .... 110
Figure 6.4 Mechanical properties of MeHA constructs compared to native cartilage................. 111
Figure 6.5 Water content of MeHA constructs compared to native cartilage.............................. 112
Figure 6.6 DNA content of MeHA constructs compared to native cartilage................................ 113
Figure 6.7 Biochemical content of MeHA constructs compared to native cartilage.................... 114
Figure 6.8 Elastin content of MeHA constructs compared to native cartilage ............................ 115
Figure 6.9  Histological stains for ECM in MeHA constructs with passaged chondrocytes........ 116
Figure 7.1 Schematic of chondrocyte isolation, encapsulation, and analysis............................. 125
Figure 7.2 Mechanical properties of explanted AU and AR constructs ...................................... 129
xiii

Figure 7.3 Water content of explanted AU and AR constructs ................................................... 130
Figure 7.4 DNA and biochemical content of explanted AU and AR constructs .......................... 131
Figure 7.5 Histological stains for ECM in explanted AU and AR constructs............................... 133
Figure 7.6 Viability of AU and AR constructs in vitro .................................................................. 134
Figure 7.7 Gene expression of AU and AR constructs cultured in vitro...................................... 136
Figure 7.8 Histological stains for ECM in AU and AR constructs cultured in vitro ...................... 137
Figure 7.9 Gene expression of dynamically loaded AU and AR constructs in vitro.................... 138
Figure 8.1 CD44 expression by MSCs........................................................................................ 151
Figure 8.2 Gene expression of MSC-laden MeHA constructs in vitro ........................................ 152
Figure 8.3 Hyaluronidase gene expression of MSC-laden MeHA constructs in vitro ................. 153
Figure 8.4 Histological stains for ECM in MSC-laden constructs cultured in vitro ...................... 154
Figure 8.5 Gene expression of MSC-laden MeHA constructs in vivo......................................... 155
Figure 8.6 Histological stains for ECM in MSC-laden constructs cultured in vivo ...................... 156
Figure 8.7 Comparison of MSC viability and elastic moduli of MeHA and PEG hydrogels ........ 157
Figure 8.8 Gene expression of MeHA constructs normalized to PEG constructs (in vitro) ........ 158
Figure 8.9 Histological stains for ECM in MSC-laden MeHA and PEG constructs (in vitro)....... 158
Figure 8.10 Gene expression of MeHA constructs normalized to PEG constructs (in vivo)....... 159
Figure 8.11 PCA plot of HA and PEG constructs cultured in vitro .............................................. 160
Figure 8.12 Heat map comparison of MSC-laden HA and PEG constructs (in vitro) ................. 163
Figure 9.1 Reaction schematic for the synthesis of MeLAHA..................................................... 172
Figure 9.2 Reaction schematic for the synthesis of MeCLHA macromer ................................... 173
Figure 9.3 Reaction schematic for the synthesis of Hema-HA macromer .................................. 174
Figure 9.4 1H NMR spectrum of MeLA-OH, MeLA-COOH, and MeLA-NHS .............................. 177
Figure 9.5 1H NMR spectrum of the sodium and TBA salt of hyaluronic acid ............................ 179
Figure 9.6 1H NMR spectrum of MeLAHA macromer ................................................................. 179
Figure 9.7 DOSY spectrum ......................................................................................................... 180
Figure 9.8 1H NMR of MeCLHA and Hema-HA .......................................................................... 182
xiv

Figure 9.9 Degradation times and profiles of MeLAHA, Hema-HA, and MeCLHA ..................... 184
Figure 9.10 Degradation of MeHA:MeCLHA copolymer hydrogels ............................................ 184
Figure 9.11 Viability and histological staining for CS for MeHA:MeLAHA hydrogels ................. 185
Figure 10.1 Elastic moduli of MeHA:MeCLHA copolymer hydrogels.......................................... 197
Figure 10.2 Live/Dead stains of MeHA:MeCLHA constructs ...................................................... 199
Figure 10.3 Metabolic activity of MeHA:MeCLHA constructs ..................................................... 199
Figure 10.4 Gene expression of MeHA:MeCLHA constructs...................................................... 201
Figure 10.5 Appearance, dimension, and weight of MeHA:MeCLHA constructs ....................... 203
Figure 10.6 Mechanical properties of MeHA:MeCLHA constructs ............................................. 205
Figure 10.7 DNA and biochemical content of MeHA:MeCLHA constructs ................................. 207
Figure 10.8 Histological stains for ECM in MeHA:MeCLHA constructs...................................... 208

xv

CHAPTER 1
Introduction
1.1 Cartilage
Cartilage is a specialized connective tissue that is found lining the articulating surfaces of
joints and in the ear, nose, larynx, rib, and intervertebral disc. It can be classified into three types:
elastic, hyaline, and fibrocartilage, where each type is specifically adapted for its given function,
from defining facial structures to distributing mechanical loads and providing frictionless gliding
surfaces in articulating joints. Cartilage is composed of sparsely distributed chondrocytes, found
in lacunae, embedded within a dense extracellular matrix (ECM) that is composed primarily of
type II collagen and proteoglycan aggregates. Collagen (5-30% by wet weight) provides tensile
strength, while the highly negatively charged proteoglycan aggregates (2-10% by wet weight)
retain water to resist compressive forces [1,2]. The composition, architecture, and remodeling of
cartilage are adapted to function over a lifetime of repetitive use. However, when injury and wear
does occur, self-repair is limited. Due to the predominantly avascular, aneural, and alymphatic
nature of cartilage, healing is usually slow and unsatisfactory, as regenerated tissue is
biochemically and mechanically inferior to healthy cartilage.

1.2 The Cartilage Problem: Clinical Aspects
Currently, injured hyaline cartilage is the culprit behind knee pain experienced by millions
of people young and old. Resulting from acute trauma, general wear, aging, or disease, cartilage
lesions cause intermittent or chronic pain and can be accompanied by swelling, joint locking, the
weakening of surrounding muscles, and/or reduced range of motion.

An estimated 41,000

surgical procedures are performed annually in the United States to repair cartilaginous defects[3],
where treatment outcomes depend on the size, depth, location, and pathology of the injured
cartilage. With an aging population and a growing problem of obesity, joint pain is on a steady
1

increase, where both increases in age and obesity are correlated with a higher prevalence of
osteoarthritis (OA) [4]. Already, 9% of the United States population aged 30 and older suffer from
OA of the hip or knee, (totaling over 21 million people), costing an estimated $28.6 billion
dollars[5,6], and more than 250,000 knee and hip replacements are performed each year for endstage disease joint failure [7]. In addition, with a more active adult population, cartilage damage
resulting from sports injuries can also result in premature cartilage degeneration.
Current treatments attempt to provide symptomatic relief, allowing patients to return to
high physical activity and delay the option of replacement surgery. These treatments include: 1)
lavage and debridement, 2) microfracture, 3) periosteal and perichondral grafting, 4) autologous
chondrocyte implantation (ACI), and 5) osteochondral autografts and allografts. Lavage and
debridement involves the removal of any unstable cartilage flaps to relieve pain and decreases
synovitis and concentrations of intra-articular inflammatory mediators [8,9].

Microfracture

involves penetration of the subchondral bone to allow mesenchymal elements from the bone
marrow to colonize the wound bed and promote the growth of fibrocartilage, which is
mechanically inferior to hyaline cartilage, within defect site [10,11]. Periosteal and perichondral
grafts can be placed in large defects, and it is thought that the milieu of cells present in these
grafts can give rise to hyaline-like cartilage. Since 1987, ACI has garnered much excitement and
has been used to treat full-thickness chondral defects in 12,000+ patients worldwide [12]. This
approach involves harvesting small biopsies of cartilage from the patient in a minimally invasive
manner, isolating chondrocytes from the donor tissue, and expanding the cells in vitro. These
cells are then delivered to the cartilage defect site under a periosteum flap to produce new
cartilage tissue. Unfortunately, this tissue is often not superior to microfracture results in the long
term [13], despite the procedure being more costly and invasive. More recently, Genzyme has
patented a treatment called matrix-induced autologous chondrocyte implantation (MACI). Here,
harvested chondrocytes are grown on a collagen 1 membrane prior to implantation.

MACI

addresses problems associated with the use of periosteum in ACI by replacing it with an inert
porcine collagen membrane that is pre-cultured with chondrocytes to prevent the leakage of
2

cells[14]. Lastly, Osteochondral autografts are taken from non-weight bearing healthy cartilage
and inserted at the site of the load-bearing defect, while allografts involve the transplantation of
cadaveric grafts. All of these treatments have shown variable success and are often limited by
cell and tissue availability, donor site morbidity, graft rejection, fear of disease transmission,
insufficient integration, or fibrocartilage repair [15].

Thus, their long-term use in clinical

applications remains inadequate.
As current treatment methods have yet to provide long-term functional cartilage repair,
researchers have turned to tissue engineering (TE) for a cartilage repair solution. Here, the goal
is to use cells, scaffolds, and signaling factors, alone or in combination, to engineer a tissue that
is structurally and functionally equivalent to healthy, native cartilage at the site of a defect.

1.3 Developing a Cartilage Solution: Cartilage Tissue Engineering
In cartilage TE, cells (typically chondrocytes) are combined with a biocompatible scaffold
to provide a suitable three-dimensional (3D) environment for cartilage tissue regeneration. These
3D environments more closely mimic the natural environment of chondrocytes, favoring
phenotype preservation and ECM elaboration. Ideally the scaffold should: 1) have directed and
controlled degradation, 2) promote cell viability, differentiation (in the case of stem cells), and
ECM production, 3) allow for the diffusion of nutrients and waste products, 4) adhere and
integrate with the surrounding native cartilage, 5) span and assume the size of the defect, and 6)
provide mechanical integrity in the case of an articular cartilage defect.
To date, a wide range of materials (natural and synthetic) and scaffold architectures (e.g.,
hydrogels, porous sponges, fibrous meshes) have been explored for cartilage TE applications
(see Chapter 3). Natural materials can often interact with cells via cell surface receptors to
regulate or direct cell function, while synthetic materials are often more controllable and
predictable with specified chemical and physical properties to dictate mechanical and degradation

3

characteristics.

These materials can then be fabricated into a variety of scaffolds (e.g.,

hydrogels, sponges, and meshes).
Hydrogels are water swollen networks that support the encapsulation of cells and
bioactive agents. As injectable scaffolds, they easily fill defects of any size and shape, and can
be implanted in a minimally invasive manner. Physically crosslinked hydrogels are held together
by molecular entanglements and/or secondary forces like ionic or hydrogen bonding or
hydrophobic interactions, while chemically crosslinked hydrogels are covalently bonded. Here,
molecular weight, macromer concentration, method of crosslinking, and crosslinking density can
dictate the physical and chemical properties of the hydrogel.
For porous sponges, scaffold properties depend on pore size, porosity, and
interconnectivity.

Porosity dictates surface area [16] for cell adhesion, while pore size and

interconnectivity affect cell infiltration and migration, matrix deposition and distribution [17], and
nutrient and waste exchange. Methods used to manufacture these scaffolds include: porogen
leaching, freeze-drying, and gas foaming.

These manufacturing methods affect scaffold

architecture, which in turn affects tissue formation.

Porous scaffolds can also be filled with

hydrogels for the delivery of growth factors or other bioactive agents [18].
Fibrous meshes are networks of woven and non-woven fibers, where variations in void
volume, fiber diameter, and fiber directionality affect cell behavior.

Three-dimensional fiber

deposition is a technique used to form scaffolds with regulated patterns [19], and electrospinning
is a technique used to produce micro- and nano-scale
cartilage ECM [20].

fibers that mimic collagen fibrils in

Fibers are generated as the surface charge of the polymer droplet

overcomes its surface tension in an applied electric field, causing an instability that creates jets of
polymer that can then be collected as solvent evaporates.

Electrospun scaffolds have high

surface areas to volume ratios and fully interconnected pores, and are capable of being aligned
for heterogeneous scaffold properties.

Scaffolds of all types have been incorporated with

chondrocytes and stem cells to produce cartilaginous tissue, and an indepth review of current
cartilage TE approaches can be found in Chapter 3.

However, advances in new materials,
4

understanding of cells, and the development of more complex culture environments provide an
opportunity for further TE approaches that may optimize healing and regeneration of cartilage.

With these limitations in current cartilage repair techniques and the advancement of the
field of TE, this thesis will introduce the development and use of engineered hydrogels, based on
hyaluronic acid, for optimization of neocartilage formation by both chondrocytes and stem cells.
This work presents an investigation of engineering tools and principles towards the advancement
of cartilage TE.
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CHAPTER 2
Research Overview
2.1 Specific Aims & Hypotheses
Although research in cartilage TE has led to significant advances, the properties and
structure of native cartilage have not been entirely mimicked by any engineered replacement.
Thus, novel scaffolds that optimize the amount, the quality, and the organizational structure of
engineered cartilage remain to be developed.

This dissertation describes work towards this

general aim with the development, characterization, and assessment of engineered
photocrosslinked hyaluronic acid (HA)-based hydrogels with encapsulated cells for cartilage
regeneration.

Hypothesis: We hypothesized that engineering a cell-laden HA scaffold, capable of providing
cellular cues and a temporal microenviroment, would lead to optimal neocartilage formation and
cartilage repair. Specifically, (1) variations in molecular weight, macromer concentration, and
degree of modification can lead to HA-based hydrogels with tunable properties, (2) encapsulated
cells (chondrocytes and mesenchymal stem cells, MSCs) will form neocartilage tissue in HA
hydrogels based on the hydrogel structure, (3) stem cells will receive specific cues towards
differentiation based on HA chemistry, and (4) the introduction of a hydrolytically degradable
component will assist in matrix production and elaboration.

To test these hypotheses, the following specific aims were proposed:
Specific Aim 1: Synthesize and characterize photocrosslinked methacrylated hyaluronic
acid (HA) hydrogels. Hydrogels of varying HA molecular weights and macromer concentrations
are explored and characterized for swelling, mechanics, degradation, and cytocompatibility. The
effects of hydrogel properties on neocartilage formation by encapsulated chondrocytes are also
examined.
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Specific Aim 2: Investigate cellular response and neocartilage formation of encapsulated
chondrocyte and mesenchymal stem cells in photocrosslinked HA hydrogels. Using an
optimized hydrogel composition, chondrocyte expansion, source, and response to mechanical
stimulation are explored.

MSC chondrogenesis in HA hydrogels is also investigated and

compared to inert non-bioactive hydrogels.

Gene expression, immunohistochemistry,

biochemical assays, and mechanical testing were performed to assess cellular response, matrix
elaboration, and tissue formation.

Specific Aim 3: Develop hydrolytically degradable HA macromers to enhance ECM
deposition and distribution.

Novel hydrolytically degradable HA-based macromers are

synthesized and incorporated into the hydrogel system to tailor degradation to enhance ECM
distribution.

Networks are formed through copolymerization of these macromers with

enzymatically degradable macromers to develop a wide range of temporal formulations.

2.2 Research Summary
The motivation for developing cartilage tissue engineering (TE) scaffolds has already
been set in Chapter 1. Cartilage has a limited ability for self repair, and the need for a cartilage
solution is evident and growing. Following an extensive review on cartilage TE approaches in
Chapter 3, the remainder of this dissertation, on the development and assessment of
photocrosslinkable HA hydrogels for cartilage regeneration, is organized into three sections: 1)
enzymatically degradable HA hydrogels, 2) exploration of cell source and cell behavior, and 3)
dynamic HA hydrogels.
Chapter 4 will explore the synthesis and characterization of enzymatically degradable
methacrylated HA (MeHA) hydrogels.

The versatility of this photocrosslinkable system is

investigated by simply altering molecular weight and macromer concentration to vary volumetric
swelling, mechanical properties, and degradation time of the hydrogel. The effects of variations
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in these hydrogel parameters on chondrocytes and neocartilage formation are then described in
Chapter 5. Chondrocytes are directly encapsulated in the MeHA hydrogels and biochemical and
histological outcomes are assessed after culture in a subcutaneous model in mice.
The choice of cell source is discussed in chapters 6, 7, and 8. Chondrocytes maintain
and remodel surrounding cartilage tissue and are the natural choice for cellular cartilage
scaffolds. However, these cells comprise only 10% of native cartilage by weight, and would
require in vitro expansion for clinical use. Unfortunately, chondrocytes have been shown to
dedifferentiate when expanded in vitro, and the effects of expansion on chondrocyte phenotype
and neocartilage quality are investigated in chapter 6.

Additionally, chondrocytes can be

harvested from a variety of cartilage sources in the body including: ears, ribs, nose, and knees.
The cartilage in each of these sources serves different functions; and thus, differences in
chondrocyte sources and how these cells respond in MeHA hydrogels are explored in chapter 7,
where the influence of mechanical loading on these specific cell types is also investigated.
Despite the vast work in the literature on chondrocytes in TE scaffolds, the use of
chondrocytes for clinical applications are still limited by low cell yields, dedifferentiation, and
donor site morbidity. Thus, MSCs have emerged as an alternative cell source. These multipotent
progenitor cells have the ability to be expanded in vitro for several passages without loss of
phenotype and can be photoencapsulated in the HA hydrogels. Given the appropriate cues,
MSCs can differentiate toward a chondrogenic pathway, which is discussed in chapter 8, and
produce type II collagen and sulfated-glycosaminoglycans. Importantly, the control over MSC
chondrogenesis by hydrogel chemistry is also investigated by comparing HA hydrogels to inert
hydrogel systems.
However, the use of enzymatically degradable hydrogels is limited, as extracellular matrix
(ECM) proteins accumulate primarily in pericellular regions within MSC-laden MeHA hydrogels
and do not distribute throughout the hydrogel, leading to inferior properties.

Therefore, to

enhance ECM distribution, hydrolytically degradable HA macromers were synthesized with a
range of hydrolytically labile groups.

The detailed synthetic schemes of these degradable
10

macromers with a range of degradation parameters is described in chapter 9. Copolymerization
of both enzymatically and hydrolytically degrading HA macromers then provided a tunable
platform to investigate the effects of temporal degradation on chondrogenesis and ECM
deposition. The benefits of these dynamic hydrogels over static hydrogels are discussed in
chapter 10.
Lastly, in chapter 11, overall conclusions and future directions are discussed.

This

includes limitations of the work presented, as well as a description of pilot studies towards the
inclusion of peptides in the hydrogels to alter and control growth factor delivery and presentation
to encapsulated cells.
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CHAPTER 3
Engineering Cartilage Tissue: A Review
(Adapted from: C Chung and JA Burdick, “Engineering Cartilage Tissue,” Adv Drug Deliv Rev, 2008,
60(2): 243-62)

3.1 Introduction
Tissue engineering is an evolving field that has the potential to provide permanent
solutions to tissue damage and tissue loss to millions of people each year [1].

The basic

approach to tissue engineering involves the use of cells, scaffolds, and signaling factors, alone or
in combination. Engineering cartilage is no exception to this approach. Due to its limited ability to
self repair, cartilage is an ideal candidate for tissue engineering. As research in the field of
cartilage tissue engineering advances, new techniques, cell sources, and biomaterials are being
explored to overcome the limitations of current treatments, mentioned in Chapter 1, which
include: limited cell and tissue availability, donor site morbidity, graft rejection, fear of disease
transmission, insufficient integration, or fibrocartilage repair. To date, the properties and structure
of native cartilage have not been entirely mimicked by any engineered replacement. This chapter
provides an overview of the emerging trends in cartilage tissue engineering, looking at cell
source, scaffolds, and stimulating factors.

The wide range of approaches investigated for

cartilage tissue engineering is summarized in Figure 3.1.

Briefly, cells (e.g., chondrocytes,

fibroblasts, stem cells) are isolated from the body and expanded in vitro with the addition of
growth factors, scaffolds, or bioreactors to sufficient numbers without loss of phenotype. These
cells are then combined with a scaffold (with or without growth factors) for polymerization in situ,
direct implantation, or subcultured with mechanical stimulation, soluble factors, or in bioreactors
prior to implantation. Once implanted, the TE construct would ideally degrade over time as new
tissue is deposited and integrated with the surrounding native cartilage, generating a suitable
repair for the cartilage defect.
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Cell Isolation & Expansion
• Chondrocytes • Fibroblasts • Stem Cells
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in situ polymerization
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+
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Scaffold Degradation
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Figure 3.1 General schematic of approaches used in cartilage tissue engineering, ranging from
injectable systems to in vitro culture prior to implantation, and numerous biomaterials and
culturing methodologies.

3.2 Cell Source
The optimal cell source for cartilage tissue engineering is still being identified.
Chondrocytes, fibroblasts, stem cells, and genetically modified cells have all been explored for
their potential as a viable cell source for cartilage repair (Table 3.1). Chondrocytes are the most
obvious choice since they are found in native cartilage and have been extensively studied to
assess their role in producing, maintaining, and remodeling the cartilage ECM. Also, fibroblasts
are easily obtained in high numbers and can be directed toward a chondrogenic phenotype [2].
Recent work has focused more on stem cells, which have multi-lineage potential and can be
isolated from a plethora of tissues. These progenitor cells can be expanded through several
13

passages without loss of differentiation potential. Additionally, all of these cells can be modified
genetically to induce or enhance chondrogenesis. The goal is to find an ideal cell source that can
be easily isolated, is capable of expansion, and can be cultured to express and synthesize
cartilage-specific molecules (e.g., type II collagen and aggrecan).

Table 3.1 Cell sources used in the regeneration of cartilage tissues.
Cell Source
Chondrocytes
Articular
Auricular
Costal
Nasoseptal
Fibroblasts
Stem Cells
Bone-marrow derived
Adipose-derived
Muscle-derived
Synovium-derived
Periosteum-derived
Embryonic

Example References
[3-9]
[10-14]
[12,15-17]
[18-22]
[2,23-25]
[26-31]
[32-37]
[38-40]
[41-43]
[44-46]
[47-51]

3.2.1 Chondrocytes
Differentiated chondrocytes are characterized by a rounded morphology and the
production of ECM molecules such as type II collagen and sulfated glycosaminoglycans (GAGs).
Chondrocytes maintain and remodel cartilage matrix tissue by a careful balance of catabolic and
anabolic processes involving matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinases (TIMPs). Preserving these characteristics is crucial for chondrocytes to be
used as a cell source for cartilage repair.

A variety of key issues involving the use of

chondrocytes as a cell source for clinical application will be covered in this section.

Chondrocyte Expansion
As mentioned above, one of the major challenges for cartilage tissue engineering is
obtaining sufficient cell numbers to fill a clinically relevant defect. Chondrocytes are limited in
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number, comprising only 5 to 10% of cartilage tissue, and thus, need to be expanded prior to use.
Unfortunately, monolayer expansion causes dedifferentiation of chondrocytes, which is
characterized by decreased proteoglycan synthesis and type II collagen expression and
increased type I collagen expression. Changes in the expression of collagens [52,53], integrins
[54], growth factors [55], and matrix modulators [56] and the activation of signaling proteins like
src homology collagen (SHC) and extracellular signal-regulated kinase 1/2 (Erk1/2) [57]
accompany dedifferentiation and are used as early markers or signs of irreversibly
dedifferentiated cells. Darling et al, showed changes in articular chondrocyte gene expression
(type I and type II collagen, aggrecan, and superficial zone protein) as early as the first passage,
even when encapsulated in alginate beads [58]. Furthermore, the use of passaged cells can
have dramatic effects on engineered cartilage tissue [10].
A variety of substrates [59-61] and growth factors (GFs) like fibroblast growth factor-2
(FGF-2) [62] have been used to prevent or slow chondrocyte dedifferentiation in monolayer
cultures.

For instance, the gene expression of chondrocytes was similar when grown on

aggrecan-coated polystyrene to cells redifferentiated in 3D agarose gels [61].

However,

substrates coated with fibronectin and type I/II collagen were unable to prevent the loss of
phenotype [60,61]; though type II collagen-expanded human articular chondrocytes are able to
regain their phenotype when cultured in pellets in chondrogenic medium and expressed higher
mRNA for type II collagen and greater GAG production over tissue culture polystyrene-expanded
chondrocytes [59].
Three dimensional cultures, such as agarose [63], alginate beads [64], and fibrin glue
[65] may preserve the chondrocyte phenotype (i.e., increased aggrecan production and type II
collagen expression). However, some complications may be encountered during cell recovery
[65]. Thermoreversible hydrogels, like poly(N-isopropylacrylamide-co-acrylic acid) (PNiPAAm-coAac), have also been used to expand chondrocytes without loss of phenotype, and the
thermoreversible nature of the gels allows for easy cell recovery [66].

Once expanded,

differentiated chondrocytes can be released and seeded onto other scaffolds. Also, Malda et al
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showed that nasal and articular chondrocytes could be expanded without dedifferentiation on
macroporous gelatin CultiSher and Cytodex-1 microcarriers, respectively, with doubling times
comparable to standard T-flask expansion [67,68].
In addition, a variety of methods have been employed to redifferentiate chondrocytes
including the use of 3D scaffolds, bioreactors (e.g., rotating wall reactors) [69], reduced oxygen
tension [70], and with GFs like transforming growth factor-β (TGF-β, FGF, and insulin-like growth
factor (IGF) [71].

In addition, co-culture with up to 20% of primary cells has up-regulated

expresson of aggrecan, type II collagen, and transcription factor Sox 9, while down-regulating
type I collagen [72]. Finally, redifferentiation can be affected by surface chemistry. Woodfield et
al showed that a substrate with low adhesion supported a chondrocytic phenotype, where cells
exhibited a round morphology and minimal expression of the α5β1 fibronectin integrin [73].

Zonal Organization
Articular cartilage is an anisotropic tissue composed of a superficial, middle, and deep
zone.

Each distinct zone varies in structure and function, responds to different stimuli, and

secretes different proteins [58]. Chondrocytes isolated from each zone have unique growth rates
[74], gene expression [75,76], and levels of biosynthesis [5,77].

For instance, chondrocytes

isolated from the superficial layer exhibit increased superficial zonal protein (SZP) expression,
while chondrocytes from middle and deep zones exhibit increased type II collagen expression
[75,76]. An increase in GAG and collagen is observed with increased depth, providing the deep
zone with superior mechanical properties compared to the superficial zone [5,77]. Typically,
articular cartilage engineering studies use homogenous cell mixtures from immature animals,
which yield chondrocytes that produce large amounts of ECM, but lack zonal organization.
Recently, more attention has been focused on the differences among these zones, and methods
of recreating zonal organization in engineered constructs are being explored, including multilayer
hydrogels and porous gradient scaffolds.
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Bilayer poly(ethylene oxide) diacrylate (PEODA) [78] and multilayer poly(ethylene glycol)
diacrylate (PEGDA) [79] hydrogels have been engineered to support the growth of isolated
articular chondrocyte subpopulations. Using sequential photopolymerization of multiple layers,
cell populations can be distributed in layers throughout a 3D construct.

These multilayered

constructs exhibited similar cell and ECM distribution patterns to that of native cartilage [79] and
the bilayer constructs expressed greater shear and compressive strengths than homogenous cellseeded constructs [78].

In addition, the influence of anisotropic pore architecture on zonal

organization has also been investigated.

Porous poly(ethylene glycol)-terephthalate–

poly(butylene terephthalate) (PEGT/PBT) copolymer scaffolds with either homogenous pores or
pore-size gradients were developed using a 3D fiber deposition technique.

In vitro cultures

yielded inhomogenous cell distributions and zonal distributions of GAGs and type II collagen
similar to that of native cartilage [80]. The regeneration of zonal organization of engineered
cartilage may be important towards the development of functional tissue.

Chondrocyte Sources
Many studies have focused on the use of articular chondrocytes as a viable cell source
for cartilage repair. However, the harvesting of joint cartilage is a highly invasive procedure
accompanied by the potential for donor site morbidity and loss of function. In addition, low cell
yields, low mitotic rates, and low bioactivity can further limit the use of articular chondrocytes in a
clinical setting. With these limitations in mind, other potential autologous chondrocyte sources in
the body including auricular, nasoseptal and costal cartilage are being investigated.

Known

differences among these chondrocyte sources in terms of function, structure, and composition
make each unique in elaborating an ECM with discrete biochemical, physical and biomechanical
properties; and thus, the eventual choice of chondrocyte depends on the desired application.
Auricular cartilage is an elastic cartilage found in the ear and epiglottis. In a study by van
Osch et al, human auricular chondrocytes were investigated for their potential use in cartilage
repair [14]. Compared to articular cartilage, auricular chondrocyte isolation resulted in cell yields
17

2-fold higher and cell proliferation rates 4 times faster, while retaining chondrogenic potential
when cultured in alginate beads. With in vivo culture, constructs exhibited proteoglycan-rich
matrices with positive type II collagen staining and faint elastin staining. In addition, auricular
chondrocyte samples produced neocartilage with greater biochemical and histological similarity to
that of native cartilage than articular counterparts when implanted in vivo [13].
Nasoseptal cartilage is a hyaline cartilage that has received attention for applications in
craniofacial and plastic surgeries. Adult nasal chondrocytes are capable of generating a matrix
with high collagen II/I ratio and GAG accumulation [18].

In addition, nasal chondrocytes

proliferate 4 times faster than articular chondrocytes in monolayer [18], and can be seeded at
very low seeding densities with an 838-fold expansion in one passage without dedifferentiation
[81]. Also, nasal chondrocytes have been successfully cultured as macroaggregates [82], on
collagen microcarriers [83], and in a number of scaffold systems including alginate [64],
PEGT/PBT block copolymer [19], methylcellulose [22], and HYAFF(R)11 [84], a hyaluronic acid
(HA) derivative.

These cells show good viability and produce an ECM-rich tissue with high

expression of type II collagen under appropriate culture conditions [19,22,82-84].

Additional

studies show that nasal chondrocytes respond to growth factors like TGF-β1, FGF-2, bone
morphogenic protein-2 (BMP-2), and IGF-1 [20,21] in serum-free culture with enhanced
proliferation and/or matrix deposition.
In a chondrocyte source comparison study, bovine nasal, articular, costal, and auricular
chondrocytes were grown on poly(L-lactide-ε-caprolactone) scaffolds for 4 weeks [15]. Growth
rates and gene expression varied with cell type, where the highest expression of type II collagen
and aggrecan was found for costal chondrocytes, followed by nasoseptal, articular, and auricular
chondrocytes. The construct size also varied, with auricular cell constructs having the largest
diameter and costal constructs the greatest thickness. Another study looked at the effect of GFs
on auricular, nasal, and costal chondrocytes and showed that all cell types exhibited increased
proliferation, GAG/DNA content, and up-regulation of type II collagen expression after GF
supplementation.

However, redifferentiation was only achieved in auricular and nasal
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chondrocyte cell pellets [16]. Furthermore, Johnson et al demonstrated that articular, auricular,
and costal chondrocytes were all able to form new cartilaginous matrix when cultured in fibrin
glue-cartilage composites in vivo [12].

Aged, Osteoarthritic, Cryogenically-Preserved Chondrocytes
As mentioned previously, efforts in cartilage regeneration have focused primarily on
chondrocytes isolated from immature animals. These neonatal and young chondrocytes have
faster growth rates, the capacity for rapid in vitro expansion, and greater chondrogenic potential
(increased Sox 9 and type II collagen expression) over chondrocytes from older donors [76].
Although these traits are advantageous for expanding chondrocytes and producing ECM-rich
neocartilage, the use of immature cartilage in a clinical setting for older patients may not be
possible. Thus, the proliferative and chondrogenic potential of adult, osteoarthritic, and even
cryogenically preserved chondrocytes are also explored as alternative cell sources.
In agarose gels, older chondrocytes exhibit decreased cell yields [85], lower proliferation
rates [76,85-87], diminished chondrogenic potential [76,87] and decreased tensile stiffness [88]
when compared to fetal and young chondrocytes. However, these limitations can be countered
with the addition of GFs like TGF-β1 [85], TGF-β2 [87], FGF-2 [85], platelet-derived growth factor
(PDGF) [85], and/or IGF-1 [87].

Also, culture in serum-free media resulted in increased

proliferation rates, a greater ratio of type II to type I collagen, and decreased expression of MMP3, which is commonly associated with matrix degradation [86]. When articular chondrocytes from
young and old sheep were encapsulated in fibrin glue and cultured subcutaneously in nude mice
for 7 and 12 weeks, constructs from old and young donors exhibited similar patterns of ECM
deposition, with increasing DNA, GAG, and hydroxyproline content over culture time [8]. Other
culture environments like the rotating wall vessel (RWV) with controlled oxygen tension were
used to show that aged articular chondrocytes were capable of aggregating and forming solid
tissue with positive staining for type II collagen after 12 weeks [89]. Research still needs to be
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performed to optimize culture techniques for these aged cells and to define their limitations and
potential use in a clinical setting.
Osteoarthritic (OA) chondrocytes have also been investigated for their potential in
cartilage repair. Both in vitro and in vivo culture of OA cells on HYAFF®11 yielded positive
staining for type II collagen and sulfated proteoglycans and negative staining for type I collagen
[90]. Furthermore, OA articular chondrocytes can be transduced with Sox 9 via adenoviral and
retroviral vectors to stimulate type II collagen expression and deposition in both monolayer and
alginate bead cultures [6].

Finally, cryogenically preserved cells may provide an alternative

source for cartilage regeneration. Septal chondrocytes frozen for 3 years showed evidence of
hyaline growth on knitted polygalactin 910 woven mesh scaffolds after 6 weeks of culture in a
slowly turning lateral vessel [91].

3.2.2 Fibroblasts
Skin presents a minimally invasive, relatively abundant source of fibroblasts for tissue
engineering. Although the direct transplantation of fibroblasts on PLA meshes in a cartilage
defect leads to fibrous tissue production [92], fibroblasts can be redirected towards a chondrocytic
phenotype when cultured under the appropriate conditions. Human dermal fibroblasts pretreated
with IGF-1 and cultured on aggrecan form dense aggregates that stain positive for GAGs and
type II collagen [24]. In addition, dermal fibroblasts cultured in the presence of demineralized
bone [93], or grown as high density micromass cultures in the presence of lactic acid [2] express
cartilage specific matrix proteins like aggrecan and type II collagen. Also, fibroblasts expressing
active TGF-β1 were injected into cartilage defects and showed evidence of newly formed hyaline
cartilage after 6 weeks [25]. Recently, Deng et al isolated a subpopulation of skin-derived cells
called dermis-isolated, aggrecan-sensitive (DIAS) cells [23]. These cells up-regulate aggrecan,
cartilage oligomeric matrix protein (COMP), and type II collagen over unpurified dermis cells.
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Furthermore, 3D self-assembled constructs developed from DIAS cells show evidence of rich
cartilage-specific ECM.

3.2.3 Stem Cells
Recently, stem cells have generated significant interest in cartilage tissue engineering as
an alternative to autologous chondrocytes.

Stem cells are multipotent cells that can be

differentiated down multiple cell lineages given the appropriate cues. In 1998, bone-marrow
derived stem cells were found to undergo chondrogenesis when cultured in cell aggregates in the
presence of TGF-β1[94]. More recently, adipose tissue has been identified as a source of stem
cells that can be isolated under local anesthesia with minimal discomfort [37]. Other sources of
stem cells investigated for cartilage repair include muscle [38,40], synovium [41-43], and
periosteum [44].

Bone Marrow-derived Stem Cells
Bone marrow-derived stem cells (BMSCs) undergo chondrogenesis in a variety of culture
conditions, which typically involves induction with TGF-β and a 3D culture environment (e.g., cell
pellets and micromasses). For in vitro culture, the addition of TGF-β has generally stimulated
enhanced chondrogenesis, regardless of culture method or scaffold; however, the degree of
chondrogenesis is scaffold dependent [95].

For example, Coleman et al showed increased

sulfated GAG production by BMSCs in alginate over agarose gels [95]. To date, numerous
scaffolds have been used in conjunction with TGF-β and chondrogenic media supplementation
towards the chondrogenesis of BMSCs including: agarose [95,96], alginate [95], poly(ethylene
glycol) (PEG) [29], poly(glycolic acid) (PGA) [97], silk [98,99], poly(DL-lactic-co-glycolic acid)collagen (PLGA-collagen) meshes [100], gelatin/chondroitin/HA tri-copolymer [101], and
electrospun polycaprolactone (PCL) [27].

Evidence of chondrogenesis was characterized by

enhanced type II collagen and aggrecan expression and accumulation. In addition to TGF-β, the
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cycling of growth factors (BMP-6 and IGF-1) during in vitro culture also affects chondrogenesis
[102]. In addition, cultures of BMSCs with components of the joint cavity, like synovial fluid or
synovial cells, induce chondrogenesis in vitro [26].
For in vivo delivery, a controlled method of TGF-β introduction is usually employed to
induce chondrogenesis. Alginate beads loaded with TGF-β1 exhibited sustained release for 35
days in PBS at 37°C and induced chondrogenesis [103]. Others have loaded TGF-β1 in gelatin
microspheres, which enhanced MSC repair in a full-thickness defect over in vitro differentiated
cells [104]. Using a gene therapy approach, human MSCs lipofected with TGF-β2 showed an upregulation of type II collagen and aggrecan expression and enhanced matrix synthesis for up to 4
weeks [105]. In addition, differentiation in vivo without GF release has also been investigated. In
these cases, BMSCs rely on the scaffold and the natural in vivo environment for differentiation
cues. Various scaffolds without incorporated GF release have been investigated including: HA
[106], PGA [107], and beta-tricalcium phosphate ceramic [105] scaffolds. One study showed that
cryopreserved human BMSCs were capable of producing cartilaginous tissue when subcultured
on PGA scaffolds in vitro, followed by implantation in nude mice for 10 weeks [97]. Furthermore,
osteoarthritic BMSCs maintained their differentiation potential during monolayer expansion in the
presence of FGF-2 [108]. Additionally, the co-culture of BMSCs and chondrocytes increased cell
proliferation and cartilaginous ECM deposition with positive expression for type II collagen
[109,110].

This may be attributed to GF secretion and cell-cell interactions [109] or a

chondrogenic microenvironment provided by the chondrocytes to promote the in vivo
chondrogenesis of MSCs [110].
However, a limitation of BMSCs is the mechanical integrity of the matrix they produce
[28]. In a long-term agarose culture, chondrogenesis was observed in the MSC-laden gels, but
the amount of matrix produced and mechanical properties were inferior to that produced by
chondrocytes from the same donor [28]. The GAG content and the equilibrium modulus of MSCladen gels plateaued with time, suggesting diminished chondrogenic capacity rather than delayed
differentiation.
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Adipose-derived Stem Cells
A fibroblast-like population of stem cells can be isolated from adipose tissue and cultured
in vitro for an extended period with stable expansion and low levels of senescence [37]. These
cells are mesenchymal in origin, as determined by immunofluorescence and flow cytometry, and
are capable of differentiating into chondrocytes in the presence of TGF-β, ascorbate, and
dexamethasone in combination with a 3D culture environment [37,111]. Differentiation has been
achieved in high density micromass cultures [35,112], and in alginate [32,34,36], agarose [32],
and collagen-based scaffolds [32,113].

During in vitro culture, chondro-induced ADSCs

produced cartilage-specific matrix proteins and exhibited an increase in equilibrium compressive
and shear moduli with accumulation of sulfated-GAGs [32]. In monolayer culture, these cells
exhibited prehypertrophic alteration in late stages after induction [36]. Masuoka et al showed
hyaline cartilage repair in full-thickness defects in rabbits using ADSCs and an atelopeptide type I
collagen honeycomb-shaped scaffold [113]. In addition, a novel elastin-like polypeptide (ELP)
has been shown to promote chondrogenic differentiation of ADSCs without media supplements
[33]. After 2 weeks of culture, similar accumulations of sulfated GAGs and type II collagen were
observed in constructs cultured in chondrogenic and standard media.
The use of GFs, like FGF-2 and BMP-6, also affects the chondrogenesis of ADSCs.
FGF-2 increases cell proliferation and enhances chondrogenesis by inducing N-Cadherin, FGFR2, and Sox 9 in micromass culture [112]. BMP-6 alone also upregulates the expression of
aggrecan (205-fold) and type II collagen (38-fold) in alginate culture [114]. Despite their ability to
undergo chondrogenesis, comparative studies suggest that ADSCs have lower chondrogenic
potential than stem cells isolated from other sources such as bone marrow [30,42,115,116]. A
lower accumulation of cartilage-specific matrix proteins [42,115,116] and lower type II collagen
gene expression [30,115] over other cell types suggests that more research needs to be done to
optimize the chondrogenic potential of ADSCs.
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Other Adult Stem Cells
Besides bone marrow and adipose tissue, muscle, synovium, and periosteum are other
sources of adult stem cells being explored for applications in cartilage repair. Nawata et al
generated cartilaginous tissue with muscle-derived stem cells (MDSCs) using type I collagen
scaffolds with the addition of BMP-2 and diffusion chambers [40]. These constructs were then
implanted into full thickness rat defects, and resembled mature cartilage after 5 weeks. MDSCseeded type I collagen gels performed similarly to chondrocyte-seeded constructs in full thickness
defects [38].
Stem cells isolated from synovium have been cultured in micromasses [41], and in
alginate [41] and collagen gels [43] to produce cartilaginous tissue. In alginate culture, BMP-2
stimulates a dose-dependent expression of Sox 9, type II collagen, and aggrecan in these
encapsulated cells that was comparable to articular chondrocytes [41]. However, this was not
true for TGF-β isoforms, suggesting that the effects of GFs may differ depending on stem cell
source. In a comparative study of mesenchymal stem cells (MSCs) isolated from 5 different
tissue sources, synovium-derived stem cells were shown to have the greatest chondrogenic
potential [42]. In fracture healing and callus distraction, periosteum-derived stem cells (PDSCs)
differentiated into chondrocytes during endochondral ossification. Although the factors regulating
this process are still unclear, GFs assist periosteum-derived stem cell chondrogenesis. In an in
vitro agarose culture, the addition of IGF-1 improved PDSC chondrogenesis in a dose-dependent
manner and was improved with the addition of TGF-β1 [44].

Embryonic Stem Cells
Embryonic stem cells (ESCs) are obtained from the inner cell mass of blastocyst stage
embryos. These cells are capable of many doublings and have the ability to differentiate into all
somatic cell types. Although ESCs are appealing as a cell source for their vast proliferation
capabilities, difficulties in ESC selection and purity, as well as antigenicity and ethical issues, may
hinder their clinical use. For chondrogenesis, ESCs must pass through an aggregation stage of
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embryonic bodies (EBs) before differentiation. Mouse embryonic bodies encapsulated in PEG
hydrogels showed chondrogenesis with upregulation of cartilage specific markers, while
stimulation with TGF-β1 resulted in basophilic ECM deposition characteristic of neocartilage
[47,48]. In addition, mouse ESCs undergo chondrogenesis with the addition of BMP-2 and BMP4, exhibiting increased Alcian blue and type II collagen staining [49]. However, different mouse
embryonic stem cells lines exhibit varying degrees of spontaneous chondrogenic differentiation
[117]. A study with human ESCs demonstrated that human ESC-derived EBs were capable of
complete chondrogenesis from chondrogenic induction to hypertrophic maturation [50]. EB cells
dissociated and plated as high-density micromasses, as well as the addition of BMP-2,
accelerated and enhanced chondrogenesis with the formation of a cartilage-rich ECM composed
of collagen and proteoglycans.

Furthermore, co-culture of human ESCs with primary

chondrocytes was shown to induce chondrogenesis, where the co-cultured cells expressed Sox 9
and type II collagen, whereas cultures of human ESCs alone did not [51].

Overall cartilage

tissue engineering research with ESCs is still relatively new and as we learn more about ESCs,
new strategies for purification and differentiation will be identified to fully access their potential as
a viable cell source for cartilage engineering.

In the work presented in this dissertation, all studies utilized either primary swine chondrocytes
(both auricular and articular) or primary human bone-marrow derived stem cells.

3.3 Scaffolds
Numerous scaffolding materials have been used for cell delivery in cartilage
regeneration.

The primary focus has been on polymeric materials, in forms of hydrogels,

sponges, and fibrous meshes (Figure 3.2).
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Hydrogel

Sponge

Mesh

Figure 3.2 Examples of different scaffold architectures used in the engineering of cartilage
tissues.

Scaffolds provide a 3D environment that is desirable for the production of cartilaginous tissue.
Ideally the scaffold should: 1) have directed and controlled degradation, 2) promote cell viability,
differentiation, and ECM production, 3) allow for the diffusion of nutrients and waste products, 4)
adhere and integrate with the surrounding native cartilage, 5) span and assume the size of the
defect, and 6) provide mechanical integrity depending on the defect location.

Scaffold

degradation can occur hydrolytically or enzymatically, and by controlling degradation temporally
and spatially, scaffolds can enhance and direct new tissue growth. For example, scaffolds with
degradable and non-degradable units show improved ECM distribution compared to completely
non-degradable scaffolds [118]. However, a balance must be found since slow degradation may
impede new cartilaginous ECM production, while fast degradation may compromise structural
support and shape retention. For instance, Solchaga et al showed that scaffolds with slower
degradation rates yielded cartilage of greater thickness in an osteochondral defect model, but
cracks and fissures were evident on the cartilage surface [119].
In designing a scaffold, cell seeding density and seeding method should be carefully
considered since the appropriate numbers of cells must be used to ensure adequate cell-cell
interactions.

Many approaches attempt to mimic the natural condensation of cells during

embryonic cartilage development by seeding in aggregates or at high densities. Higher initial
seeding densities tend to facilitate greater ECM synthesis and deposition, presumably due to cellcell interactions [96,120,121]. The method of seeding, statically or dynamically, can dictate cell
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distribution and infiltration into the scaffold. In sponge and mesh scaffolds, dynamic seeding can
improve cellular distribution [120], whereas hydrogels typically support uniform cell distributions if
cells are adequately suspended during gelation.
To date, a wide range of natural and synthetic materials have been investigated as
scaffolding for cartilage repair. Natural polymers that have been explored as bioactive scaffolds
for cartilage engineering include: alginate, agarose, fibrin, HA, collagen, gelatin, chitosan,
chondroitin sulfate, and cellulose (Table 3.2).

Table 3.2 Types of biomaterials used in cartilage tissue engineering.
Biomaterial
Natural Polymers
agarose
alginate
cellulose
collagen
chitosan
chondroitin sulfate
fibrin glue
gelatin
hyaluronic acid
silk fibroin
Synthetic Polymers
poly(α-hydroxy esters)
poly(ethylene glycol/oxide)
poly(NiPAAm)
poly(propylene fumarate)
poly(urethane)
poly(vinyl alcohol)
Self-assembling Peptides

Example References
[7,28,63,122,123]
[41,103,124-126]
[22,127]
[128-132]
[133-137]
[104,138,139]
[140-143]
[137,144-146]
[11,84,147-150]
[98,99,151-153]
[154-160]
[29,48,79,118,161-163]
[66,164-166]
[167-169]
[141,170-172]
[173-175]
[176-179]

Natural polymers can often interact with cells via cell surface receptors and regulate or
direct cell function. However, due to this interaction, these polymers may also stimulate an
immune system response; thus, antigenicity and disease transfer are of concern when using
these biomaterials. In addition, natural polymers may be inferior mechanically and subject to
variable enzymatic host degradation.

On the other hand, synthetic polymers are more

controllable and predictable, where chemical and physical properties of a polymer can be
modified to alter mechanical and degradation characteristics.

Synthetic polymers currently
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explored for cartilage repair include: poly(α-hydroxy esters), PEG, poly(NiPAAm), poly(propylene
fumarates), and polyurethanes (Table 3.2). However, unless specifically incorporated, synthetic
polymers do not benefit from direct cell-scaffold interactions, which can play a role in adhesion,
cell signaling, directed degradation, and matrix remodeling. In addition, degradation byproducts
may be toxic or elicit an inflammatory response. Finally, scaffold architecture also plays a major
role in dictating cellular behavior. Scaffolds can be categorized into hydrogels, sponges, and
fibrous meshes (Figure 3.2). The following sections outline the advantages and disadvantages to
each scaffold structure and introduce materials that have been investigated for cartilage tissue
engineering.

3.3.1 Hydrogels
Hydrogels are water swollen networks, suitable for the delivery of cells and bioactive
agents. Hydrogels may be used as injectable scaffolds since they easily fill defects of any size
and shape and may be implanted in a minimally invasive manner.

Hydrogels support the

transport of nutrients and waste, and can homogenously suspend cells in a 3D environment,
where encapsulated cells typically retain a rounded morphology that may induce a chondrocytic
phenotype.

Hydrogels are also capable of transducing mechanical loads to exert controlled

forces on encapsulated cells, similar to physiological conditions.

Though their mechanical

properties can be altered by crosslinking density (which may compromise cell viability) limited
mechanics may be the major drawback to using hydrogels [4].
Hydrogels are crosslinked either physically or chemically. Physically crosslinked gels are
held together by molecular entanglements and/or secondary forces like ionic or hydrogen bonding
or hydrophobic interactions, while chemically crosslinked gels are covalently bonded. Molecular
weight, macromer concentration, method of crosslinking, crosslinking density, and mesh size
dictate the physical and chemical properties of the hydrogel including: swelling ratio, mechanics,
cell viability, and degradation rate. Photopolymerization is one approach to chemically crosslink
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hydrogels using ultraviolet or visible light, and provides uniform cell seeding with both spatial and
temporal control over polymerization [180]. Careful screening of photoinitiating conditions has
been performed to optimize cell viability within these crosslinked networks [181].
PEG is a relatively inert polymer and supports chondrogenesis when crosslinked into
hydrogels [4]. Further modifications to PEG, including the addition of hydrolyzable units and
bioactive peptides have improved cartilage tissue growth [118]. For instance, degradable lactic
acid units have been added to PEG hydrogels to increase cell proliferation and ECM deposition
[4,118,182,183].

Recently, Lee and colleagues covalently incorporated a collagen mimetic

peptide (CMP) into PEG hydrogels [163]. CMP is known to associate with type I collagen and
other ECM fibers, forming physical crosslinks that can then be manipulated by cells. This study
showed that PEG hydrogels conjugated with CMP limited the diffusion of exogenous type I
collagen and increased ECM production by encapsulated chondrocytes. PEG has also been
combined with methacrylated poly(glycerol succinic acid) dendrimers [184].
Another polymer used for cartilage tissue regeneration is HA, a linear polysaccharide
found natively in cartilage. It functions as a core molecule for the binding of keratin sulfate and
chondroitin sulfate in forming aggrecan in cartilage and degrades primarily by hyaluronidases
found throughout the body.

HA plays a role in cellular processes like cell proliferation,

morphogenesis, inflammation, and wound repair [185], and may function as a bioactive scaffold,
where cell surface receptors for HA (CD44, CD54, and CD168) allow for cell/scaffold interactions.
For photopolymerization, HA can be modified with methacrylate groups [150,186], and by varying
the molecular weight and concentration of the modified HA, a wide range of properties can be
obtained [147].

Increases in macromer concentrations significantly increased the network

compressive modulus and degradation time while decreasing the swelling ratio and cell viability
[147]. These variations in scaffold properties also affected neocartilage formation by auricular
chondrocytes in vivo [11]. In a recent in vivo rabbit defect model, Liu et al investigated the quality
of repair using HA-gelatin hydrogels seeded with MSCs. Defects with MSCs alone exhibited
hyaline-like cartilage on the peripheral defect area and fibrous repair in the middle, whereas
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defects filled with a scaffold and MSCs resulted in elastic, firm, translucent cartilage with zonal
architecture and good integration with the surrounding cartilage [187].

Chondroitin sulfate,

another major constituent of cartilage, can also be photopolymerized with similar modifications to
produce hydrogels that exhibit viscoelastic behavior [139].

These chondroitin sulfate based

hydrogels support viable chondrocytes and can be degraded in the presence of chondroitinase
ABC. Furthermore, chondroitin sulfate can be copolymerized with PEG to increase the hydrogel
pore size and provide bioactive cues for encapsulated cells [139].
Fibrin glue is a natural polymer formed from the polymerization of fibrinogen with
thrombin, and it elicits good biocompatibility as a wound adhesive and can facilitate cell-matrix
interaction via integrin binding [188]. It is attractive as a natural scaffold because it can be made
from autologous blood. However, one drawback is that gels tend to shrink in vivo. Recently, a
long-term stable fibrin gel has been developed that is transparent and stable for 3 weeks [140].
This gel exhibits a broad linear viscoelastic region, withstands loads of 0.0001 to 10kPa, and
supports chondrocyte proliferation and cartilaginous ECM production while retaining its size and
shape. Studies in nude mice have shown the suitability of using fibrin glue as a biomaterial,
where degradation and polymerization time can be controlled by fibrinogen and thrombin
concentrations, respectively [142]. Fibrin glue has also been combined with other polymers like
polyurethane and improved cell seeding viability and distribution, and increased the expression of
aggrecan and type II collagen [141].
Type I and type II collagen scaffolds have inherent biological cues that allow
chondrocytes to interact and remodel the hydrogel. A type I collagen gel seeded with autologous
chondrocytes has been used to treat full thickness defects in rabbits with newly regenerated
cartilaginous tissue formation seen after 6 months and tissue organization after 12 months [129].
Gelatin, which is derived from collagen, is also biocompatible and can be modified to crosslink
with visible light and support chondrocytes, though some potential diffusion limitations may exist
[145]. Also, gelatin/alginate gels promoted chondrocyte proliferation, a rounded morphology, and
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expression of hyaline matrix molecules with increased spatial deposition of proteoglycans and
constant expression of type II collagen [189].
Alginate is a polyanionic polymer found in brown algae, and can be crosslinked with
bivalent cations to form stable ionically crosslinked gels. Alginate beads and hydrogels have
been used to expand chondrocytes and induce stem cell differentiation [32,34,36]. Recently,
investigators have modified alginate gels with synthetic adhesion peptides [190] or combined
alginate with other materials to make hybrid scaffolds [189,191,192]. RGD-functionalized alginate
has been shown to affect articular chondrocyte attachment and morphology and chondrogenesis
[124,190]. Also with increasing crosslinking density and substrate stiffness, chondrocytes grown
on alginate gels exhibited a more flattened morphology with stress fibers observed via phalloidin
staining [124]. Despite its advantages for studying in vitro chondrogenesis, limitations to alginate
gels include low mechanical properties and slow degradation rate.
Agarose is a linear polysaccharide derived from Asian seaweeds that solidifies when
cooled, and has been widely used to study chondrocyte response to deformational loading since
it is able to transmit applied mechanical forces to cells during compression [7]. Chitosan is a
biosynthetic polysaccharide derivative of chitin that is found in the exoskeletons of arthropods that
is a liquid at room temperature and gels at physiological temperatures. It is a semi-crystalline
polymer that is biocompatible, degraded in vivo by lysozymes, and can interact with GFs and
adhesion proteins. In addition, a number of methods have been used to ionically or covalently
crosslink chitosan or chitosan derivatives, to improve mechanical properties [136,193]. Chitosan
and chitosan hybrid hydrogels support normal chondrocyte phenotypes in 2D [136,193] and 3D
cultures [194]. Some synthetic copolymers have also been investigated as thermoreversible
hydrogels, with gelation occurring above their lower critical solution temperature (LCST). These
include p(NiPAAm-co-AAC) and poly(propylene fumarate-co-ethylene glycol) (p(PF-co-EG)),
which are capable of retaining chondrocyte phenotype and viability [164,167]. Within these gels,
cells remained responsive to co-encapsulated soluble factors like HA and TGF-β3, which can
lead to increased expression and synthesis of cartilage-specific ECM proteoglycans [165].
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Self-assembling peptides constitute another class of biomaterials that can be made into
hydrogels, and form by amino acid sequences of alternating ionic hydrophobic and uncharged
hydrophilic side groups.

These self-assembling peptide hydrogels form stable β-sheets of

interwoven nanofibers when exposed to an electrolyte solution and are capable of rapidly
encapsulating chondrocytes at physiological electrolyte concentrations and pH levels. RAD-,
ELK-, and EAK-based peptides form strong β-sheet secondary structures in aqueous solutions
[176].

For example, Zhang and coworkers have produced a stable self-assembling EAK16

membrane that does not dissolve by the addition of heat, acidic or alkaline solutions, or
proteolytic enzymes [179]. This stability may be due to complementary ionic bonds between
glutamic and lysine side chains. Kisiday et al showed that articular chondrocytes maintain their
phenotype and produce cartilage-like ECM after 4 weeks when encapsulated in self-assembling
peptide KLD-12 hydrogels in vitro [177] and respond to dynamic compression loading, with an
increase in proteoglycan synthesis and mechanical properties over free-swelling controls [178].
In addition, synthetic self-assembling peptides can be modified to incorporate biologically active
motifs that promote cell-matrix interactions [176].

3.3.2 Sponges
Sponges are porous scaffolds whose properties are dependent on pore size, porosity,
and interconnectivity. Porosity dictates surface area [184] for cell adhesion, while pore size and
interconnectivity affect cell infiltration and migration, matrix deposition and distribution [195], and
nutrient and waste exchange. To date, several methods have been employed to manufacture
sponges, including: porogen leaching, freeze-drying, and gas foaming. These manufacturing
methods affect scaffold architecture, which in turn affects tissue formation, and can be used to
encapsulate GFs [196].

To date, numerous materials have been used to fabricate sponge

scaffolds, including poly(α-hydroxy esters) [197,198], alginate [126], polyglactin/polydioxanone
[199], chitosan [134,135,137], silk fibroin [98,99,151,153], HA [104,119], collagen [200] and
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gelatin [104,137,144]. A novel biodegradable elastomer scaffold from poly(1,8 octanediol citrate)
(POC) has been fabricated by salt-leaching and supported the growth of chondrocytes in vitro
[201]. This POC scaffold is capable of complete recovery from compressive deformation, and
may provide good structural support in the mechanically loaded knee environment. In addition,
resorbable polyglactin/polydioxanone scaffolds have been used in full thickness equine defects
and showed good cartilage repair with integration into surrounding tissue [199].
Chitosan can also be formed into sponges via freeze-drying and lyophilization [135]. In a
study by Kuo et al, chitosan and chitin hybridized scaffolds in various compositions were
investigated as potential scaffolds [134]. An increase from 20 to 50 wt % of chitin resulted in
smaller pore diameters, increased surface area, a higher Young’s modulus, and lower
extensibility, which resulted in increased cell numbers and ECM production in 28 days. Chitosan
has also been hybridized with gelatin, which serves as a substrate for cell adhesion [137]. This
chitosan/gelatin scaffold was used for elastic cartilage repair and neocartilage exhibited type II
collagen, elastic fibers, and GAG production, with total GAG content ~90% of that found in native
auricular cartilage [137].
Silk fibroin is composed of a filament core protein called fibroin with a glue-like coat of
sericin proteins. Sponges can be formed from silk fibroin by a solvent casting/salt leaching
method that supports both chondrocytes [152] and stem cells [99]. Compared to fast degrading
collagen scaffolds, silk scaffolds supported greater proliferation and chondrogenesis of MSCs
[98,151]. Collagen and collagen hybrid sponges have also been formed that support chondrocyte
growth and phenotype retention [200]. The use of collagen microsponges in the porous openings
of PLGA fibers [202] and sponges [198] has yielded new hybrid scaffolds with improved
properties. Furthermore, type II collagen-GAG scaffolds with varying crosslinking densities can
mediate cell behavior. In a study by Vickers et al, chondrocytes seeded on type II collagen-GAG
scaffolds with low crosslinking densities experienced cell-mediated contraction, an increase in cell
number, enhanced chondrogenesis, and increased degradation rates [200].
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3.3.3 Meshes
Meshes are networks of woven and non-woven fibers, where variations in void volume
and fiber diameter and directionality can dictate cell behavior. Non-woven meshes have high
void volumes and surface areas that are well suited for tissue regeneration, whereas woven
meshes exhibit greater strengths and can be made in a wide range of porosities. In general,
these prefabricated forms can be cultured in vitro with cells to create mechanically stable
scaffolds and then implanted in vivo for complete repair. A drawback to prefabricated scaffolds is
a difficulty in filling irregularly shaped-defects, where incomplete contact with surrounding
cartilage may hinder complete integration. 3D fiber deposition is one technique used to form
scaffolds with regulated patterns [203].

Moroni et al were able to produce a scaffold with

biomechanical properties comparable to bovine articular cartilage using 3D fiber deposition of
poly(ethylene oxide) terephthalate/poly(butylene) terephthalate (PEOT/PBT) [204]. This group
also adapted the method to develop a shell-core fiber architecture [205].
Recently, electrospinning has generated much interest to produce biomaterials with
nano-scale polymer fibers that mimic collagen fibrils in cartilage ECM [156]. Fibers are generated
as the surface charge of the polymer droplet overcomes its surface tension in an applied electric
field, causing an instability that creates jets of polymer that can then be collected as solvent
evaporates. Advantages to using electrospun scaffolds include high surface areas to volume
ratios and fully interconnected pores, and the ability to create aligned fibers. By collecting the
nanofibers on a rotating mandrel, aligned fibrous scaffolds can be fabricated, and can mimic the
anisotropic morphology of some tissues. These nanofibrous scaffolds support chondrocytes and
stem cells [27,156].
The most commonly used meshes are made of poly(α-hydroxy esters). These meshes
have been used since the early 1990’s for cartilage regeneration and include poly(lactic acid)
(PLA), PGA, and their copolymers (PLGA).

PGA is the most hydrophilic of this group and

degrades into a natural metabolite that is completely resorbed through metabolic pathways. On
the other hand, PLA, with an additional methyl group, is more hydrophobic, resulting in slower
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degradation. Copolymers of PLA and PGA can be optimized for mechanical and degradation
properties. Shin et al showed that changes in copolymer composition resulted in differential
degradation, where PLGA at a 50:50 composition degraded faster than 75:25 due to the higher
PGA content [158]. Furthermore, polyester scaffolds can be modified with biological agents like
type II collagen [155] and HA [206]. Immobilization of type II collagen on PLLA/PLGA scaffolds
increased chondrocyte proliferation and GAG deposition while decreasing inflammatory
responses by preventing host tissue infiltration and capsule formation [155].

Immobilization of

HA to the surface of PLGA scaffolds enhanced chondrocyte attachment and substantially
increased GAG and collagen synthesis [206]. Furthermore, MSCs seeded on PLGA scaffolds
resulted in smooth, shiny white hyaline-like tissue after 12 weeks of in vivo culture in a rabbit
defect [160]. PCL is another member of the poly(α-hydroxy ester) family with slower degradation
kinetics.

Recently, PCL has been electrospun to form nanofibrous scaffolds capable of

supporting

proliferating

chondrocytes

that

produce

proteoglycan-rich

matrices

[156].

Furthermore, these scaffolds can also support chondrogenesis of MSCs comparable to cell pellet
controls [27].
Several natural materials have also been processed as fibrous scaffolds, including
cellulose [127] and HA derivatives [84,149,207,208]. Non-woven cellulose II fabrics coated with
calcium phosphate supported better cell adhesion than unmodified fabrics, where calcium
leaching from the scaffold has the potential to mimic the cartilage microenvironment in the vicinity
of subchondral bone [127].

Non-woven HA esters (HYAFF® derivatives) are semisynthetic,

resorbable meshes that support cell adhesion, proliferation, and production of cartilage-specific
ECM in vitro [84,207,208] and in vivo [119,149]. In a pilot study by Radice et al, HYAFF®11
elicited no inflammatory response and completely degraded within 4 months of implantation [149].
In a clinical setting, Hyalograft® C (a graft composed of autologous chondrocytes grown on a
HYAFF®11 scaffold) has been used to treat a number of human articular cartilage defects
[148,209,210].

Hyalograft® C repaired cartilage showed significant improvements over pre-
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operation assessments with cartilage regeneration even in joints with progressed osteoarthritis
[210].

In the work presented in this dissertation, all studies utilized photopolymerizable methacrylated
hyaluronic acid hydrogels engineered for controlled degradation (enzymatic versus hydrolytic) as
cell carriers. Photopolymerizable poly(ethylene glycol) hydrogels were routinely used as control
materials.

3.4 Stimulating Factors
As the third component of the tissue engineering triad, stimulating factors have been
employed to induce, accelerate, and/or enhance cartilage formation. For instance, GFs and other
additives may be added to culture media in vitro or incorporated into scaffolds for in vivo delivery
to control cellular differentiation and tissue formation. In addition, gene therapy has emerged as
another method of local delivery, where cells can be engineered to over-express bioactive
molecules. An additional approach is the introduction of mechanical signals through loading
regimes such as hydrostatic or dynamic pressure or through the use of bioreactors. Since many
types of cartilage depend on mechanical forces to maintain healthy function, this approach has
been used to alter cellular differentiation and tissue production.

3.4.1 Growth Factors and Additives
A number of growth factors like TGF-β[211-213], FGF [130,214,215], BMP [216-218] and
IGF [168,219,220], along with other soluble factors like HA [126,144,221], chondroitin sulfate
[128,130], and insulin [222], have been explored for their effects on cartilage tissue engineering.
These factors have been investigated independently and synergistically, with outcomes
dependent on cell type and culture conditions. Members of the TGF-β family have been shown to
play a major role in cartilage development. They are commonly used to induce chondrogenesis
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in embryonic [47] and adult MSCs [212,223], to increase cartilage ECM synthesis [133], and to
enhance proliferation of chondrocytes [211,224].

Several studies have shown that TGF-β

isoforms differ in their effects on various cell types, where TGF-β1 is responsible for initial cell-cell
interactions between condensing progenitor cells [213], TGF-β2 mediates hypertrophic
differentiation, and TGF-β3 has stronger effects on MSC differentiation [225,226].

Another

growth factor, IGF-1, acts in an anabolic manner to increase the production of proteoglycans and
type II collagen [44,227].
FGF-2 is a mitogen involved in wound healing that has been used to preserve the
chondrogenic potential of monolayer expanded chondrocytes [228,229] and to increase cell
proliferation [214,229,230], which in turn can result in greater ECM deposition [215] and
accelerated repair [130]. BMPs impact both chondrogenesis and osteogenesis, and are attractive
for in vivo osteochondral defect studies as they can assist osteochondral integration at the
implant site.

These morphogens regulate chondrocyte differentiation states and ECM

composition.

Specifically, BMP-2 and -7 have been shown to increase matrix production in

chondrocytes and progenitor cells. BMP-2 increases TIMP-1 [231], Sox 9 [41], type II collagen
[41,216], and aggrecan [41] expression levels, while BMP-7 stimulates the production of
proteoglycan-rich ECM and suppresses fibroblast infiltration into the scaffold [217].

BMP-7

transfection into periosteal-derived MSCs resulted in complete or near complete bone and
cartilage regeneration in an osteochondral rabbit defect model with a PGA scaffold after 8 weeks
[218]. Furthermore, BMP-2 and -7 act synergistically, resulting in even better matrix production
[216].
Methods to incorporate GFs and other soluble factors directly into scaffolds have been
developed to improve cartilage formation. For delivery in vivo, these additives can be loaded in
the scaffold itself and/or in microspheres or microparticles, which are then incorporated into the
scaffold. Release profiles of these additives are dictated by degradation and diffusion properties.
For in vivo applications, TGF-β has been incorporated into hydrogels composed of
oligo(poly(ethylene glycol) fumarate) (OPF) [168,232], PEODA [233], and fibrin [234], and/or
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loaded into microspheres or microparticles, made of PLGA [235], gelatin [104,168], and chitosan
[133,236]. Thus, growth factor release can be controlled by crosslinking density and/or variations
in the size of the microparticles. In general, the burst release of the GF is decreased when
loaded microspheres are encapsulated within a scaffold [168,235]. Many in vitro studies have
shown additive benefits of using TGF-β and IGF-1 in combination [123]. However, Holland and
colleagues showed that these in vitro results may not be as effective in an in vivo environment. In
an osteochondral repair in rabbits, microparticle delivery of IGF-1 in OPF gels with articular
chondrocytes showed significantly better repair overall over controls without IGF-1, yet this
enhancement was not observed when delivered in combination with TGF-β1 [237].
In addition, others have incorporated soluble HA to improve tissue quality. Scaffolds
supplemented with soluble HA have improved cell proliferation [144], increased expression of
cartilage-specific matrix proteins [221], and increased matrix synthesis [119,126,144,238].
Furthermore, for photopolymerization applications, HA increases the viscosity of the precursor
solution, allowing for better retention of the solution at the injection site [233]. The addition of
chondroitin sulfate has been shown to promote cell ingrowth and tissue formation [128], while
chondroitinase ABC treatment has been shown to induce maturational growth and enhanced
tensile integrity of cartilage explants [239].

3.4.2 Gene Therapy
Many biological agents have a short half life, which limits their in vivo efficacy. Gene
therapy is an alternative approach to encapsulating bioactive molecules in scaffolds. Ex vivo
gene therapy has drawn much interest as a method to transiently over-express and release
proteins from cell-seeded scaffolds to provide local delivery [240]. Both viral (e.g. retroviruses
and adenoviruses) and non-viral agents (polymers and liposomes) can be used to transfect cells.
Viral vectors typically have higher transfection efficiencies but carry greater safety concerns,
whereas non-viral vectors exhibit lower transfection efficiencies and carry fewer safety concerns.
38

FuGene 6 is a non-viral vector that has been successfully used to transfect articular chondrocytes
at an efficiency of 35% with the transgene IGF-1 [219]. Encapsulation of these transfected cells
in alginate spheres resulted in IGF-1 expression for up to 6 weeks. Transfection of BMSCs has
also been accomplished within the scaffold, where porous chitosan/collagen scaffolds were
created by freeze drying with TGF-β1 plasmids [241].

Transfected scaffolds increased

proliferation rates and the expression of type II collagen and aggrecan. Success has also been
shown with PGA sponges, where periosteal-derived stem cells were tranduced ex vivo with BMP7, and showed improved healing of full thickness cartilage defects after only 6 weeks [242]. With
gene therapy for cartilage regeneration in its infancy, much remains to be investigated, including
endless combinations of modified cells and scaffolds.

3.4.3 Hydrostatic Pressure
In the joint cavity, cartilage exists in an environment of reduced oxygen and intermittent
hydrostatic pressure.

Thus, mimicking these conditions may provide a means to improve

chondrogenesis in vitro. Low oxygen tension (5%) has stimulated the proliferation and type II
collagen expression [243], as well as increased cartilage-specific biosynthesis [70,244], of
chondrocytes. Hydrostatic pressure applied within physiological levels has been beneficial [244247]; however, the effects of loading are highly dependent on the loading regimen [243] and
require much optimization.

Chondrocytes loaded at 10MPa and 1Hz for 4hours/day, 5

days/week, for up to 8 weeks showed an increase in collagen production and prevention of GAG
loss over static controls [247]. The benefits of hydrostatic loading were also noted in chondroinduced MSCs, where 0.1MPa of loading increased Sox 9 and aggrecan expression and 10MPa
of loading generated a maximum response for type II collagen, while matrix condensation was
observed with increasing hydrostatic pressure [245].

Hansen and colleagues reported that

chondrocytes loaded at 0.2MPa and 0.1Hz for 30/2 or 2/30 minutes of on/off loading showed
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inhibited proliferation and increased collagen secretion or increased proliferation and lowered
collagen expression, respectively [244].

3.4.4 Dynamic Compression
There is significant evidence that dynamic compressive loading has a stimulatory effect
on cartilage, chondrocytes, and stem cells. Chondrocytes exhibit compressibility and behavioral
changes with compressive load as a function of strain. Numerous loading regimes ranging from a
single application [248,249] to continuous loading [7,132,250,251] have been investigated as a
means to accelerate and improve tissue formation. In each case, loading regimes must be
optimized for cell type, seeding density, and scaffold. Recently Ng and colleagues attempted to
engineer a stratified cartilage construct with layered 2% and 3% agarose with dynamic loading
over 28 days. However, increased bulk mechanical and biochemical properties were only seen in
the 2% gel [252]. In addition, chondrocytes encapsulated in fibrin glue were not affected by
dynamic loading, even though loading has been shown to positively stimulated chondrocytes in
agarose [253].
Studies have shown catabolic and anabolic effects of compressive loading, hinting at a
structural remodeling effect of the newly synthesized matrix through loading [248]. A single
application of a uniaxial compressive load (1kPa, 1Hz, 30min) increased collagen and
proteoglycan synthesis and improved mechanical properties [249]. This single application of load
transiently increased MMP-3 and MMP-13 expression, and produced a catabolic change 2 hours
post-stimulation characterized by the release of proteoglycans and collagen into the culture
media.

This was followed by an anabolic change with an increase in type II collagen and

aggrecan expression 12 hours post-stimulation, indicating that cyclic loading has a remodeling
effect involving the mitogen-activated protein kinase (MAPK) pathway.
Furthermore, the addition of growth factors with loading appears to have a synergistic
effect. Mauck et al showed that stimulatory responses could be increased with the addition of
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TGF-β1 and IGF, including increased proteoglycan and collagen contents and equilibrium
aggregate modulus of chondrocytes cultured in agarose gels [123]. Furthermore, Chowdhury and
colleagues showed that TGF-β3 modulates cellular responses during dynamic loading via an
integrin mediated mechanotransduction, where the addition of the peptide GRGDSP, a
competitive ligand for α5β1 integrin binding, was able to reverse the compression-induced
stimulation [254]. However, one problem encountered with dynamic loading is the loss of newly
synthesized matrix proteins to the culture media [132].

3.4.5 Bioreactors
Bioreactors have been employed to accelerate and improve the growth of engineered
cartilage in vitro.

They serve to enhance nutrient transport and provide a hydrodynamic

environment that imposes a fluid-induced shear stress to promote the synthesis of cartilagespecific matrix proteins. Dynamic cell seeding of porous scaffolds, typically done in spinner
flasks, has led to faster adhesion and better cell distributions [120]. Though the effects are
scaffold dependent, chondrocyte-laden scaffolds grown in perfusion culture increased cell
proliferation and biochemical content compared to static culture [255,256]. For long-term in vitro
culture, low shear stresses stimulate ECM synthesis and deposition, yielding greater tissue
formation, while high shear stresses suppress GAG deposition.

In general, higher seeding

densities have enhanced GAG content, potentially due to cell-cell interactions [69,120], while
scaffolds seeded at low cell densities fail to elicit a response in bioreactor culture [257].
Bioreactors currently being investigated for cartilage tissue engineering include: a parallel-plate
bioreactor [258], rotating wall bioreactor [69], and a concentric cylinder bioreactor [259].
Recently, a newly developed wavy-wall bioreactor (WWB) has been shown to increase
chondrocyte proliferation and ECM deposition on PGA scaffolds over the common spinner flask
culture [260]. Compared to a spinner flask, the novel bioreactor reduces fluid shear stresses and
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increases axial mixing.

The addition of growth factors, like IGF-1, can also be used in

combination with bioreactors to further enhance matrix accumulation [227].

In the work presented in this dissertation, constructs were either cultured statically in vitro or
implanted subcutaneously in nude mice. One study utilized dynamic compression of formed
constructs. For experiments investigating mesenchymal stem cells, constructs were cultured in
the presence of transforming growth factor – β3 as an induction molecule.

3.5 Conclusions
Cell source, scaffolds, and signaling factors make up the tissue engineering triad. One of
the biggest challenges for cartilage tissue engineering is cell source.

Current work on

alternatives to chondrocytes is expanding, and the potential and limitations of fibroblasts and
stem cells are being explored. Novel biomaterials are being continuously developed and are
leading to unique interactions with cells through controlled biomaterial chemistry, structure, and
the addition of biological molecules.

Also, the incorporation of stimulatory factors such as

bioactive molecules, gene therapy, mechanical loading, and bioreactors are leading to enhanced
cartilage production. Ultimately, clinical translation and feasibility needs to be considered with all
of these approaches if a successful tissue engineered cartilage product is to make it through the
regulatory process and into patients.
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CHAPTER 4
Synthesis and Characterization of Methacrylated Hyaluronic Acid Hydrogels

(Adapted from: JA Burdick, C Chung, X Jia, MA Randolph, R Langer, “Controlled degradation and
mechanical behavior of photopolymerized hyaluronic acid networks,” Biomacromolecules, 2005, 6(1):
386-91)

4.1 Introduction
The choice of hyaluronic acid (HA) as the base material for this tissue engineering (TE)
scaffold is inspired by cartilage itself. Found natively in cartilage, hyaluronic acid is a linear
polysaccharide of alternating D-glucuronic acid and β-N-acetyl-D-glucosamine that functions as a
core molecule for the binding of keratin sulfate and chondroitin sulfate in forming aggrecan and
degrades primarily by hyaluronidases found within the body or through oxidative mechanisms to
yield oligosaccharides and glucuronic acid.

This natural polymer plays a role in cellular

processes like cell proliferation, morphogenesis, inflammation, and wound repair [1], and can
function as a bioactive scaffold, where cell surface receptors for HA (CD44, CD54, and CD168)
allow for cell/scaffold interactions. For TE, it can be readily modified through its carboxyl [2,3]
and hydroxyl groups [4-6] and polymerized to form 3D scaffolds in the form of hydrogels [7-9],
sponges [10], and meshes [11]. The HA scaffolds are biocompatible and can serve as delivery
vehicles for cells.
Photopolymerization is one approach to chemically crosslink hydrogels using ultraviolet
or visible light, and provides uniform cell seeding with both spatial and temporal control over
polymerization [12]. Since hydrogels are water-swollen networks, they are typically suitable for
the delivery of cells and bioactive agents, and can be used as injectable scaffolds, filling cartilage
defects of any size and shape in a minimally invasive manner. These scaffolds support the
transport of nutrients and waste, and can homogenously suspend cells in a 3D environment,
where encapsulated cells typically retain a rounded morphology. Elisseeff and coworkers [13]
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were the first to report the use of photopolymerization to suspend chondrocytes in hydrogels for
cartilage regeneration.

These efforts have focused primarily on photopolymerizable hydrogels

based on poly(ethylene glycol) (PEG). Careful screening of photoinitiating conditions has been
performed to optimize cell viability within these crosslinked networks [14].

Through this

screening, one specific initiating system that uses a water soluble initiator, 2-methyl-1-[4(hydroxyethoxy)phenyl]-2-methyl-1-propanone

(I2959)

at

0.05wt%,

was

found

to

be

cytocompatible, supporting a high viability of photoencapsulated chondrocytes. Later, Bryant and
Anseth showed that photocrosslinked scaffolds, spanning the thickness of native cartilage found
in vivo, could be fabricated while maintaining spatial uniformity of glycosaminoglycans, and that
the hydrogel properties (e.g. crosslinking density) influence both the mechanical properties of the
hydrogel and the production of collagen by encapsulated chondrocytes [12]. In addition, Setton
and coworkers[4] illustrated the ability to encapsulate articular chondrocytes in one
photopolymerizable HA network in vivo.
The objective of this study is to combine the benefits of a photocrosslinkable network with
the desirable properties of HA for future application in cartilage tissue engineering.

In this

chapter, the effects of HA molecular weight, the degree of methacrylation and macromer
concentration on the physical properties (e.g., swelling, mechanics, and degradation) of the
resulting hydrogels are systematically investigated. In addition, photoencapsulated cell viability
was investigated as a preliminary test for the potential use of photopolymerizable HA networks as
cell carriers for cartilage regeneration.

4.2 Materials & Methodology
4.2.1 Macromer Synthesis and Polymerization
Methacrylated HA (MeHA) was synthesized as previously described [6].

Briefly,

methacrylic anhydride (Sigma, ~20-fold excess) was added to a solution of 1 wt% HA (Lifecore,
MW = 50kDa, 350kDa, 1100kDa) in deionized water, adjusted to a pH of 8 with 5 N NaOH
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(Aldrich), and reacted on ice for 24 hours (Figure 4.1A). The macromer solution was purified via
dialysis (MW cutoff 5-8kDa) against deionized water for a minimum of 48 hours with repeated
changes of water. The final product was obtained by lyophilization and stored at -20°C in powder
form prior to use.

1

H NMR (Bruker Advance 360 MHz, Bruker) was used to determine the final

functionality and purity of the macromer (Figure 4.1B).

Percent modification (Table 4.1) was

determined by the integration and comparison of methacrylate peaks to HA backbone peaks (Figure 4.1).

Figure 4.1 (A) Synthetic Scheme of MeHA. (B) 1H NMR of MeHA macromer in D2O. The HA
backbone consists of 10 protons, while a, b, and c represent protons associated with
methacrylate alkene (2 protons), the methyl group on the methacrylate (3 protons), and the
methyl group on HA (3 protons).
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Hydrogels were fabricated by dissolving the MeHA macromers at various concentrations
(2, 5, 10, 20 wt%) in phosphate buffered saline (PBS) containing 0.05 wt% I2959 (Ciba).
Macromer solutions were pipetted between glass slides with a 1 mm spacer and polymerized with
the addition of ~4 mW/cm2 ultraviolet light for 10 minutes using a long-wave ultraviolet lamp
(Model 100AP, Blak-Ray). A general schematic of the free radical polymerization of MeHA to
form crosslinked hydrogel networks is illustrated in Figure 4.2.

O

+

MeHA

O

OH

hv, 10 min

HO

0.05wt% I2959

Hydrogel

Figure 4.2 A general schematic of the free radical polymerization of MeHA to form crosslinked
hydrogel networks. This process involves the formation of radicals from the exposure of the
initiator to light, which propagate through the vinyl groups of the MeHA to form kinetic chains
(shown as dashed lines). These networks eventually degrade by enzymatic cleavage of the HA
backbone.

4.2.2 Hydrogel Characterization
After polymerization, hydrogels were swollen in PBS for 48 hours to equilibrium, weighed
(wet weight), and dried (dry weight) to determine volumetric swelling ratio (QV) (n=3). QV is
determined by:
Eq. 4.1

QM = (wet weight / dry weight)

Eq. 4.2

Qv = 1 + (ρP/ρS) × (QM -1),

where ρP is the density of the dry polymer (1.23 g/cm3) and ρs is the density of the solvent (1
g/cm3)16.
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The average molecular weight between crosslinks (Mc) can then be calculated using the FloryRehner equation:
Eq. 4.3

Qv5/3 ≅ (v Mc)/V1 × (0.5 - Χ) [15,16],

where v is the specific volume of polymer (for HA in water at 37ºC: v = 0.547 cm3/g) [17], Mc is the
average molecular weight between crosslinks, V1 =is the molar volume of the solvent (for H2O: V1
= 18 mol/cm3), and Χ is the Flory polymer-solvent interaction parameter.

Assuming HA is

comparable to dextran and differences between soluble, unmodified HA and crosslinked HA is
negligible, Χ = 0.473[18]. In addition, effective crosslinking density and theoretical mesh size can
be estimated using:
Eq. 4.4

vc = effective crosslinking density = ρP/ Mc

Eq. 4.5

ξ = mesh size (nm) = 0.1748 (Mc)1/2 Qv1/3 [18,19].

Samples (n=5) for mechanical testing (~2 mm height, ~7 mm diameter) were compressed
at a strain rate of 10% initial thickness/min until 60% of the initial thickness or failure on an Instron
5542 mechanical tester using a parallel plate apparatus.

The compressive modulus was

determined as the slope of the stress versus strain curve at low strains (<20%).
For degradation studies, polymer disks (1 mm thickness, 9 mm diameter) were punched
from hydrogel slabs using stainless steel bores. Samples (n = 3) were degraded in solutions of
either 10 or 100 U hyaluronidase (Sigma)/ml PBS (replaced every 48 hours throughout the study
and stored frozen until analysis) at 37ºC on an orbital shaker. The amount of uronic acid (a
degradation component of HA) released during degradation was measured using a previously
established carbazole reaction technique[20].

Briefly, 100μl of the degradation solution was

added to a concentrated sulfuric acid/sodium tetraborate decahydrate (Sigma) solution and
heated to 100°C for 10 minutes. After adding 100μl of 0.125% carbazole (Sigma) in absolute
ethanol and heating to 100°C for 15 minutes, the solution absorbance at 530 nm was measured.
The amount of uronic acid was determined using solutions of known concentrations of the 50 kDa
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HA as a standard. Degradation products were also analyzed with 1H NMR to determine if any
unreacted or partially reacted monomer was present.

4.2.3 Cell Viability
For cell encapsulation, lyophilized macromer was sterilized using a germicidal lamp in a
laminar flow hood for 30 minutes prior to dissolving in a sterile solution of PBS containing 0.05
wt% I2959 for polymerization.

This technique was used for sterilization because higher

concentrations of MeHA solution were too viscous to filter sterilize. As an initial assessment of
viability, 3T3-fibroblasts (ATCC, p=5) were suspended in 50μl of the sterile macromer solution at
a concentration of 40x106 cells/ml and polymerized with the addition of ~4 mW/cm2 ultraviolet
light for 10 minutes using a long-wave ultraviolet lamp. Viability of photoencapsulated fibroblasts
was assessed immediately after encapsulation and after 1 week of in vitro culture (DMEM, 10%
fetal bovine serum, Invitrogen) using a commercially available MTT viability assay (ATCC).
Briefly, 100μl of MTT reagent (tetrazolium salt solution) was added to each well and incubator at
37°C for 4 hours. The purple formazen produced by active mitochondria was solubilized by
construct homogenization in 1 ml of the detergent solution and orbital shaking for 2 hours. The
absorbance was then read at 570nm (Molecular Devices SpectraMax 384).

4.2.4 Statistical Analysis
Statistical analysis was performed using a Student’s t-test (only to compare two individual
samples) with a minimum confidence level of 0.05 for statistical significance. All values are
reported as the mean and standard error of the mean.

78

4.3 Results & Discussion
4.3.1 Network Synthesis
HA networks were fabricated from MeHA precursors with varying molecular weights and
methacrylations and with different MeHA concentrations to determine the range of properties
possible for these potentially useful biomaterials.

As illustrated in Figure 4.2, the MeHA

macromers undergo a free radical polymerization with the addition of light and an initiator to form
a crosslinked hydrogel that consists of HA and kinetic chains of poly(methacrylic acid). The
various MeHA solutions investigated in this work are summarized in Table 4.1.

Table 4.1 Hydrogel Compositions
Macromer MW (kDa)

% Methacrylation*

Macromer wt%

1100

6

2

350

7

2
5
2

50

12

5
10
20

1

*Determined by H NMR

Although the MeHA macromers were synthesized using the same techniques and with
the same concentrations of HA and methacrylic anhydride, a slightly higher methacrylation was
obtained with the 50 kDa HA. This is potentially explained due to decreased viscosity during this
reaction compared to the 350 and 1100 kDa HA, increasing the mobility of various species during
the reaction.

The macromer concentrations investigated were chosen as the highest

concentrations of MeHA that could still be pipetted into molds or for suspending cells.

For

instance, this was only possible up to 2 wt% of the 1100 kDa MeHA macromer, but was possible
for a 10-fold higher amount of the 50 kDa macromer, allowing for a wider range of network
properties.
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4.3.2 Network Swelling, Mechanics, and Degradation
The equilibrium volumetric swelling ratio of the various HA networks are shown in Figure
4.3. As expected, a decrease in QV is seen with an increase in the concentration of macromer in
the precursor solutions. For example, QV is ~41 for networks fabricated from 2 wt% of the 50 kDa
macromer, but decreases to ~8 when the macromer concentration is increased 10-fold to 20 wt%.
The same trend is seen for the 350 kDa macromer. For each of the molecular weights, there is a
statistically significant (p>0.05) decrease in QV with an increase in macromer concentration, but
there were no statistical differences between the different MeHA molecular weights when the
same concentration of macromer was used for network formation.

Using Flory-Rehner

calculations[15], the network mesh size and the crosslinking density, which are important when
explaining mechanics and degradation, are directly correlated to QV (Table 4.2).

Table 4.2 Mesh Size
Macromer MW
(kDa)

Macromer wt%

1100

2

Mesh Size
(nm)
400 ± 60

2

486 ± 6

5

270 ± 26

2

470 ± 40

5

279 ± 6

10

171 ± 8

20

71 ± 2

350

50

Figure 4.3 QV for various photocrosslinked HA networks. Statistical difference (p<0.05) between
groups is denoted by *.

The general slope of the stress-strain data is linear at low strains (<20%) and then
increases with an increase in strain. Overall, the modulus (i.e., slope of stress versus strain curve
at low strain) correlates well with the network crosslinking density (i.e., swelling).

As the
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macromer concentration increases for each of the MeHA molecular weights, a statistically
significant increase in the modulus is seen. For instance, networks fabricated from 2 wt% of the
50 kDa macromer had a modulus of only ~12 kPa, but increased substantially to ~100 kPa when
the macromer concentration was increased to 20 wt%. These follow trends with the network
mesh size with a decrease in the mesh size corresponding to an increase in the compressive
modulus.

Figure 4.4 (A) Representative stress versus strain plots of hydrogels fabricated from 10 (solid)
and 5 (dotted) wt% macromers (50 kDa MeHA).

(B) Compressive modulus for various HA

networks at equilibrium swelling. Statistical difference (p<0.05) between groups is denoted by *.

The hyaluronidase degradation of HA results in the cleavage of internal beta-N-acetyl-Dglucosaminidic linkages, which yields fragments with N-acetyl-glucosamine at the reducing
terminus and glucuronic acid at the non-reducing end. In the body, these hyaluronidases are
located in lysosomes and are most active at low pH levels. Because predicting the quantity or
concentration of hyaluronidase that is active in specific locations in the body is not feasible, the
chosen enzyme concentrations (100 U hyaluronidase/ ml of PBS) served merely to illustrate the
trend of HA network degradation in relation to changes in molecular weight and macromer
concentration overall time (Figure 4.5).
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A

B

C

Figure 4.5 (A) Time for complete degradation of HA hydrogels in 100 U hyaluronidase/ml of PBS,
where the hyaluronidase was replenished every other day throughout degradation. (B)
Cumulative percentage of uronic acid detected for HA hydrogels formed from 2 (●), 5 (), and 10
(▲) wt% of the 50 kDa MeHA and degraded in 100 U hyaluronidase/ml.

(C) Cumulative

percentage of uronic acid detected for HA hydrogels formed from 5 wt% 350 kDa MeHA and
degraded in both 100 (●) and 10 () U hyaluronidase/ml.

In general, the swollen networks decreased in size throughout the degradation and
exposure to the hyaluronidase.

This behavior was previously seen for other crosslinked
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hyaluronic acid hydrogels [21].This is potentially due to both an increase in erosion at the surface
of the gels due to diffusion restrictions of the enzyme into the interior of the gel (particularly with
networks with higher crosslinking densities) and an attraction of the positive amine groups
produced during degradation and the negatively charged carboxylic acid groups of the HA.
Again, there was good correlation between degradation time and the hydrogel crosslinking
density. An increase in macromer concentration extended the time for complete degradation in a
dose-dependant fashion. Also, no measurable double bonds were found during NMR analysis of
the degradation products, indicating that the radical polymerization reaches near 100%
conversion with the initiation conditions used (i.e., 10 minutes, 10 mW/ cm2, 0.05wt% I2959). It
should be noted that the degradation products are not simply HA fragments, but HA fragments
attached to kinetic chains from the radical polymerization of the methacrylate groups, which could
influence any potential biological activity and metabolic catabolism of the degradation products.
The amount of uronic acid (a component of HA) in the degradation solutions is shown in
Figure 4.5 (B and C) and plotted as the overall percentage of uronic acid detected with
degradation time. For networks formed with the 50 kDa MeHA macromer, an increase in the
macromer concentration (i.e., crosslinking density) extended the time for complete uronic acid
release.

For the 5 wt% HA network, ~40% of uronic acid is detected within two days of

degradation and then a near linear release of uronic acid is observed until complete degradation.
For the 10 wt% HA network, ~50% of the uronic acid is detected in the first 5 days of degradation,
yet degradation extends to almost 20 days. A burst is observed at the end of degradation, due to
the rapid solubilization of kinetic chains and HA when the network becomes loosely crosslinked.
The rapid uronic acid release at short degradation periods could be due to the release of HA with
low methacrylation, as a distribution of methacrylations is expected throughout the MeHA
macromers. As seen in Figure 4.5C, the overall time and rate of hydrogel degradation is faster
with a higher enzyme concentration (100 versus 10 U/ml).
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4.3.3 Cell Encapsulation and Viability
3T3-fibroblasts were encapsulated in the various networks and their viability was
determined both immediately after encapsulation and after 1 week of in vitro culture. These
results are shown in Figure 4.6.

Figure 4.6 Viability of photoencapsulated 3T3-fibroblasts in the HA hydrogels.

Absorbance

(indicative of encapsulated cell mitochondrial activity and viability) for the various HA networks
after 1 day (black) and 1 week (white) of in vitro culture. The MTT solution was diluted 4-fold for
all samples to obtain absorbance values in the linear range. The absorbance is statistically
different (denoted by * between two bars) between the different macromer concentrations for the
50 kDa MeHA at the 1 week time point.

Immediately after polymerization, a range of fibroblast viability is noted, with a decrease
in viability as the macromer concentration increased. This could potentially be attributed to an
increase in the radical concentration during encapsulation due to an increase in the reactive
group concentration (i.e., methacrylates) in the precursor solutions with higher macromer
concentrations. The reduction in MeHA molecular weight did not seem to affect the viability of the
encapsulated cells. After 1 week of culture, a further decrease in viability is seen with many of
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the macromer solutions, especially with the more highly crosslinked ones.

For the 50 kDa

macromer, a statistically significant decrease in viability is found with each increase in macromer
concentration. The high crosslinking density can decrease the ability of nutrients and wastes to
be exchanged between the encapsulated cells and surrounding culture media and lead to
compromised cell viability. In general, the highest and sustained viability was observed in both
the 1100 kDa and 50 kDa macromers at 2 wt%. Overall, these results indicate that although the
higher macromer concentrations led to desirable mechanical properties, their application as cell
carriers is limited due to low viability of photoencapsulated cells.

4.4 Conclusions
This work presents a systematic study of the ability to fabricate photopolymerizable HA
networks with a wide range of properties. Specifically, alterations in the HA molecular weight
allowed high macromer concentrations to be incorporated in the precursor solution, leading to
networks with high crosslinking densities. Although networks with a compressive modulus over
100 kPa were formed, the viability of fibroblasts in these networks was compromised potentially
due to restrictions in nutrient transport through the network and a high radical concentration
during polymerization. However, in the less crosslinked networks, viability was sustained. The
variability in macromer molecular weight at concentrations that promoted cell viability will allow for
a wide variety of precursor solution viscosities, which will be important for clinical and noninvasive implantation of these gels.
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CHAPTER 5
Optimization of Methacrylated HA Hydrogel Properties for Neocartilage
Formation by Auricular Chondrocytes
(Adapted from: C Chung, J Mesa, MA Randolph, M Yaremchuk, JA Burdick, “Influence of Gel
Properties on Neocartilage Formation by Auricular Chondrocytes Photoencapsulated in Hyaluronic
Acid Networks,” J Biomed Mater Res A, 2006, 77(3): 518-25)

5.1 Introduction
Cells have the ability to sense their environment, where physical and chemical cues can
dictate cell morphology, viability, and metabolism. Chondrocytes are no exception as they have
been shown to differentially respond to scaffolds of varying chemistry [1-3], architecture [4], and
stiffness [5], as well as to external mechanical stimulation [6-9].

The addition of bioactive

molecules (e.g., chondroitin sulfate, hyaluronic acid) to the relatively inert synthetic scaffolds
resulted in up-regulation of cartilage specific genes and glycosaminoglycan (GAG) and collagen
matrix production [2,3], demonstrating that scaffold chemistry can regulate cell function.
Furthermore, the addition of bioactive molecules also alters chondrocyte response to mechanical
stimulation.

In a study by Appelman et al, various proteins were conjugated within PEG

hydrogels and exhibited differential chondrocyte responses when mechanically stimulated [10].
Extensive work with poly(ethylene glycol) (PEG) hydrogels has shown that increased
crosslinking density can compromise cell viability and limit cell proliferation [4].

Restricted

diffusion of nutrients and waste may contribute to a decrease in viability, while physical
restrictions of encapsulated chondrocytes may inhibit cell proliferation.

Similarly, increased

crosslinking density can also limit the diffusion of extracellular matrix (ECM) proteins resulting in
pericellular accumulation.

When mechanically loaded, increased crosslinking density in the
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hydrogel can yield greater cell deformations, which can lead to changes in mechanically
transduced signaling pathways [6].
Tied hand in hand with crosslinking density in many hydrogel systems are volumetric
swelling ratio and mechanical properties. Lower crosslinking densities yield higher swelling ratios
that can improve the diffusion of newly synthesized glycosaminoglycans (GAGs). Surprisingly, in
a study by Bryant and Anseth, PEG hydrogels with moduli of 360 kPa showed increased type II
collagen synthesis compared to hydrogels with moduli of 960 and 30 kPa.

This study also

demonstrated that the addition of degradable components was able to increase type II collagen
synthesis and distribution of GAGs within the hydrogel [11]. Thus, in optimizing cartilage tissue
engineering (TE) scaffolds, the critical balance of hydrogel swelling, mechanics, and degradation
must be found.
In the previous chapter, we showed that by altering hyaluronic acid (HA) macromer
concentration and molecular weight, the properties of the hydrogel can be varied. As properties
of a scaffold can affect cell morphology, viability, proteoglycan biosynthesis, and ECM
distribution, this chapter investigates how these same changes in the network structure and
properties influence the ability of photoencapsulated chondrocytes to produce cartilaginous tissue
in

vivo.

To

accomplish

this,

auricular

chondrocytes

were

harvested

from

swine,

photoencapsulated in the various HA hydrogels, and implanted subcutaneously in nude mice.
Biochemical assays and histological analysis were then used to compare cartilage production
between the various hydrogels.
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5.2 Materials & Methodology
5.2.1 Macromer Synthesis and Polymerization
Methacrylated hyaluronic acid (MeHA) was synthesized as described in Chapter 4
(section 4.2). For cell encapsulation, MeHA of varying molecular weights (50 kDa, 350 kDa, 1100
kDa) was sterilized with exposure to the germicidal lamp in a laminar flow hood for 30 minutes
and dissolved in a sterile solution of PBS containing 0.05 wt% I2959 (Ciba).

5.2.2 Chondrocyte Isolation and Photoencapsulation
Swine aged 3 to 6 months were euthanized using an overdose of Pentobarbital (100
mg/kg IV) and auricular cartilage tissue was harvested in a sterile fashion from the ears of the
swine. The harvested cartilage was cut into ~1mm3 pieces, washed in PBS, and digested for 18
hours at 37ºC in a sterile 0.1% collagenase (Worthington) solution in Ham’s F-12 medium. After
digestion, the solution was passed through a 100 μm filter to remove undigested cartilage and
centrifuged to obtain a chondrocyte pellet. The chondrocytes were washed twice with PBS,
counted using a hemacytometer, and determined viable using the trypan blue exclusion dye test
prior to encapsulation. Chondrocytes (40 × 106 cells/ml) were photoencapsulated in the various
hydrogel networks by suspension in a solution of 2, 5, 10, and 20 wt% macromer (MeHA)
containing 0.05 wt% I2959.

Solutions were pipetted into sterile molds (50 μl volume) and

polymerized with ~4 mW/cm2 ultraviolet light for 10 minutes using a long-wave ultraviolet lamp
(Model 100AP, Blak-Ray). These conditions were previously determined to be cytocompatible for
the photoencapsulation of chondrocytes[12].

A general schematic of the chondrocyte

photoencapsulation process and subsequent analysis is depicted in Figure 5.1. Auricular and
articular cartilage were harvested from the same source and used as controls for biochemical
analysis.
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Figure 5.1 General schematic of the photoencapsulation process and subsequent analysis.

5.2.3 Implantation in Nude Mice
Nude mice were anesthetized with ketamine (80 mg/kg) and xylazine (12 mg/kg). A 2 cm
midline incision was made on the back of each mouse and 4 subcutaneous pockets were made
using blunt dissection. A chondrocyte/hydrogel construct was placed in each of these pockets
and the wound was closed with sterile stainless steel skin clips. After 6 and 12 weeks, mice were
euthanized and constructs were harvested for analysis. NIH guidelines for the care and use of
laboratory animals (NIH Publication #85-23 Rev. 1985) were observed.

5.2.4 Biochemical Analysis
For biochemical analysis (n = 4), constructs were weighed initially (wet weight),
lyophilized and weighed again (dry weight).

Samples were digested in a papain solution (125

μg/ml papain type III, 10 mM l-cysteine, 100 mM phosphate, and 10 mM EDTA at pH 6.3) for 15
hours at 60ºC. Total DNA content was determined using a PicoGreen dsDNA Assay[13] with
chondrocyte number determined using a conversion factor of 7.7 pg of DNA per chondrocyte [14].
Briefly, 10μl of sample were combined with 90μl of 1xTris-HCl, EDTA buffer (pH 7.5) and 100μl of
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picogreen solution, mixed, and incubated with 3 minutes.

Fluorescence was read using a

microplate reader (ex: 480nm, em: 520nm). Total GAG content was determined using the
dimethylmethylene blue (DMMB) dye method [15] with chondroitin sulfate as a standard. Briefly,
5μl of each sample was combined with 200μl of DMMB dye (8mg 1,9 dimethylmethlene blue,
2.5ml ethanol, 1g sodium formate, and 1ml formic acid in 500ml of DI water), and absorbance
was read in a 96-well microplate reader at a wavelength of 525nm to determine GAG content.
Total collagen content was determined using the hydroxyproline assay [16], with a collagen to
hydroxyproline ratio of 7.25 [17,18]. Samples were hydrolyzed in 6N HCl for 16 hours overnight
at 110°C. HCl was evaporated with nitrogen and the hydrolyzate was reconstituted with DI water.
Sample was then combined with chloramine-T solution (1.41g chloramines-T, 10ml DI water,
10ml n-propanol, 80ml OHP buffer (25g citric acid.H2O, 12ml acetic acid, 60g sodium
acetate.3H2O, 12g sodium hydroxide, 600ml DI water, 150ml n-propanol, pH 6.0)), and incubated
at room temperature for 20 minutes. This was then followed by the addition of p-DAB solution
(15g p-dimethyl-amino-benzaldehyde, 60ml n-propanol, 26ml percloric acid) and incubation at
60°C for 15 minutes. Absorbance was read in a microplate reader at a wavelength of 550nm for
hydroxyproline content. Values reported for GAG and collagen contents were normalized to
construct wet weight.

5.2.5 Histological Analysis
For histological analysis, constructs were fixed in 10% formalin for 24 hours, embedded
in paraffin, and processed using standard histological procedures. The histological sections (7
μm thick) were stained with hematoxylin and eosin to observe the morphology and distribution of
encapsulated chondrocytes and Safranin O to visualize glycosaminoglycans (GAG). Type I and
type II collagen distributions were detected using a Vectastain Universal Elite ABC Kit (Vector
Laboratories) and a DAB Substrate Kit for Peroxidase (Vector Laboratories).

Sections were

predigested in 0.5 mg/ml hyaluronidase for 30 min at 37ºC and incubated in 0.5 N acetic acid for
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4 hours at 4ºC prior to overnight incubation with primary antibodies at dilutions of 1:200 and 1:3
for type I (mouse monoclonal anti-collagen type 1, Sigma) and type II collagen antibodies (mouse
monoclonal anti-collagen type II, Developmental Studies Hybridoma Bank), respectively.

5.2.6 Statistical Analysis
Anova with Tukey’s post-hoc test was used to determine significant difference among
groups, with p < 0.05. All values are reported as the mean ± the standard deviation.

5.3 Results & Discussion
Photocrosslinkable hyaluronic acid hydrogels were investigated in this study as carriers
for auricular chondrocytes for cartilage regeneration.

In the fabrication of these hydrogels,

several factors including the molecular weight of the HA, the acrylation percentage, and the
concentration of the HA in the prepolymer solution can influence the properties of the resulting
construct. The previous chapter investigated the fabrication of these networks and illustrated the
wide range of hydrogel properties that can be obtained. Auricular chondrocytes were used in this
study to investigate the influence of hydrogel properties on neocartilage formation, which has
direct implications for plastic surgery applications and also a consideration for articular cartilage
regeneration. Auricular cartilage is easily harvested with little donor-site morbidity and auricular
chondrocytes can be obtained at yields twice as high as articular chondrocytes[19]. Proliferating
approximately four times faster than articular chondrocytes in monolayer culture, auricular
chondrocytes have also been shown to express high levels of type II collagen and
glycosaminoglycans when implanted in vivo in 3-dimensional scaffolds[19].
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5.3.1 Macroscopic Appearance
After 12 weeks, the macroscopic appearance (Figure 5.2) of the constructs varied
dramatically depending on the prepolymer solution (e.g., macromer molecular weight and
concentration) used for encapsulation.

Figure 5.2 Explanted HA constructs 12
weeks after subcutaneous implantation
in nude mice.

Specifically, constructs fabricated from 2wt% of the macromers were noticeably more
opaque, exhibiting a white, shiny appearance, compared to those fabricated with higher
macromer concentrations, which remained relatively translucent. Restrictions in nutrient transport
through the construct and high radical concentration during polymerization potentially
compromised cell viability, growth, and ECM production in these higher wt% hydrogels.

In

addition, the 2wt% 350 and 1100 kDa hydrogels exhibited a noticeable increase in size after the
12 weeks of subcutaneous culture in nude mice, which may be due to a lower degree of
methacrylation modification, whereas the 2 wt% 50 kDa hydrogel more closely maintained initial
construct dimensions (i.e., 5 mm diameter).

5.3.2 Biochemical Analysis
The water content of the explanted constructs was determined from wet and dry weights
(Figure 5.3). In general, constructs exhibited a decrease in water content from 6 weeks to 12
weeks, where a significant decrease was noted for the 2wt% 1100, 350, and 50 kDa constructs.
The observed decrease in water content is likely due to increased tissue formation (e.g., cell
proliferation and extracellular matrix deposition) within the construct. Of the 12 week explants,
94

the 2 wt% 50 kDa construct (81±2.7% water) was most comparable to auricular (74±2.4% water)
and articular (79 ± 5.1% water) cartilage, and no statistically significant differences were found
between the values.

Water Content (%)
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Figure 5.3 Water content of HA constructs after 6 (black) and 12 (white) weeks of subcutaneous
culture in nude mice (n=4). Significant decrease (p<0.05) in water content for the 50 kDa, 2wt%
constructs from 6 to 12 weeks. All groups were significantly different from native auricular and
articular cartilage at 12 weeks with the exception of the 50 kDa, 2wt% group.

The total DNA content was determined for all harvested constructs and converted into
numbers of chondrocytes per sample (Figure 5.4). The 2wt% constructs exhibited an increase in
chondrocyte number from 6 to 12 weeks, indicating cellular proliferation with culture time.
Constructs with macromer concentrations greater than 2 wt% showed little cell growth, potentially
due to compromised cell viability during encapsulation or higher crosslinking densities that can
limit 3-dimensional cell proliferation.

The 2wt% constructs appeared to support the greatest

number of chondrocytes regardless of molecular weight, where the 2 wt% 50 kDa constructs had
the greatest number of chondrocytes at ~600,000 cells per sample after 12 weeks. Values were
also normalized to sample wet weight for comparison to control auricular and articular cartilage
(not shown).

The 2 wt% 50 kDa constructs exhibited the greatest amount of DNA per wet
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weight, which was approximately 80 and 87% of that found for native auricular and articular
cartilage, respectively. No significant differences were detected for the 2 wt% 1100 kDa and 2
wt% 50 kDa hydrogels when compared to auricular and articular cartilage for the normalized DNA
values. Hydrogels (2 wt% 50 kDa) without encapsulated cells served as a control and exhibited
minimal fluorescence, comprising less than 3.5% of any sample.
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Figure 5.4 Number of chondrocytes per sample for HA constructs after 6 (black) and 12 (white)
weeks of subcutaneous culture in nude mice (n=4).

For the 12 week explants, the 2 wt%

constructs showed a statistical difference (p<0.05) from constructs with higher macromer
concentrations.

GAG content was measured in the explanted constructs and is reported as the quantity
of chondroitin sulfate normalized to sample wet weight (Figure 5.5).

The GAG content in

constructs increased from 6 to 12 weeks, where the 2 wt% 1100 and 50 kDa constructs showed
the greatest amount of GAGs (0.049 ± 0.007 and 0.049 ± 0.005 μg GAGs/μg

wet weight,

respectively) after 12 weeks of culture. This value is approximately 80% and 53% of the GAG
content found in native auricular and articular cartilage, respectively. There was no significant
difference between GAG production by chondrocytes encapsulated in the 2 wt% networks formed
from both the 1100 and 50 kDa macromers compared to native auricular cartilage. Virtually no
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measurable GAGs were found in the hydrogels fabricated from the higher macromer
concentrations (5 to 20wt%). HA hydrogel controls showed little GAG detection and were similar
to control hydrogels formed from a non-polysaccharide PEG hydrogel [20].
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Figure 5.5 Glycosaminoglycan content of HA constructs normalized to construct wet weight after
6 (black) and 12 (white) weeks of subcutaneous culture in nude mice (n=4).

The 2 wt%

constructs are statistically different (p<0.05) from those with higher macromer concentration after
both 6 and 12 weeks.

As a final quantification of biochemical content, the amount of collagen in the explanted
constructs was determined by the hydroxyproline content and is normalized to sample wet weight
(Figure 5.6). Similar to the GAG content, the majority of the constructs exhibited an increase in
collagen content from 6 to 12 weeks.

The 2 wt% 50 kDa construct is statistically different

(p<0.05) from all of the samples after 6 weeks and showed the greatest amount collagen content
(0.0658 ± 0.0161 μg collagen/μg wet weight) after 12 weeks. This value represents ~65% and
~74% of the total collagen that was found in control samples of auricular and articular cartilage,
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respectively. Again, only small amounts of collagen were detected in the hydrogels fabricated
from the higher macromer concentrations (5 to 20 wt%).
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Figure 5.6 Total collagen content of HA constructs normalized to construct wet weight after 6
(black) and 12 (white) weeks of subcutaneous culture in nude mice (n=4). The 2 wt% constructs
are statistically different (p<0.05) from those with higher macromer concentration after 12 weeks.

5.3.3 Histological Analysis
Representative stains for GAG, type I collagen, and type II collagen are shown in Figure
5.7 for several constructs harvested 12 weeks after implantation. Specifically, the histology is
shown for the two compositions that looked the most promising both macroscopically and
biochemically (i.e., 2 wt% of 1100 and 50 kDa macromers) and, for contrast, a sample that
showed little production of extracellular matrix (10 wt% 50 kDa macromer). Unfortunately, the
hydrogels exhibit background staining for HA when using the Safranin O stain, but the images still
capture the large production of GAGs after 12 weeks in vivo and illustrate the morphology and
distribution of the cells.
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Figure 5.7 Representative histological sections of 2 wt% 1100 kDa, 2 wt% 50 kDa, and 10 wt%
50 kDa constructs stained for glycosaminoglycans, type I collagen, and type II collagen after 12
weeks of subcutaneous culture in nude mice. Scale bar = 100 μm.

In constructs fabricated with a 2 wt% macromer solution, chondrocytes are evenly
distributed and appear viable throughout the gels. In contrast, morphology indicative of cell death
is evident in constructs fabricated with higher macromer concentrations (5 to 20 wt%) as
illustrated by the 10 wt% 50 kDa construct. GAG staining is found abundantly throughout the
histological sections, including the pericellular regions surrounding the cells in the 2 wt%
hydrogels. The representative stains for type I and type II collagen support results observed in
the biochemical analysis, where more intense staining is observed in the 2 wt% 1100 and 50 kDa
constructs in contrast to the other samples. Though light staining for type I collagen is observed
sporadically throughout the 1100 kDa sample, type II collagen appears more abundant. The lack
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of type II collagen staining in certain regions of the 2 wt% 1100 kDa construct is potentially due to
cell clustering, as the highly viscous precursor solution may have prevented an even cell
distribution. For the 2 wt% 50 kDa sample, viscosity did not play a hindering role, and an even
distribution of type II collagen is found throughout the constructs, while no staining for type I
collagen is present. Again, no staining is observed in the 5 to 20 wt% 50kDa samples for either
type I or type II collagen, illustrating the lack of ECM production in these constructs.

5.4 Conclusions
Overall, this chapter illustrates the importance of HA hydrogel structure for both the
quality and distribution of tissue produced by encapsulated cells. After screening several factors,
the results indicate that hydrogels formed from 2 wt% of the 50 kDa macromer supported the
greatest amount of biochemical components and the best distribution of extracellular matrix
components. The enhanced neocartilage production in the 2 wt% hydrogels may be due to: (i) a
lower radical concentration during the polymerization of the 2 wt% hydrogels than for higher
macromer concentrations, which may increase cell viability, (ii) an increase in nutrient and waste
transport with a more loosely crosslinked hydrogel, and (iii) more rapid hydrogel degradation with
a larger hydrogel mesh size, which may increase the distribution of extracellular matrix
components. Additionally, the low viscosity of the 2 wt% solution makes it more amenable not
only in the distribution of encapsulated chondrocytes, but also clinical application of these gel
solutions through arthroscopic techniques.
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CHAPTER 6
Effects of Chondrocyte Expansion on Neocartilage Formation
in Hyaluronic Acid Hydrogels
(Adapted from: C Chung, J Mesa, GJ Miller, MA Randolph, Gill TJ, JA Burdick, “Effects of Auricular
Chondrocyte Expansion on Neocartilage Formation in Photocrosslinked Hyaluronic Acid Networks,”
Tissue Eng, 2006, 12(9): 2665-73)

6.1 Introduction
Chondrocytes, native inhabitants of cartilage tissue, are the natural selection as a TE
scaffold cell source. However, comprising only 10% of cartilage tissue by wet weight, these
harvested cells need to be expanded in vitro to provide the quantity of cells acceptable for
adequate repair using a TE scaffold. Unfortunately, for rapid expansion in monolayer culture,
chondrocytes isolated from both articular and auricular cartilage have been shown to
dedifferentiate, losing their chondrogenic phenotype [1,2].

Originally rounded in shape,

chondrocytes flatten and take on a more fibroblastic phenotype with in vitro expansion [2,3].
Additionally, when chondrocytes are removed from their extracellular matrix (ECM) environment,
a decrease in type II collagen and an increase in type I collagen are seen [4], leading to a
mechanically inferior fibrocartilage tissue.

Although dedifferentiation seems inevitable in

monolayer culture, some studies have shown slower dedifferentiation, stabilization of the
differentiated phenotype, or even redifferentiation (i.e., return to a chondrocytic phenotype after
dedifferentiation) when chondrocytes are cultured under conditions such as in liquid
suspension[5], agarose [1], alginate [6], or methacrylated HA hydrogels [7].
In chapter 5, we showed retention of the chondrogenic phenotype by auricular
chondrocytes when photoencapsulated in 2 wt%, 50 kDa hyaluronic acid (HA) hydrogels, which
exhibited continued glycosaminoglycan and type II collagen production [8].

Auricular cartilage

proves to be a promising cell source for cartilage regeneration for applications in plastic surgery
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and potentially for articular surface repair. Auricular chondrocytes are easily harvested with little
donor-site morbidity and can be obtained at yields twice as high as articular chondrocytes [9] and
proliferate approximately four times faster than articular chondrocytes when grown in monolayer
culture[10]. Additionally, when implanted in vivo on three-dimensional scaffolds, primary auricular
chondrocytes

have

been

glycosaminoglycans [9].

shown

to

express

high

levels

of

type

II

collagen

and

Furthermore, auricular chondrocytes have been successfully

encapsulated in a variety of materials such as poly(glycolic acid )[11,12], alginate [13],
chitosan[14], and Pluronic F127 [15], and have been shown to produce extracellular matrix and
form neocartilage.

In a study by Xu et al[16] auricular chondrocytes encapsulated in fibrin

polymer exhibited the highest equilibrium modulus compared to those encapsulated with articular
and costal chondrocytes.
The overall objective of this study was to examine the effects of in vitro expansion of
auricular chondrocytes on neocartilage formation in a previously optimized HA hydrogel. This
work also allows more insight into the potential use of auricular chondrocytes as a cell source for
cartilage regeneration. To accomplish this, initially isolated (p = 0) and expanded (p = 1 and p =
2) swine auricular chondrocytes were photoencapsulated in a HA hydrogel, implanted
subcutaneously in nude mice for 12 weeks, and explanted for mechanical, biochemical, and
immunohistochemical analysis with comparisons to controls of the HA gel alone and native
cartilage tissue.

6.2 Materials & Methodology
6.2.1 Macromer Synthesis and Polymerization
Methacrylated hyaluronic acid (MeHA) was synthesized as described in Chapter 4
(section 4.2). 50 kDa MeHA was sterilized with exposure to the germicidal lamp in a laminar flow
hood for 30 minutes and dissolved in a sterile solution of PBS containing 0.05 wt% I2959 (Ciba)
for cell encapsulation. A general schematic of the experimental layout is illustrated in Figure 6.1.
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Figure 6.1 General schematic of chondrocyte expansion, photoencapsulation, and subsequent
analysis.

6.2.2 Chondrocyte Isolation, Expansion, and Photoencapsulation
As described in Chapter 5 (section 5.2), cartilage tissue was harvested in a sterile fashion
from the ears (auricular) of 3 to 6 months old swine that were euthanized with an overdose of
Pentobarbital (100 mg/kg IV).

Briefly, the harvested auricular cartilage was cut into ~1mm3

pieces, washed in PBS, and digested overnight at 37ºC in Ham’s F-12 medium containing 0.1%
collagenase (Worthington). Digested tissue was passed through a 100 μm filter and centrifuged
to obtain a chondrocyte pellet.

Chondrocytes were washed with PBS, counted using a

hemacytometer, and determined viable using the trypan blue exclusion dye test prior to
encapsulation and plating. Chondrocytes (40 × 106 cells/ml) were photoencapsulated in hydrogel
networks by suspension in a 2 wt% MeHA solution containing 0.05 wt% I2959. The solution was
106

pipetted into sterile molds (50 μl volume) and polymerized with ~4 mW/cm2 ultraviolet light for 10
minutes using a long-wave ultraviolet lamp (Model 100AP, Blak-Ray). Remaining chondrocytes
were plated in T-150 flasks at a seeding density of 1×106 cells/150 cm2 (~6700
chondrocytes/cm2) for expansion in Ham’s F-12 culture medium containing 10% FBS, 1%
penicillin-streptomycin, and 1% non-essential amino acids.

After reaching ~90% confluency,

chondrocytes were trypsinized and photoencapsulated as stated above (p=1) or replated at 1×106
cells/150 cm2, trypsinized, and photoencapsulated after reaching ~90% confluency again (p=2).
Constructs were placed in culture media and implanted within 2 hours of gelation.

6.2.3 Implantation in Nude Mice
Nude mice were anesthetized with ketamine (80 mg/kg) and xylazine (12 mg/kg). A 2 cm
midline incision was made on the dorsum of each mouse and 5 subcutaneous pockets were
made using blunt dissection. One chondrocyte/hydrogel construct was placed in each of these
pockets and the wound was closed with sterile stainless steel skin clips. After 12 weeks, mice
were euthanized and constructs were harvested for analysis. NIH guidelines for the care and use
of laboratory animals (NIH Publication #85-23 Rev. 1985) were observed.

6.2.4 Mechanical Testing
Samples (n=5) were cored with a 3/16 inch diameter punch and weighed (wet weight).
Cored samples were mechanically tested in confined compression in a PBS bath (Figure 6.2).
For complete confinement, samples were initially loaded in creep to a tare load of 5 grams until
reaching equilibrium (defined as less than 10 μm of change in 10 min) before undergoing stress
relaxation. Stress relaxation was carried out by applying a ramped displacement to 10% strain,
and then the sample was allowed to relax to equilibrium (defined as less than 0.5 g of change in
10 min). The equilibrium confined compression modulus (EY) for each sample was calculated by:
σ = EY ε, where σ = F (force, N) / A (loaded area, m2).
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Figure 6.2 (A) Custom-made mechanical tester used for confined compression testing [17,18].
The tester consisted of a computer-controlled stepper motor, a linear variable differential
transformer to measure displacement, and a 250g or 1000g load cell to measure load. Labview
software (National Instruments) was used for stepper motor control and data acquisition.
Representative plots of creep (B) and stress relaxation (C), where load (black) and displacement
(gray) are plotted over time.

6.2.5 Biochemical Analysis
For biochemical analysis (n = 5), mechanically tested samples were lyophilized, weighed
(dry weight), and digested in a proteinase K solution (200 μg/ml proteinase K (Roche), 100 mM
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ammonium acetate, pH 7.0) overnight at 60ºC. Proteinase K was then inactivated at 100ºC for 5
min. Total DNA, GAG, and collagen contents were determined using the PicoGreen dsDNA
Assay[19], the dimethylmethylene blue dye method[20] with chondroitin sulfate as a standard,
and the hydroxyproline assay[21] using a collagen to hydroxyproline ratio of 7.25[22,23],
respectively (as described in section 5.2). Values reported for DNA, GAG, and collagen content
were normalized to the sample wet weight. Elastin content was measured using the Fastin
Elastin Assay (Accurate Chemical & Scientific Corp)[24] with an α–elastin solution as a standard.
Briefly, 100 μl of the sample digest solution was combined with 200 μl of 90% ammonium sulfate
and 1 ml of Fastin dye reagent to form the elastin-dye complex. Contents were reacted for 1 hr
and centrifuged to pellet the complex. The pellet was solubilized with the Fastin dissociation
reagent and the absorbance was measured at a wavelength of 513 nm.

The proteinase K

digestion solution was used as a negative control for the hydroxyproline and elastin assays.

6.2.6 Histological Analysis
For histological analysis, constructs were fixed in 10% formalin for 24 hours, embedded
in paraffin, and processed using standard histological procedures. The histological sections (7
μm thick) were stained for chondroitin sulfate and collagen distributions using the Vectastain ABC
kit (Vector Labs) and the DAB Substrate kit for peroxidase (Vector Labs).

Sections were

predigested in 0.5 mg/ml hyaluronidase for 30 min at 37ºC and incubated in 0.5 N acetic acid for
4 hours at 4ºC to swell prior to overnight incubation with primary antibodies at dilutions of 1:100,
1:200, and 1:3 for chondroitin sulfate (mouse monoclonal anti-chondroitin sulfate, Sigma), and
type I (mouse monoclonal anti-collagen type 1, Sigma) and type II collagen antibodies (mouse
monoclonal anti-collagen type II, Developmental Studies Hybridoma Bank), respectively. Nonimmune controls underwent the same procedure without primary antibody incubation.
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6.2.7 Statistical Analysis
Anova with Tukey’s post-hoc test was used to determine significant difference among
groups, with p < 0.05. All values are reported as the mean ± the standard deviation.

6.3 Results & Discussion
One of the major obstacles for cartilage tissue engineering is finding a cell source and
adequate cell numbers for delivery to a defect. Auricular chondrocytes, chosen for their ease of
harvest, high yield, and rapid proliferation[9], were photoencapsulated in 2wt%, 50 kDa MeHA
hydrogels (optimized in the previous chapter) to determine the effects of chondrocyte expansion
(p = 0, 1 and 2) on neocartilage formation. Constructs were explanted, mechanically tested,
analyzed, and compared to controls of the HA gel alone and native auricular and articular
cartilage. Macroscopically, the explants were white and opaque and resembled native cartilage
tissue. The p = 0 and p = 1 constructs are noticeably larger (0.5 cm diameter when implanted)
and more opaque, potentially indicating more ECM production and neocartilage formation,
compared to the p = 2 constructs (Figure 6.3) that appeared slightly translucent.

Figure 6.3 Explanted HA constructs 12
weeks after subcutaneous implantation.
Scale bar = 1cm.

6.3.1 Mechanical Behavior
Samples were tested in confined compression in a PBS bath to simulate a cartilage
defect environment using a protocol similar to those that have been previously used to the
determine equilibrium moduli of hydrogel systems[25] and native cartilage[26]. In Figure 6.4, the
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p = 0 and p = 1 engineered constructs (51.2 ± 8.0 kPa and 72.5 ± 35.2 kPa, respectively)
exhibited a significant increase in compressive equilibrium moduli from the HA hydrogel (12.3 ±
1.3 kPa), indicative of ECM deposition. However, no significant difference was detected for the p
= 2 constructs (26.8 ± 14.9 kPa) and the HA hydrogel, suggesting limitations due to cell
expansion. Though the moduli of the engineered constructs were all significantly lower than the
articular cartilage (259.2 ± 20.0 kPa), they were all either higher than or not statistically different
than that of native auricular cartilage (35.1 ± 12.2 kPa). Although the equilibrium moduli reported
here for native cartilage is lower than the aggregate moduli reported in other literature[27], these
differences in literature can be attributed to the specific conditions of the testing system (e.g.
percent total strain) or testing method (e.g. indentation), and relative comparisons between the
HA hydrogel constructs and native cartilage can still be made. It is important to note that the
equilibrium moduli we obtained for articular cartilage is comparable to that determined by Strauss

Co mp ressive Eq u ilib riu m M o d u lu s (kPa)

et al[26], using a similar protocol.
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Figure 6.4 Compressive equilibrium modulus of constructs after 12 weeks of subcutaneous
implantation in nude mice compared to controls of the HA gel alone and native auricular (AU) and
articular (AR) cartilage. Significant difference (p<0.05) is denoted by *. Native articular cartilage
is significantly greater than all groups.
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6.3.2 Biochemical Analysis
The water content of the tissue engineered constructs and control samples were
determined from wet and dry weights (Figure 6.5). In general, constructs exhibited an increase in
water content with passage number. All constructs exhibited a significantly lower water content,
due to the deposition of ECM proteins, when compared to the HA gel (97.0 ± 0.3% water), while
having a significantly higher water content when compared to native auricular (66.5 ± 2.7% water)
and articular (72.7 ± 4.0% water) cartilage. The p = 0 constructs (83.1 ± 1.3% water) were most
comparable to native articular cartilage.

Figure 6.5 Water content of constructs after 12 weeks of subcutaneous implantation in nude mice
compared to controls of the HA gel alone and auricular and articular cartilage. The water content
of all constructs (p=0, p=1, p=2) was significantly less than that of HA gel alone and significantly
greater than that of native auricular and articular cartilage (p<0.05).

Total DNA content was determined using the dsPicoGreen assay and normalized to
sample wet weight in Figure 6.6. Minimal background fluorescence was detected for the HA gel
and was determined to be insignificant when normalized to wet weight. In general, no significant
differences were detected among sample groups, with DNA content ranging from ~0.3 to 0.5 pg
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DNA/ μg wet weight. However, the p = 1 constructs exhibited the lowest amount of DNA/wet
weight among the engineered constructs.

Figure 6.6 DNA content normalized to wet weight for constructs after 12 weeks of subcutaneous
implantation compared to controls of the HA gel alone and native auricular and articular cartilage.
There were no statistically significant differences between groups.

In Figure 6.7A, GAG content is reported as the quantity of chondroitin sulfate normalized
to sample wet weight. In general, constructs exhibited a decrease in GAG content with passage
number, where p = 0 and p = 1 constructs (0.049 ± 0.009 and 0.046 ± 0.004 μg CS/ μg wet
weight, respectively) are significantly greater than the p = 2 constructs (0.029 ± 0.005 μg CS/ μg
wet weight). All engineered constructs exhibited a significantly higher GAG content than the
control HA gels, indicating neocartilage formation, while the significant decrease from p = 1 to p =
2 potentially indicates the dedifferentiation of the encapsulated chondrocytes during expansion.
When compared to native cartilage, the p = 0 and p = 1 constructs are ~75-80% and ~53-57% of
the GAG content measured for auricular and articular cartilage, respectively. Articular cartilage
was significantly greater than all engineered constructs, but there was no significant difference
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detected in GAG content between auricular cartilage and the p = 0 constructs. Non-significant
GAG content was detected for the HA gels.
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Figure 6.7 Sulfated GAG (A) and collagen (B) content of samples normalized to construct wet
weight after 12 weeks of subcutaneous implantation compared to controls of the HA gel alone
and native auricular and articular cartilage. Significant difference (p<0.05) among constructs is
denoted by *. Sulfated GAG and collagen contents for native articular cartilage are significantly
greater (p<0.05) than all constructs.

Total collagen content, normalized to wet weight and reported in Figure 6.7B, exhibited
similar trends to those observed for GAG content, with a general decrease in collagen observed
with passage number. The collagen content of the p = 0 constructs (0.051 ± 0.017 μg collagen/
μg wet weight) was most comparable to native cartilage (i.e., ~57% and ~50% of measured
collagen content for auricular and articular cartilage, respectively). Again, the control HA gels
showed minimal levels with this assay.
As a final measure of construct biochemical levels, elastin was quantified to determine if
the implanted auricular chondrocytes still produced elastin after isolation and expansion (Figure
6.8). In general, the trend of elastin content with passage was similar to that of the GAG content
and similar to findings by van Osch et al, where phenotypic changes and decreases in elastin
were observed as auricular chondrocytes are expanded 2-dimensionally in vitro[9].

Elastin

content decreased with passage number, with a significant decrease from p = 1 to p = 2.
114

However, no significant difference for p = 0 (2.7 ± 0. 4 pg elastin/ μg wet weight) or p = 1
constructs (2.5 ± 0.5 pg elastin/ μg wet weight) was observed when compared to auricular
cartilage (2.9 ± 0.5 pg elastin/ μg wet weight), indicating a retention of the auricular chondrocyte
phenotype. Lower levels of elastin were detected in articular cartilage and p = 2 constructs (0.3
± 0.4 and 1.1 ± 0.7 pg elastin/ μg wet weight, respectively), which were significantly lower than
elastin found in the p = 0 and p = 1 constructs and auricular cartilage. No elastin was detected in
the HA gels.
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Figure 6.8 Elastin content of constructs normalized to construct wet weight after 12 weeks of
subcutaneous implantation compared to controls of the HA gel alone and native auricular and
articular cartilage. Significant difference (p<0.05) among constructs is denoted by *. Elastin
content for native articular cartilage is significantly lower than that of p=0 and p=1 groups.

6.3.3 Immunohistochemical Analysis
Representative stains for chondroitin sulfate, type I collagen, and type II collagen are shown in
Figure 6.9 with non-immune controls for comparison.
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Figure 6.9 Histological sections of constructs stained for chondroitin sulfate and type I and type II
collagen compared to non-immune controls (NIC), with no primary antibody, after 12 weeks of
subcutaneous implantation in nude mice. Scale bar = 100um.

In general, histological sections illustrate the morphology and distribution of the auricular
chondrocytes and the distribution of extracellular components.

Chondroitin sulfate is evenly

distributed throughout all constructs with similar intensity. Though little to no type I collagen
staining was detected, type II collagen staining was detected in all constructs, where it was most
intense and most widely distributed for the p = 0 constructs. Differences in chondroitin sulfate
and type II collagen distribution can result from a difference in molecule size, where smaller
chondroitin sulfate molecules can fill voids of the hydrogel with greater ease. The histological
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observations of ECM deposition and distribution are consistent with the results from the
biochemical analysis.

The non-immune controls exhibited no background staining of the

constructs.

6.4 Conclusions
This study showed that p = 0 and p = 1 auricular chondrocytes retain a more
chondrogenic phenotype when photoencapsulated in a HA hydrogel for 12 weeks while possible
changes in phenotype may occur after p = 1 and may compromise neocartilage formation in vivo.
Although constructs were all mechanically inferior to articular cartilage, the p = 0 and p = 1
constructs showed comparable if not greater compressive moduli than auricular cartilage and
show an increase in modulus over the HA gel.

Even though biochemical content generally

decreased with passage, significant decreases were only found after p = 1. Histologically, all
constructs exhibited aggrecan and type II collagen staining, characteristic of native cartilage.
These results show that p = 0 and p = 1 auricular chondrocytes produce cartilaginous tissue in a
2 wt%, 50 kDa hyaluronic acid hydrogel that is comparable to auricular cartilage, but are lower
than values for articular cartilage.

However, it is possible that mechanical stimuli or the

introduction of growth factors could lend to the production of more hyaline-like cartilage (i.e.,
articular cartilage).
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CHAPTER 7
Auricular and Articular Cartilage:
How do chondrocytes differ in Hyaluronic Acid Hydrogels?

Adapted from: C Chung, IE Erickson, RL Mauck, JA Burdick, “Differential Behavior of Auricular and
Articular Chondrocytes in Hyaluronic Acid Hydrogels,” Tissue Eng Part A, 2008, 14(7): 1121-31.)

7.1 Introduction
As mentioned in chapter 6, the choice of cell source still remains a question in
approaches for cartilage tissue engineering with hyaluronic acid (HA) hydrogels. We showed that
directly isolated and first passage auricular chondrocytes could produce cartilaginous tissue in
2wt% MeHA hydrogels with comparable properties to that of native auricular cartilage. However,
for applications in articular cartilage repair, would articular chondrocytes perform more
successfully and how does the hydrogel environment influence successful neocartilage
production? Chondrocytes can be isolated from a variety of sources including articular (AR),
auricular (AU), nasoseptal, and costal cartilage, and each type of cartilage tissue has discrete
chemical, physical, and mechanical properties. As chondrocyte behavior is dependent on where
it is isolated from, it is important to determine how chondrocytes from each source function and
behave in an engineered environment (e.g. biomaterial, soluble factors, mechanical loading).
To date, researchers have shown differences among chondrocyte sources with respect to
cell yields, proliferation rates, and phenotype retention[1-4]. In a study by van Osch et al, higher
cell yields and faster proliferation rates were obtained for AU chondrocytes when compared to AR
chondrocytes[1]. Furthermore, these AU chondrocytes were able to retain their chondrocytic
phenotype when cultured in alginate beads. Likewise, nasal chondrocytes can proliferate four
times faster than AR chondrocytes in monolayer[3], and can be seeded at very low densities with
an 838-fold expansion in one passage without extensive dedifferentiation[2]. With the addition of
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growth factors, AU, nasal, and costal chondrocytes all exhibit increased proliferation, GAG/DNA
content, and up-regulation of type II collagen expression; however, redifferentiation was achieved
only in AU and nasal chondrocyte cell pellets [4]. These studies provide motivation for exploring
multiple chondrocyte sources towards tissue engineering approaches.
Source dependent differences can also be found in the resulting engineered cartilage
tissues, including differences in construct size, gene expression, biochemical content, and
mechanical properties. Panossian and coworkers showed that AU chondrocyte-seeded samples
produced neocartilage with greater biochemical and histological similarity to that of native
cartilage than AR counterparts when implanted in vivo[5]. Xu et al have also shown that AU
chondrocytes encapsulated in fibrin exhibited the highest equilibrium modulus compared to those
encapsulated with AR and costal chondrocytes[6]. In a comparison study of bovine nasal, AR,
costal, and AU chondrocytes grown on poly(L-lactide-ε-caprolactone) scaffolds[7], construct size
and gene expression varied with chondrocyte type. AU chondrocyte-seeded constructs had the
largest diameter while costal chondrocyte-seeded constructs had the greatest thickness, and
costal chondrocytes, followed by nasoseptal, AR, and AU chondrocytes had the highest
expression of type II collagen and aggrecan. However, despite cell differences, Johnson et al
demonstrated that AR, AU, and costal chondrocytes were all able to form new cartilaginous
matrix when cultured in fibrin glue-cartilage composites in vivo [8]. This information is important
towards isolating a specific cell source, yet the behavior of cells is dependent on the biomaterial
used as a carrier. Specifically, variables in biomaterial design, such as mechanics, permeability,
and incorporation of biological motifs can dictate cellular behavior. Thus, data on the sourcedependent differential responses of chondrocytes can assist in biomaterial choice, scaffold type,
and cartilage repair application, e.g. in plastic, reconstructive, or orthopaedic surgery.

The

objective of this study was to investigate and characterize the differences in cell behavior of AU
and AR chondrocytes when encapsulated and cultured in MeHA hydrogels.
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7.2 Materials & Methodology
7.2.1 Macromer Synthesis and Polymerization
Methacrylated hyaluronic acid (MeHA) was synthesized as described in Chapter 4. 64
kDa MeHA (Lifecore) was sterilized with exposure to the germicidal lamp in a laminar flow hood
for 30 minutes and dissolved in a sterile solution of PBS containing 0.05 wt% I2959 (Ciba) for cell
encapsulation.

A switch to 64 kDa molecular weight was due to availability from Lifecore.

However, as determined in Chapters 4 and 5, molecular weight can alter the viscosity of the
macromer solution, but insignificantly affects hydrogel properties and neocartilage formation.

7.2.2 Chondrocyte Isolation and Photoencapsulation
Cartilage tissue was harvested in a sterile fashion from the ears (AU) and the knees (AR)
of 3 to 6 month old swine. The harvested cartilage was cut into ~1mm3 pieces, washed in PBS,
and digested overnight at 37ºC in DMEM containing 0.1% and 0.05% collagenase (Worthington)
for AU and AR cartilage, respectively. Digested tissue was passed through a 100 μm filter and
centrifuged to obtain a chondrocyte pellet. Chondrocytes were washed with PBS, counted using
a hemacytometer, and determined viable using the trypan blue exclusion dye test prior to
encapsulation.

Chondrocytes (40 million cells/ml) were photoencapsulated in hydrogels by

suspension in a 2 wt% macromer (MeHA) solution, injection into sterile molds (50 μl volume) and
polymerization with ultraviolet light for 10 minutes using a long-wave ultraviolet lamp (Topbulb,
F8T5BLB).

7.2.3 In Vivo and In Vitro Culture Methods
For in vivo culture, constructs (n=5/group per time point) were implanted subcutaneously
in nude mice within 2 hours of gelation. Nude mice were anesthetized with isoflurane and 5
subcutaneous

pockets

were

made

using

an

incision

and

blunt

dissection.

One
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chondrocyte/hydrogel construct was placed in each of these pockets and the wound was closed
with sterile stainless steel skin clips. After 6 and 12 weeks, mice were euthanized and constructs
were harvested for analysis. NIH guidelines for the care and use of laboratory animals (NIH
Publication #85-23 Rev. 1985) were observed.
For in vitro culture, AU and AR-seeded constructs, fabricated in the same manner as
described above, were cultured for 14 days in DMEM supplemented with 10% fetal bovine serum,
1% penicillin/streptomycin, 1% sodium bicarbonate, 1% non-essential amino acids, and 50μg/mL
ascorbic acid 2-phosphate (growth media). Media was changed every 2 days. Relative gene
expression and histology were analyzed after 6 and 14 days of culture.

7.2.4 Mechanical Stimulation
Loading parameters for in vitro mechanical stimulation in the bioreactor system were
validated using an Instron 5848 Microtester equipped with a 50N load cell and the WaveMaker
Software package.

Acellular HA macromer solution was polymerized between glass plates

(2.25mm thickness) and cylindrical hydrogels were produced with a 5mm diameter biopsy punch.
Samples (n=3) were immersed in a PBS custom bath at room temperature and positioned
between two impermeable platens. A 5% static compression was applied and after equilibrium
was achieved, dynamic compression was applied with a sinusoidal waveform of 10% amplitude
and a frequency of 1 Hz. Loading was carried out for a minimum of 10 minutes and each test
was repeated three times. Additional tests with larger amplitudes (15%) and higher frequencies
(3 Hz) were also tested.

For mechanical stimulation of cell-seeded constructs within the

bioreactor system, hydrogels (n=4/group per time point) were formed in the same fashion with a
seeding density of 40 million cells/ml. After 5 days of subculture, the hydrogels were immersed in
growth media and subjected to uniaxial unconfined cyclic compression (5% tare, 10% strain, 1
Hz) in a custom made bioreactor[9]. Dynamic loading was carried out for 3 hours per day for 1 or
5 consecutive days at 37°C and 5% CO2 in a humidified environment. Samples were removed
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from the bioreactor after each mechanical loading session. At the end of loading on day 1 or day
5, samples were removed from culture and analyzed for gene expression and compared to freeswelling controls. A general schematic of the experimental layout is illustrated in Figure 7.1.

Figure 7.1 General schematic of chondrocyte isolation, encapsulation, and analysis.

Inset:

Macroscopic image of explanted AU (left) and AR (right) chondrocyte-seeded constructs after 12
weeks of in vivo subcutaneous culture.

7.2.5 Mechanical Testing
Explanted samples (n=5) were cored with a 3/16 inch diameter punch and weighed (wet
weight). Cored samples were mechanically tested in confined compression in a PBS bath. To
ensure complete confinement, samples were initially loaded in creep to a tare load of 5 grams
until reaching equilibrium (defined as less than 10 μm of change in 10 min) before undergoing
stress relaxation. Stress relaxation was carried out by applying a ramped displacement (1μm/s)
to 10% strain, after which the sample was allowed to relax to equilibrium (defined as less than 0.5
g of change in 10 min). The equilibrium confined compression aggregate modulus (EY) for each
sample was calculated by dividing the equilibrium load by the sample cross-sectional area and
the applied strain. Native AU and AR cartilage samples were similarly tested (n=5).
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7.2.6 Biochemical Analysis
For biochemical analysis (n = 5), mechanically tested samples were lyophilized, weighed
(dry weight), and digested in a proteinase K solution (200 μg/ml proteinase K (Roche), 100 mM
ammonium acetate, pH 7.0) overnight at 60ºC. Proteinase K was then inactivated at 100ºC for 5
min. Total DNA, GAG, and collagen contents were determined using the PicoGreen dsDNA
Assay[10], the dimethylmethylene blue dye method[11] with chondroitin sulfate as a standard,
and the hydroxyproline assay[12] using a collagen to hydroxyproline ratio of 7.25[13,14],
respectively as outlined in section 5.2. Values reported for DNA, GAG, and collagen content
were normalized to the sample wet weight. The proteinase K digestion solution was used as a
negative control.

7.2.7 Viability
The viability of AU and AR chondrocytes in the HA hydrogel was determined using an
MTT assay. Mitochondrial activity (n=3) was assessed on days 0 (2 hrs after encapsulation), 7,
and 14 of in vitro culture.
incubated for 4 hours.

Briefly, 100μl of MTT reagent was added to 1ml of media and

Samples were then removed from the media, homogenized in the

detergent solution with a tissue grinder, and incubated for 4 hrs before reading in a
spectrophotometer. Absorbance readings at 570 nm were normalized to day 0 values to account
for differences in mitochondrial activity between cell sources.

7.2.8 Gene Expression Analysis
Samples (n=4) were homogenized in Trizol Reagent (Invitrogen) with a tissue grinder and
RNA was extracted according to the manufacturer’s instructions.

RNA concentration was

determined using an ND-1000 spectrophotometer (Nanodrop Technologies). One microgram of
RNA from each sample was reverse transcribed into cDNA using reverse transcriptase
(Superscript II, Invitrogen) and oligoDT (Invitrogen).

Polymerase chain reaction (PCR) was
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performed on an Applied Biosystems 7300 Real-Time PCR system using a 25μl reaction volume
for SybrGreen and Taqman (5’-nuclease) reactions.

Primers and probes specific for

glyceraldehydes 3-phosphate dehydrogenase (GAPDH), type I and type II collagen, aggrecan,
and hyaluronidases (Hyal) 1, 2 and 3 are listed in Table 7.1. SybrGreen reaction was used for all
genes except type II collagen and GAPDH was used as the housekeeping gene. The relative
gene expression was calculated using the ΔΔCT method, where fold difference was calculated
using the expression 2-ΔΔCt.

Table 7.1 Porcine primer and probe sequences for real-time PCR.
Gene

Forward Primer

Reverse Primer

GAPDH

CGTCCCTGAGACACGATGGT

CCCGATGCGGCCAAAT

Collagen I [15]

GGCTCCTGCTCCTCTTAGCG

CATGGTACCTGAGGCCGTTC

Collagen II

CTCCTGGCACGGATGGT

CTGGAGGGCCCTGAGC

Aggrecan [16]

GCAGACCAGAAGCTGTGTGAGA

TGACGATGCTGCTCAGGTGT

HYAL1 [17]

TGCCCTATGCCCAGATCTTC

CAGCTCCTCCCGAGACAGAA

HYAL2 [17]

AGGGCTTAGCGAGATGGATCT

TGTCAGGTAATCCTTGAGGTATTGG

HYAL3 [17]

TGAACTTGTGCAGACCATTGGT

GCCAACACTCCTCCTCAGAACT

Probe

CCCAAAGGCGCATCTG

7.2.9 Histological Analysis
For histological analysis, constructs were fixed in 10% formalin for 24 hours, embedded
in paraffin, and processed using standard histological procedures. The histological sections (7
μm thick) were stained for aggrecan and collagen distributions using the Vectastain ABC kit
(Vector Labs) and the DAB Substrate kit for peroxidase (Vector Labs).

Sections were

predigested in 0.5 mg/ml hyaluronidase for 30 min at 37ºC and incubated in 0.5 N acetic acid for
4 hours at 4ºC to swell the samples prior to overnight incubation with primary antibodies at
dilutions of 1:100, 1:200, and 1:3 for chondroitin sulfate (mouse monoclonal anti-chondroitin
sulfate, Sigma), and type I (mouse monoclonal anti-collagen type 1, Sigma) and type II collagen
antibodies (mouse monoclonal anti-collagen type II, Developmental Studies Hybridoma Bank),
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respectively.

Non-immune controls underwent the same procedure without primary antibody

incubation.

7.2.10 Statistical Analysis
All values are reported as the mean ± the standard error of the mean (SEM). ANOVA
was used to determine significant differences among groups, with p ≤ 0.05. Sensitivity of the data
was analyzed using a non-parametric Wilcoxon Rank-Sum test, given small sample sizes.

7.3. Results & Discussion
Chondrocytes can be isolated from a variety of sources and behave and respond
differently to their local environment (e.g., exposure to mechanical forces, soluble factors, varying
compositions of ECM molecules, or scaffold material) depending on the chondrocyte source[18].
Thus, it is important to investigate the response of specific chondrocyte sources to this
microenvironment for assessment of tissue engineering approaches.

This study focused

specifically on differences in neocartilage production by AU and AR chondrocytes in HA
hydrogels. AU cartilage is a non-load bearing and elastic tissue found primarily in the ear and
epiglottis, whose primary role is to maintain shape and structure. Alternatively, AR cartilage is a
hyaline cartilage that is capable of distributing mechanical loads and providing low friction
articulation in diarthrodial joints.

Therefore, chondrocytes isolated from these two types of

cartilage differ in the ECM they produce in order to carry out their respective physiological
roles[19].
7.3.1 In Vivo Culture
Dramatic differences in neocartilage formation were observed in vivo depending on
whether AU or AR chondrocytes were used as a cell source, suggesting differential cell
interactions with the HA scaffold. These interactions could be affected by differences in cell
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specific binding to the hydrogels, matrix degradation through enzyme production, and the
reproduction of the environment seen natively by these cells, i.e. non-loaded, subcutaneous
environment versus mechanically loaded joint. The macroscopic appearance (Figure 7.1 inset) of
AU and AR chondrocyte-seeded samples after 12 weeks of culture show dramatic differences,
where AU constructs increased in size in all dimensions and were shiny and white in appearance
after subcutaneous culture, while AR samples more closely resembled implanted constructs and
retained their size and translucency.
The neocartilage mechanical properties reflected these macroscopic observations, where
the confined compression aggregate modulus of AU explants (28.2 ± 2.2 kPa, 79.3 ± 6.7 kPa)
was significantly greater than that of AR explants (7.0 ± 0.3 kPa, 8.0 ± 0.7 kPa) after 6 and 12
weeks, respectively (Figure 7.2), and increased with culture.

Figure 7.2 Mechanical properties of explanted constructs. (A) Modulus of AU (black) and AR
(white)

chondrocyte-seeded

constructs

compared

to

HA

hydrogel

alone

(shaded).

Representative stress relaxation curves for AU chondrocyte-seeded (B) and AR chondrocyteseeded explants (C) after 12 weeks of in vivo culture compared to HA hydrogel alone (D) and
native AU (E) and AR (F) cartilage. Stress relaxation curves are normalized to peak stress.
Significant differences (p ≤ 0.05) between AU and AR groups are denoted by *.
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Increases in modulus correlated with decreases in water content and increases in GAG
content (Figure 7.3 and 7.4), in accordance with previously established data [20,21].

When

normalized to their peak load, stress relaxation curves for AU explants more closely resembled
those of native AU and AR cartilage, while those of AR explants more closely resembled profiles
of HA hydrogel alone with a high peak load followed by rapid relaxation. This suggests a higher
permeability of AR constructs compared to AU constructs and native cartilage. The aggregate
modulus of AU constructs represented ~226% and ~31% of native AU and AR cartilage,
respectively, while the modulus of AR constructs only represented ~23% and ~3% of the native
tissue values, respectively.
The change in water content indirectly influences mechanical properties as a decrease in
water content can represents an increase in ECM within the constructs. A decrease in water
content was observed in both AU (87.8% ± 2.7% water) and AR (95.0% ± 1.4% water) constructs
after 12 weeks when compared to HA hydrogel alone (97.0% ± 0.3% water), with a greater
decrease observed for AU constructs.

*

*

Figure 7.3 Water content of explanted AU (black) and AR (white) constructs compared to
acellular HA hydrogel (shaded) and native auricular (striped) and articular cartilage (hashed).
Significant differences (p ≤ 0.05) between AU and AR groups are denoted by *.
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After 12-weeks of subcutaneous culture, the DNA content was significantly greater in AU
constructs (1.35 ± 0.17 million chondrocytes) versus AR constructs (0.54 ± 0.08 million
chondrocytes), although the DNA content was similar between these groups when normalized to
the wet weight (Figure 7.4). Since the number of chondrocytes per sample remained relatively
constant over time, the decrease in DNA content per wet weight from 6 to 12 weeks was
observed and may be attributed to the accumulation of newly synthesized ECM (i.e., increased
GAG and collagen content). It is also important to note that cell loss was observed during
photoencapsulation; thus, the number of cells encapsulated may be less than the seeding density
would suggest. However, comparisons between cell types are still valid.

Figure 7.4 Biochemical content of AU (black) and AR (white) explants reported as millions of
chondrocytes per sample (A) and DNA (B), chondroitin sulfate (C) and collagen content (D) per
wet weight. Significant differences (p ≤ 0.05) between AU and AR groups are denoted by *.
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Sulfated-GAG and collagen contents also reflect the macroscopic differences between
the two cell sources. After 12-weeks of in vivo culture, AU constructs were comprised of 0.056 ±
0.003 μg chondroitin sulfate (CS)/ μg wet weight and 0.58 ± 0.003 μg collagen/ μg wet weight,
while AR constructs contained 0.004 ± 0.0002 μg CS/ μg wet weight and 0.012 ± 0. μg collagen/
μg wet weight (Figure 7.4). The biochemical content of AU constructs more closely resembled
that of native cartilage tissues. Specifically, the GAG content was ~92% of AU and ~65% of AR
cartilage and the collagen content was ~64% of AU and ~57% of AR cartilage after 12 weeks of
in vivo culture. The orientation of these ECM components was not assessed in this work.
Immunohistochemistry of the constructs (Figure 7.5) was used to assess the distribution
of cells and ECM components in the neocartilage. Greater type II collagen staining versus type I
collagen staining was observed for both AU and AR constructs, suggesting phenotype retention.
An even distribution of type II collagen and CS was observed in AU constructs, while more
clustering of cells and ECM proteins was observed in AR constructs. Within the HA hydrogel, AR
chondrocytes appeared to undergo interstitial growth, forming lacunae and isogenous groups
surrounded by pericellular and territorial matrix. Since the orientation of the collagen and CS in
the constructs was not assessed, no conclusions can be made regarding this potential difference
with respect to mechanics.

132

Figure 7.5 Representative sections of AU and AR constructs stained for type I and II collagen
and chondroitin sulfate after 12 weeks of subcutaneous in vivo culture compared to native
cartilage tissue sections. Scale bar = 100μm.
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7.3.2 In Vitro Culture
With dramatic differences observed in neocartilage formation in vivo, short-term in vitro
cultures were used to investigate the potential causes of these differences, including comparisons
of viability, gene expression, and ECM deposition. AU and AR constructs showed comparable
viability in HA hydrogels, and both exhibited increases in mitochondrial activity from day 7 to day
14 (Figure 7.6).

Figure 7.6 (A) Relative mitochondrial activity of AU (black) and AR (white) hydrogels cultured in
vitro for 7 and 14 days. Values were normalized to day 0 absorbance readings. (B) Absorbance
readings at 570 nm for AU and AR constructs at day 0 (shaded), 7 (black) and 14 (white). Inset:
Macroscopic image of constructs at day 0 after 4 hrs of MTT reagent incubation. The dark purple
color is indicative of mitochondrial activity.

The hydrated hydrogel environment allowed cells to maintain a rounded morphology,
which can assist in cell proliferation and phenotype retention. The lower mitochondrial activity
level observed for AR chondrocytes in HA hydrogels on day 0 compared to AU chondrocytes may
result from inherent differences between cell sources and may play a role in the differences in
neocartilage formation. Free radical polymerization effects on cell death were deemed negligible,
as the photoinitiating system implemented has been used extensively and others have shown it to
be cytocompatible[22], and AR chondrocytes exposed to the photoinitiator and radical
polymerization conditions have shown comparable cell survival to unexposed controls[23]. Thus,
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free radicals present during polymerization should not significantly affect the survival or
mitochondrial activity of AR chondrocytes over AU chondrocytes.
Gene expression data (Figure 7.7) was collected at 6 and 14 days of culture and
normalized to the gene expression of the respective chondrocytes at the time of encapsulation.
Although similar trends in gene expression were observed for AU and AR chondrocytes in HA
hydrogels, the type I and type II collagen expression was significantly different between the two
cell sources. Specifically, the normalized type I collagen expression was greater in AR samples
and the normalized type II collagen expression was greater in AU samples. Natively, less type I
collagen and more type II collagen is found in AR versus AU cartilage[19]. Thus, differences in
gene expression may reflect differences in the primary cells rather then differential response in
vitro. However, the data does suggest that AU chondrocytes behave more like primary cells than
AR chondrocytes when cultured in vitro in HA hydrogels, since AR chondrocytes exhibited a
greater increase in type I collagen and a greater decrease in type II collagen expression during
culture compared to isolated cells. Both groups exhibited a trend of increased type I collagen
expression with culture time and fairly constant type II collagen expression, though downregulated when compared to respective cells at encapsulation.
Hyaluronidase expression within the hydrogels was also examined to gain insight on the
potential catabolism of the HA scaffold by encapsulated cells. Hyaluronidases are enzymes that
cleave the β-1,4-glycosidic bonds between glucuronic acid and N-acetylglucosamine[24] and are
responsible for HA turnover, which can affect cell migration, differentiation, and matrix catabolism.
Hyal 1 cleaves HA into small molecular masses of less than 20kDa[25], while Hyal 2, the most
prominent hyaluronidase in cartilage, hydrolyzes high molecular mass HA into intermediate-sized
fragments of approximately 20kDa[26]. Hyal 3 has also been detected in cartilage, but little is
known about its enzymatic activity[27].
With in vitro culture, both AU and AR constructs exhibited decreased gene expression of
Hyal 2 and 3, suggesting down-regulation of HA turnover and matrix catabolism.

When
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comparing between cell sources, AR constructs exhibited equal or higher expression levels of
three isoforms of hyaluronidases.

Figure 7.7 Relative gene expression for AU (A, B) and AR (C, D) constructs after 6
(black) and 14 (white) days of in vitro culture. GAPDH was used as the housekeeping gene and
expression was normalized to cells encapsulated at day 0. Significant differences (p ≤ 0.05)
between AU and AR groups are denoted by * using parametric and non-parametric statistics or #
using parametric only.

Histological analysis indicated pericellular staining of type II collagen and evenly
distributed staining for CS throughout the gel in both AU and AR samples after 14 days of in vitro
culture (Figure 7.8).

Although staining for both type I and II collagen was observed in the

perimeter of the hydrogel, no type I collagen staining was observed within the core of the
hydrogel. Positive staining for type II collagen and aggrecan was observed for both in vivo and in
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vitro culture; however, type II collagen was more distributed within the constructs after 12 weeks
of in vivo culture.

Type I Collagen

Type II Collagen

Chondroitin Sulfate

AU

AR

Figure 7.8 Representative sections of AU and AR constructs stained for type I and II collagen
and chondroitin sulfate after 2 weeks of in vitro culture. Scale bar = 100μm.

7.3.3 Mechanical Stimulation
With in vivo and in vitro culture, AU chondrocyte-seeded constructs exhibited greater
neocartilage formation and better phenotype retention.

However, in these cultures, the

encapsulated chondrocytes are exposed to a non-load bearing environment that more closely
resembles that of native AU cartilage.

Thus, it was hypothesized that exposure to external

mechanical stimulation would have a positive effect on AR chondrocytes, since they have
responded to dynamic compression loading regimes in other scaffolds[28].

Hydrogels are

capable of transducing mechanical loads, which may stimulate ECM production via cell signaling
resulting from cell deformation or mechanotransduction by cell surface receptors. However, it is
important to note that scaffold chemistry and properties, as well as loading regime can affect
chondrocyte response[29].
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Validation of mechanical loading parameters was performed on acellular HA hydrogels
(Figure 7.9A). Hydrogels were subjected to a 5% tare strain with a superimposed dynamic axial
strain of 10% at 1 Hz, where load and displacement during cyclic compression were acquired.
Load response showed no capping or other deviation from the sinusoidal path under these
conditions, indicating that the HA hydrogel remained in contact with the indenter without any
evidence of lift-off occurring.

Figure 7.9 Validation of mechanical loading of HA hydrogels at 5% tare, 10% strain, and
frequency of 1 Hz (A). Relative gene expression of dynamically loaded AU (B, C) and AR (D, E)
hydrogels for 1 (black) and 5 days (white) normalized to free-swelling controls. Significant
differences (p ≤ 0.05) between free-swelling and mechanically loaded samples are denoted by *
using parametric and non-parametric statistics and # using parametric only.
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Using these validated loading parameters, dynamic mechanical stimulation was applied
to cell-seeded HA constructs and the effects of stimulation were monitored with relative gene
expression (Figure 7.9). Up-regulation of type II collagen and aggrecan was evident for both AU
and AR samples after 5 days of consecutive loading, where significant differences for loaded
constructs over free-swelling constructs were noted for AU samples with only parametric
statistics, while significant differences (p≤0.05) for AR samples were determined with both
parametric and non-parametric tests. For loaded AR constructs, 2.3-and 1.5-fold increases in
type II collagen and aggrecan, respectively, over free-swelling controls was observed, while only
1.4- and 1.3-fold increases were observed for loaded AU samples. This data indicates that
dynamic compression alone, without the addition of growth factors, is capable of stimulating type
II collagen and aggrecan expression.

Additionally, type I collagen gene expression was

significantly down-regulated for AU constructs after 5 days of loading.
Furthermore, studies have shown catabolic and anabolic effects of compressive loading,
hinting at a structural remodeling effect of the newly synthesized matrix through loading [30]. In
our study, cyclic compressive loading also increased gene expression of Hyal 3 for both cell
sources, with greater increases observed for AR samples (2.9-fold) over AU samples (1.9-fold),
which suggests that mechanical loading may stimulate local HA turnover and matrix remodeling.

7.4 Conclusions
In conclusion, we have shown that AU and AR chondrocytes photoencapsulated in HA
hydrogels exhibit differences in cell behavior in both in vivo and in vitro culture, and differ in their
response to mechanical stimulation. AU chondrocytes excelled in producing neocartilage in vivo,
in a subcutaneous environment that more closely resembled native AU cartilage, while AR
chondrocytes exhibited enhanced gene expression in a mechanically loaded environment, more
akin to that of a loaded joint environment.
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CHAPTER 8
Mesenchymal Stem Cell Chondrogenesis in Hyaluronic Acid Hydrogels

(Adapted from: C Chung and JA Burdick, “Influence of Three-Dimensional Hyaluronic Acid
Microenvironments on Mesenchymal Stem Cell Chondrogenesis,” Tissue Eng Part A, 2009, 15(2):
243-54.)

8.1 Introduction
Mesenchymal stem cells (MSCs) are multipotent progenitor cells that have the ability to
self-replicate and differentiate down multiple cell lineages when given the appropriate
environmental cues[1]. Although they were first identified in bone marrow by Friedenstein and
colleagues[2] in the 1970s, MSCs have since been isolated from various adult tissues and
differentiated into several cell types, including osteoblasts, chondrocytes, and adipocytes[1,3-5].
With their plasticity and self-renewal capacity, these cells have generated significant interest for
applications in cell replacement therapies and tissue regeneration.
Particularly, MSCs have garnered interest as an alternative cell source for cartilage tissue
engineering, since they can be isolated from adults via a bone marrow biopsy.

To induce

chondrogenic differentiation, MSCs are typically grown in pellet culture in the presence of
transforming growth factor-βs (TGF- βs) [6-10], and differentiation is monitored by the production
of cartilaginous matrix proteins such as sulfated glycosaminoglycans (GAGs) and type II collagen.
In recent years, both natural and synthetic biomaterials have been used to create niches or
microenvironments to control stem cell behavior and differentiation [11,12]. These biomaterials
serve as 3D scaffolds capable of enhancing and templating tissue formation through cell
morphology and organization, intercellular interactions, mechanical forces, and/or the delivery of
bioactive molecules [11,13].
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For this study, the ability of MSCs to undergo chondrogenesis in photocrosslinked HA
hydrogels was investigated. Previous chapters documented the optimization of a methacrylated
HA (MeHA) hydrogel system for the encapsulation of chondrocytes. Cytocompatibility, phenotype
retention, and neocartilage formation within these hydrogels was characterized using both
auricular and articular chondrocytes. However, inherent limitations to the use of chondrocytes
(e.g., low cell yields and a tendency to dedifferentiate when expanded in vitro, as emphasized in
chapter 6) have motivated the use of MSCs as an alternative cell source. MSCs are easily
expanded in vitro without loss of differentiation potential and can express CD44[14], one of the
primary receptors for HA. Thus, we hypothesized that photocrosslinked MeHA hydrogels could
provide a favorable niche for MSC chondrogenesis.

8.2 Materials & Methodology
8.2.1 CD44 Staining and Flow Cytometry
To determine the presence of CD44 receptors, human MSCs (Lonza Walkersville, Inc.)
were cultured in 2D on glass coverslips and fixed in accustain (Sigma) for immunofluorescent
staining. Briefly, the cells were blocked with 5% fetal bovine serum (FBS), stained with primary
antibody anti-CD44 clone A3D8 (4μg/ml, Sigma) for 2 hours, incubated with secondary antibody
anti-mouse IgG (whole molecule) F(ab’)2 fragment-FITC (1:50 dilution) for 15 minutes, and
counterstained with DAPI (2μg/ml) for nuclei visualization. In addition, MSCs were labeled with
phycoerythrin (PE)-conjugated CD44 (0.25 μg/ml, eBioscience) monoclonal antibody for 1 hr on
ice and analyzed by flow cytometry (Guava EasyCyte 3.10).

8.2.2 Macromer Syntheses
Methacrylated HA (MeHA) was synthesized as previously described in chapter 4. Briefly,
methacrylic anhydride (Sigma) was added to a solution of 1 wt% HA (Lifecore, MW = 64 kDa) in
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deionized water, adjusted to a pH of 8 with 5 N NaOH, and reacted on ice for 24 hours. The
macromer solution was purified via dialysis (MW cutoff 6-8k) against deionized water for a
minimum of 48 hours with repeated changes of water.

The final product was obtained by

lyophilization and stored at -20ºC in powder form prior to use. Poly(ethylene glycol)-diacrylate
(PEGDA) was synthesized as previously reported[15]. Briefly, triethylamine (1.5 molar excess)
was added to PEG-4600 (Sigma) dissolved in methylene chloride. Acryloyl chloride (1.5 molar
excess) was added dropwise under nitrogen and reacted on ice for 6 hrs, followed by reaction at
room temperature for 30 hours. The product was precipitated in ethyl ether, filtered, dried in a
vacuum oven, redissolved in deionized water, dialyzed for 3 days, lyophilized, and stored at 20ºC in powder form prior to use. The macromer structure was characterized by 1H NMR (Bruker
Advance 360 MHz, Bruker). Macromers were sterilized using a germicidal lamp in a laminar flow
hood for 30 minutes and dissolved in a sterile solution of phosphate buffered saline (PBS)
containing 0.05 wt% I2959 for polymerization.

Hydrogels were polymerized by injecting the

macromer solution into a mold or between glass slides and exposing to ultraviolet light (Eiko, ~1.9
mW/cm2) for 10 minutes.

8.2.3 Mechanical Characterization
Acellular hydrogels (n=5) with ~7mm diameter and ~1mm thickness were tested in
unconfined compression with a Dynamic Mechanical Analyzer Q800 (DMAQ800, TA Instruments)
in a PBS bath. Hydrogels were compressed at a rate of 10%/min until failure or until 70% of the
initial thickness. The modulus was determined as the slope of the stress versus strain culture at
low strains (<20%).

The elastic modulus of PEG hydrogels was matched to 2wt% MeHA

hydrogels by varying the macromer concentration (5-10 wt%).
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8.2.4 MSC Photoencapsulation and Culture
Human MSCs were expanded to passage 4 in growth media consisting of α-MEM with
16.7% FBS and 1% penicillin/streptomycin. MSCs (20 × 106 cells/ml) were photoencapsulated in
hydrogels by suspension in 2 wt% MeHA or 5.5 wt% PEG solutions with or without 200ng/ml
TGF-β3.

The cell/macromer solutions were pipetted into sterile molds (50 μl volume) and

polymerized with ultraviolet light (Eiko, ~1.9 mW/cm2) for 10 minutes.
To evaluate chondrogenesis, MSC-laden MeHA hydrogels were cultured in vitro in either
growth media or DMEM supplemented with 1% penicillin/streptomycin, 1% ITS+, 1mM sodium
pyruvate, 40mg/ml L-proline, 100nM dexamethasone, 50μg/ml ascorbic acid 2-phosphate, and
10ng/mL TGF-β3 (chondrogenic media). For in vivo culture, MSCs were encapsulated in MeHA
hydrogels with (HA+T3) and without (HA-MSCs) TGF-β3 and implanted in nude mice, or cultured
in vitro in chondrogenic media for 2 weeks prior to implantation (HA-C).

Nude mice were

anesthetized with isoflurane, a 2 cm midline incision was made on the dorsum of each mouse,
and 5 subcutaneous pockets were made using blunt dissection. One construct was placed in
each pocket and the wound was closed with sterile stainless steel skin clips. Constructs were
cultured in vivo for 2 weeks. NIH guidelines for the care and use of laboratory animals (NIH
Publication #85-23 Rev. 1985) were observed.

For scaffold comparison, MSCs were

encapsulated in PEG hydrogels and cultured in vitro and in vivo in the same manner as the
MeHA hydrogels.

8.2.5 Viability
The viability of MSCs in the MeHA and PEG hydrogels was assessed using a live/dead
cytotoxicity kit (Molecular Probes) and an MTT assay (ATCC). Live/dead images were taken 1
and 24 hrs after encapsulation. Mitochondrial activity (n=3) was assessed after 7 and 14 days of
in vitro culture. Briefly, 100μl of MTT reagent was added to 1ml of media and incubated for 4
hours. Samples were then removed from the media, homogenized in the detergent solution with
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a tissue grinder, incubated for 4 hrs, and read at an absorbance of 570nm in a Synergy HTTM
(Bio-Tek Instruments) spectrophotometer.

8.2.6 Gene Expression Analysis
Samples (n=4) were homogenized in Trizol Reagent (Invitrogen) with a tissue grinder and
RNA was extracted according to the manufacturer’s instructions.

RNA concentration was

determined using an ND-1000 spectrophotometer (Nanodrop Technologies). One microgram of
RNA of each sample was reverse transcribed into cDNA using reverse transcriptase (Superscript
II, Invitrogen) and oligoDT (Invitrogen). Polymerase chain reaction (PCR) was performed on an
Applied Biosystems 7300 Real-Time PCR system using a 25μl reaction volume for Taqman (5’nuclease)

reactions.

Primers

and

probes

specific

for

glyceraldehydes

3-phosphate

dehydrogenase (GAPDH), type I and type II collagen, aggrecan, sox 9 and hyaluronidases (Hyal)
1, 2 and 3 are listed in Table 8.1. GAPDH was used as the housekeeping gene. Relative gene
expression was calculated using the ΔΔCT method, where fold difference was calculated using
the expression 2-ΔΔCt.

Table 8.1 Human quantitative PCR primers and probes.
Gene

Forward Primer

Reverse Primer

Probe

GAPDH

AGGGCTGCTTTTAACTCTGGTAAA

GAATTTGCCATGGGTGGAAT

CCTCAACTACATGGTTTAC

Col I

AGGACAAGAGGCATGTCTGGTT

GGACATCAGGCGCAGGAA

TTCCAGTTCGAGTATGGC

Col II

GGCAATAGCAGGTTCACGTACA

CGATAACAGTCTTGCCCCACTT

CTGCACGAAACATAC

Acan

TCGAGGACAGCGAGGCC

TCGAGGGTGTAGCGTGTAGAGA

ATGGAACACGATGCCTTTCACCACGA

Sox 9

AAGCTCTGGAGACTTCTGAACGA

GCCCGTTCTTCACCGACTT

HYAL1

AAAATACAAGAACCAAGGAATCATGTC

CGGAGCACAGGGCTTGACT

HYAL2

GGCGCAGCTGGTGTCATC

CCGTGTCAGGTAATCTTTGAGGTA

HYAL3

GCCTCACACACCGGAGATCT

GCTGCACTCACACCAATGGA
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8.2.7 Microarray Assay
Isolated total RNA (n=3 per group) from day 14 in vitro samples were processed by the
Penn Microarray Facility. RNA was amplified and hybridized to GeneChip® Human Exon 1.0 ST
array (Affymetrix). Microarray expression data was analyzed using Partek Genomics Software
Package Suite 6.4 to determine fold change and Significant Analysis of Microarray (SAM) 3.02 to
determine significant differences between MSC-laden MeHA and PEG hydrogels.

Ingenuity

pathway analysis was also used to explore potential differentially regulated pathways.

8.2.8 Histological Analysis
For histological analysis, constructs were fixed in 10% formalin for 24 hours, embedded
in paraffin, and processed using standard histological procedures. The histological sections (7
μm thick) were stained for aggrecan and collagen distributions using the Vectastain ABC kit
(Vector Labs) and the DAB Substrate kit for peroxidase (Vector Labs).

Sections were

predigested in 0.5 mg/ml hyaluronidase for 30 min at 37ºC and incubated in 0.5 N acetic acid for
4 hours at 4ºC to swell the samples prior to overnight incubation with primary antibodies at
dilutions of 1:100, 1:200, and 1:3 for chondroitin sulfate (mouse monoclonal anti-chondroitin
sulfate, Sigma), and type I (mouse monoclonal anti-collagen type 1, Sigma) and type II collagen
antibodies (mouse monoclonal anti-collagen type II, Developmental Studies Hybridoma Bank),
respectively.

Non-immune controls underwent the same procedure without primary antibody

incubation.

8.2.9 Statistical Analysis
All values are reported as the mean ± SEM. Student’s t-test and Wilcoxon Sum-Rank
test were used to determine significant differences among groups, with p < 0.05.

149

8.3 Results & Discussion
Recently, MSCs have been explored as an alternative cell source for cartilage
regeneration and repair due to their chondrogenic potential and their ease of isolation from
sources such as bone marrow without damage to native cartilage tissue.

To this end, 3D

scaffolds have been developed to create microenvironments for stem cells, where numerous
factors including material chemistry, functionalization with biological cues, interactions with
surrounding cells, and mechanical properties[11] play a role to direct stem cell differentiation. In
this study, we investigated the use of a photocrosslinked HA hydrogel to provide a favorable
niche for MSC chondrogenesis both in vitro and in vivo by providing cell interactive cues with a
naturally found polysaccharide. Increases in the gene expression and production of cartilaginous
matrix proteins were used as markers for chondrogenesis.

8.3.1 MSC interactions with HA
One of the advantages of using an HA-based scaffold is the potential for cell/scaffold
interactions via cell surface receptors, which could direct cell behaviors and assist in stem cell
differentiation. CD44 is a cell surface receptor that binds to HA, providing a means to retain and
anchor proteoglycan aggregates to the plasma membrane of a cell.

In addition, intimate

association with the underlying cytoskeleton permits CD44 to initiate intracellular signaling[16,17],
allowing it to sense changes in the ECM environment and signal a cellular response.

This

receptor is also of particular interest because it is essential for the maintenance of cartilage
homeostasis[17] and plays a role in the catabolism of HA via phagocytosis[18]. To demonstrate
the potential of MSCs to interact with our HA scaffold, CD44 expression was verified with
immunofluorescent staining and flow cytometry (Figure 8.1 A and B). This HA receptor was
present on 99.6% of the cell population and stained uniformly on MSCs cultured in 2D.

In

addition, nearly all of the MSCs remained viable (>98%) as indicated by live/dead staining 6
hours after encapsulation (Figure 8.1C), indicating that these MeHA hydrogels could be
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successfully used as MSC delivery vehicles.

The even distribution of cells throughout the

hydrogel demonstrates the advantage of using photopolymerization as a facile means to
encapsulate cells in a 3D hydrogel matrix.

Figure 8.1 (A) Immunofluorescence staining of CD44 (green) with nuclear counterstain (blue) of
MSCs cultured in 2D on glass coverslips (scale bar = 100μm) (A), (B) flow cytometry staining for
CD44 (yellow) compared to an unstained (black) population of MSCs prior to encapsulation, and
(C) live (green)/ dead (red) image of MSCs encapsulated in MeHA hydrogel 6 hours after
photopolymerization (scale bar = 200μm).

8.3.2 MSC Chondrogenesis
MSC chondrogenesis in MeHA hydrogels was induced in vitro by culture in chondrogenic
media containing TGF-β3, which has been shown to induce chondrogenesis in a variety of other
scaffolds[19,20].

Comparisons between MSC-laden HA hydrogels cultured in growth and

chondrogenic media (+TGF-β3) showed significant differences in gene expression between
culture media at 3, 7, and 14 days of culture (Figure 8.2).
Specifically, up-regulation of sox 9 (a transcription factor required for successive steps in
chondrogenesis), type II collagen, and aggrecan was observed for constructs cultured in
chondrogenic media over cultures in growth media at all time points.

In addition, with the

exception for aggrecan at day 3, an up-regulation of the chondrogenic genes (type II collagen,
151

aggrecan, sox 9) and down-regulation of the fibroblastic marker (type I collagen) was observed
compared to initially encapsulated cells for all hydrogels cultured in chondrogenic media.
Interestingly, type II collagen was also initially up-regulated in hydrogels cultured in growth media
with decreases in expression after day 3. This suggests potential chondrogenic effects of the
hydrogel alone on MSC differentiation.

Figure 8.2 Relative gene expression of type I and type II collagen, sox 9 and aggrecan for MSCs
encapsulated in hydrogels cultured in vitro in growth (white) and chondrogenic (black) media.
GAPDH is used as the housekeeping gene and expression is normalized to cells at the time of
encapsulation (indicated by the dashed line). Gene expression of MSCs cultured in chondrogenic
media is significantly different than MSCs cultured in growth media (p<0.05) for all genes at all
time points.
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In addition, the expression of hyaluronidases observed in MSCs indicates the potential
for HA hydrogel remodeling. Hyaluronidases are enzymes that cleave the β-1,4-glycosidic bonds
between glucuronic acid and N-acetyl-glucosamine[21], which can affect cell differentiation and
matrix catabolism.

Each enzyme isoform plays a specific role in cleaving HA into discrete

fragment sizes that regulate different cellular processes[22-24].

Significant differences in

hyaluronidase expression were observed between culture media for hyal 2 and 3 (Figure 8.3) at
several time points.

Figure 8.3 Relative gene expression of hyaluronidases (Hyal) for MSCs encapsulated in
hydrogels cultured in growth (white) and chondrogenic (black) media. GAPDH is used as the
housekeeping gene and expression is normalized to cells at the time of encapsulation (indicated
by the dashed line). Significant differences (p<0.05) between hydrogels cultured in growth and
chondrogenic media are denoted by *.

Histologically, increased deposition of type II collagen and chondroitin sulfate (CS) was
observed for MSC-laden HA hydrogels cultured in chondrogenic media (Figure 8.4), where
intense pericellular staining was observed after only 14 days of culture. In addition, in agreement
with gene expression data, light staining for type II collagen and CS in hydrogels cultured in
growth media, suggesting that the scaffold alone could promote chondrogenesis. Light staining
for type I collagen was also observed in hydrogels cultured in chondrogenic media. MSCs are
known to produce type I collagen, and it remains unclear whether complete inhibition of type I
collagen is possible during chondrogenic differentiation.
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Type I Collagen

Type II Collagen

Chondroitin Sulfate

Growth
Media

Chondrogenic
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Figure 8.4 Representative stains for type I and II collagen and chondroitin sulfate for MSC-laden
hydrogels cultured in growth and chondrogenic media for 14 days in vitro. Scale bar = 100μm.

In vivo, MSC chondrogenesis was explored with and without TGF-β3, which was
delivered without a carrier via direct encapsulation within the hydrogel. MSCs in all groups (HAMSC, HA+T3, HA-C) exhibited increases in gene expression for all genes of interest (Figure 8.5)
compared to cells at the time of encapsulation after 14 days of implantation. Without growth
factors present, there were ~3000-, ~18-, and ~13-fold increases in type II collagen, aggrecan,
and sox 9 gene expression, respectively. With the addition of TGF-β3 (HA+T3 group) and with 2
weeks of pre-culture in chondrogenic media (HA-C group), type II collagen increased ~17.5- and
~2370-fold and aggrecan increased ~3.7 and ~4.6-fold, respectively, compared to the HA-MSC
group. These results indicate that the MeHA hydrogel as a cell delivery vehicle alone supports
MSC chondrogenesis, which is then further enhanced with the addition of TGF-β3. It is important
to note that the single dose of encapsulated TGF-β3 was capable of altering gene expression
during short-term in vivo culture. In addition, data showed that the pre-programming of MSCs
toward chondrogenesis with 2 weeks of pre-culture in vitro was also sufficient to maintain
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chondrogenesis in short-term in vivo culture. Furthermore, increases in hyaluronidase expression
in vivo may reflect potential cell-dictated remodeling of the MeHA hydrogel.

Figure 8.5 Relative gene expression for type I and type II collagen, aggrecan, sox 9 (A) and
hyaluronidases (B) for MSCs encapsulated in hydrogels cultured 2 weeks in vivo. GAPDH is
used as the housekeeping gene and expression is normalized to cells at the time of
encapsulation (indicated by the dashed line). The groups included the hydrogel alone (HA-MSC,
black), hydrogels with TGF-β3 co-encapsulated with cells (HA+T3, white), and hydrogels precultured in chondrogenic media for 2 weeks (HA-C, shaded). All groups are significantly different
(p<0.05) for type I and II collagen, while HA-MSC is significantly different from both HA+T3 and
HA-C for aggrecan. In addition, HA+T3 is significantly different from HA-C for Hyal 2 and 3 and
sox 9.

Histological analysis of the in vivo samples showed pericellular staining for HA-MSC and
HA+T3 groups for type II collagen and CS, with more elaborate staining for the HA-C group
(Figure 8.6). Again, some staining was also noted for type I collagen in these samples, similar to
in vitro results. Though the bolus delivery of TGF-β3 initiated the expression and deposition of
type II collagen and aggrecan, optimization of TGF-β3 quantity and delivery method, as well as
hydrogel degradation properties could improve ECM synthesis, deposition, and distribution within
the constructs in vivo, and will be addressed in later chapters.
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Figure 8.6 Representative stains for type I and II collagen and chondroitin sulfate for HA-MSC,
HA+T3, and HA-C groups after 3 week culture in vivo. Scale bar = 100μm.
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8.3.3 Comparison between HA and PEG hydrogels
To better evaluate the effect of scaffold material on MSC chondrogenesis, MeHA
hydrogels were compared to a relatively inert PEG hydrogel system. PEG hydrogels were used
as comparative controls due to their resistance to protein adsorption and relatively inert
interaction with cells. First, the elastic modulus of PEG hydrogels was matched to 2 wt% MeHA
hydrogels by altering macromer concentration. A 5.5 wt% PEG formulation with a modulus of
13.3±1.0 kPa was found to be comparable (i.e., no statistical differences between moduli) to the 2
wt% MeHA hydrogels (13.0±1.4 kPa) and was used for all comparison studies to minimize
mechanical influences on cellular differentiation (Figure 8.7A). In addition, live/dead staining and
an MTT assay (Figure 8.7B, C) demonstrated that viable MSCs were successfully encapsulated
in both hydrogel systems and exhibited no statistical difference in cell viability.

Figure 8.7 MeHA compared to PEG. Modulus of acellular HA and PEG hydrogels (A), live
(green)/dead (dead) images of MSC-laden hydrogels at 1 and 24 hrs after polymerization; scale
bar = 200 mm (B), relative mitochondrial activity for HA (black) and PEG (white) hydrogels after 7
and 14 days of in vitro culture (C). There were no statistical differences in hydrogel moduli and
viability between HA and PEG groups.
With both in vitro and in vivo cultures, the gene expression of encapsulated MSCs
differed depending on the hydrogel chemistry. With in vitro culture, type II collagen expression by
MSCs in MeHA hydrogels was up-regulated ~7.3- and ~6.6-fold over PEG counterparts after 7
and 14 days, respectively (Figure 8.8). Aggrecan was also up-regulated in MeHA hydrogels
(~1.5- and ~1.2-fold after 7 and 14 days, respectively), but to a lesser extent. These differences
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were also observed in immunohistochemical staining, where more intense type II collagen and
CS staining is observed in MeHA over PEG hydrogels (Figure 8.9).

Figure 8.8 Relative gene expression of type I and type II collagen, sox 9, and aggrecan (A) and
hyaluronidases (B) for MSCs encapsulated in HA hydrogels cultured in vitro in chondrogenic
media for 7 (white) and 14 days (black).

GAPDH is used as the housekeeping gene and

expression is normalized to PEG counterparts (indicated by the dashed line).

Significant

differences (p<0.05) between HA and PEG hydrogels are denoted by *.

Figure 8.9 Representative stains for type I and II collagen and chondroitin sulfate for MSC-laden
HA and PEG hydrogels cultured in chondrogenic media for 14 days in vitro. Scale bar = 200μm.
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For in vivo culture, differences between MeHA and PEG hydrogels are most noticeable
for MSCs plus scaffold alone, where type II collagen and aggrecan were up-regulated by ~43and ~6-fold, respectively, for MSCs in MeHA hydrogels compared to PEG hydrogels (Figure
8.10), indicating that hydrogel chemistry alone can greatly influence the commitment of MSCs to
undergo chondrogenesis. These differences between MeHA and PEG decreased to ~11.5- and
~4.1-fold with the addition of TGF-β3, suggesting more prominent induction by chondrogenic
growth factor addition, and become negligible (~0.7- and ~1.5-fold) when chondro-induced MSCs
are encapsulated in both hydrogel systems. With pericellular deposition after 2 weeks of in vitro
culture, MSCs may interact with newly deposited matrix rather than the surrounding scaffold
material; thus, differences as a result of polymer choice are minimized when compared after in
vivo culture. Hyaluronidase expression also differed, where the expression of enzymes was
down-regulated in vitro but up-regulated in vivo for HA+T3 and HA-C groups when compared to
their PEG counterparts.

Figure 8.10 Relative gene expression for type I and II collagen, aggrecan, sox 9 (A) and
hyaluronidases (B) of MSCs in HA-MSC (black), HA+T3 (white), and HA-C (shaded) groups
cultured in vivo for 2 weeks. GAPDH is used as the housekeeping gene and expression is
normalized to PEG counterparts (indicated by the dashed line). Significant differences (p<0.05)
between HA and PEG hydrogels are denoted by *.
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To further investigate the effects of hydrogel chemistry on MSC chondrogenesis, genome
expression profiling of MSC-laden HA and PEG hydrogels cultured in vitro was assayed by
microarray.

The principle component analysis (PCA) plot demonstrates distinct differences

between HA and PEG groups (Figure 8.11).

Figure 8.11 PCA plot of MSC-laden HA (red) and PEG
(blue) hydrogels after 14 days of in vitro culture.

Significant differences between the two groups, as illustrated by the heat map (Figure
8.12), can shed light on possible mechanisms of HA enhanced chondrogenesis. Chondrogenesis
is controlled by a complex interplay of regulatory factors.

Sox9, a Sry-related HMG box

transcription factor expressed throughout chondrogenesis, is required for the activation of early
cartilage markers[25]. It also acts as an activator of Sox5 and -6, which are co-expressed with
Sox9 in cartilage[26]. These Sox genes regulate the activation of Col2a1, Col9a1, and Col11a1.
While Sox5 is active during embryogenesis, Sox6 is active postnatally [27]. From the microarray
analysis, it is observed that both Sox9 and Sox6 are significantly up-regulated in HA hydrogels
over PEG counterparts, which may have resulted in the subsequent up-regulation of type 2, 9,
and 11 collagens. Type 2 collagen makes up 85-90% of collagen in hyaline cartilage and is
responsible for providing cartilage with its tensile strength. Type 11 collagen is a regulatory
collagen whose role is to initiate assembly of thin fibrils and limit the radial growth of collagen
fibrils, providing cartilage with structural integrity [28]. Type 9 collagen is a fibril associated
collagen with interrupted triple helices (FACIT) that associates with both type 2 and 11 collagens.
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In addition, there are a range of other genes that are up-regulated in HA hydrogels (over
PEG) and are related to ECM synthesis and stabilization. These include chondroitin sulfate Nacetylgalactosaminyltransferase 1 (CSGALNACT1) which is responsible for the initiation and
elongation of chondroitin sulfate synthesis [29], and leucine proline-enriched proteoglycan 1
(LEPRE1) that encodes for a collagen prolyl hydroxylase enzyme that is required for the proper
synthesis and assembly of collagen.

Matrix stabilizers upregulated in HA gels include

hyaluronan and proteoglycan link protein 1 (HAPLN1) and matrilin 3 (MATN3). HAPLN1, also
regulated by Sox9, stabilizes HA-aggrecan interaction and can form ternary complexes with
versican and HA [30,31].

Matrilins are non-collagenous ECM adapter proteins that form

filamentous networks connecting type 2 and type 9 collagen, aggrecan, small proteoglycans, and
cartilage oligomeric matrix protein (COMP). MATN1 and 3 are cartilage specific and microarray
studies have shown that these are among the most up-regulated ECM proteins during MSC
chondrogenesis [9]. Pei et al. showed that MATN1 and 3 work in conjunction with TGF-β1 to
maintain and enhance chondrogenesis with increased GAG accumulation [32].

The most

differentially up-regulated gene (48-fold) was C-type lectin domain family 3, member A (CLEC3A).
This sugar-binding protein, found only in cartilage, likely plays a role in matrix organization or the
formation of fibrillar structures, and is most abundant in the epiphysis region, where considerable
remodeling of the ECM is performed [33].

CLEC3A is cleaved by MMP-7, which was also

differentially up-regulated in the HA group. While some matrix metallopeptidases (MMPs) are upregulated, others like MMP-13, which preferentially cleaves type 2 collagen, are down-regulated.
Genes associated with signaling pathways that regulate chondrocyte maturation were
also differentially regulated.

These include signaling molecules like Indian hedgehog (IHH),

parathyroid hormone-like hormone (PTHLH), Wnts, and Smads which play important roles in
skeletal development and function. IHH promotes chondrocyte proliferation and maturation while
PTHLH is its antagonist inhibiting chondrocyte maturation [34].

Wnt5a has been shown to

promote early chondrogenesis and inhibit terminal hypertrophic differentiation, while Wnt-1 and 7a increase cell adhesion and arrest of chondrogenic differentiation [35].

In this microarray
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experiment, IHH was up-regulated in HA hydrogels, indicating the potential for eventual
hypertrophic differentiation. However, type 10 collagen, a common hypertrophic marker, was not
differentially up-regulated.
Using Ingenuity pathway analysis, growth differentiation factor 2 (GDF2), bone
morphogenetic protein-2 (BMP-2), and PTHLH were recognized as potential key players in
differential gene regulation, as several downstream genes were differentially up-regulated in HA
over PEG hydrogels. GDF2 regulates cell growth and differentiation, while BMP-2 and PTHLH
regulate cartilage and bone formation. Microarray results are also in agreement with real time
PCR data.
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Figure 8.12 Heat map comparison of MSC-laden HA and PEG hydrogels after 14 days of in vitro
culture.

Significantly up-regulated (red) and down-regulated (green) genes in HA hydrogels

compared to PEG hydrogels, with a false discovery rate < 5%. Black denotes no significant
difference.
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8.4 Conclusions
This chapter demonstrated that MSCs are capable of undergoing chondrogenesis in
photocrosslinked HA hydrogels in vitro and in vivo in short-term culture.

Gene expression

showed that scaffold choice affects the expression of cartilaginous matrix proteins, where
favorable cell/scaffold interactions can assist in chondrogenic differentiation.

Though the

mechanisms behind this interaction are not well understood, the microarray data has provided
some insight on genes of interest to be further investigated. Additionally, we have shown that
TGF-β3 can be delivered within HA hydrogels and alter gene expression of encapsulated MSCs
in vivo. The following chapter will address methods to optimize the MSC-laden HA hydrogel
system for enhanced ECM distribution and tissue maturation.
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CHAPTER 9
Synthesis of Hydrolytically Degradable Hyaluronic Acid Hydrogels

(Adapted from: S Sahoo, C Chung, S Khetan, JA Burdick, “Hydrolytically degradable hyaluronic acid
hydrogels with controlled temporal structures,” Biomacromolecules, 2008, 9(4):1088-92. C Chung, M
Beecham, RL Mauck, JA Burdick, “The Influence of Degradable Characteristics of Hyaluronic Acid
Hydrogels on In Vitro Neocartilage Formation by Mesenchymal Stem Cells.” Biomaterials, 2009,
Epub.

9.1 Introduction
HA is a linear polysaccharide of alternating D-glucuronic acid and N-acetyl-Dglucosamine, found natively in many tissues (e.g., cartilage)[1-3], and degrades primarily by
hyaluronidases found throughout the body or through oxidative mechanisms to yield
oligosaccharides and glucuronic acid[4].

HA plays a role in cellular processes like cell

proliferation, morphogenesis, inflammation, and wound repair, and interacts with cells through
surface receptors (CD44, CD54, and CD168)[1,2,5,6]. These biological interactions make HA a
candidate for the development of biomaterials that can directly interact with cells.
Importantly, HA can be readily modified through its carboxyl and hydroxyl groups to form
hydrogels in the presence of water[7-13]. These hydrogels have found numerous applications in
tissue regeneration [8,13-15], drug delivery[12], and microdevices[16]. However, the design of
these current hydrogels is limiting in that (i) enzymes are needed to degrade the hydrogel, which
can hinder the diffusion of growth factors, migration of cells, and distribution of extracellular matrix
proteins if enzymes are not abundant and (ii) degradation products are typically modified forms of
HA (e.g., due to methacrylate addition) rather than potentially biologically active unmodified
HA[17-20]. Although an ester group may exist between the HA backbone and the reactive group,
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this bond is typically very stable, potentially due to steric hindrance or the hydrophobicity of the
surrounding chemical groups.
These limitations motivated our work in designing the next generation of HA hydrogels
with superior properties. Specifically, we sought to design a new macromer that forms hydrogels
that are hydrolytically degradable to allow further control over their structures towards a range of
biological applications.

These macromers can be polymerized into hydrogels alone or

copolymerized with other macromers to produce hydrogels with diverse properties, specifically
related to temporal structures with degradation. Here, we report the synthesis of the novel HA
macromer and illustrate potential diversity in applications through the release of drugs and
interactions with cells.

9.2 Materials & Methodology
9.2.1 Methacrylated HA (MeHA) Macromer Synthesis
MeHA was synthesized as previously stated (chapter 4, section 4.2) by the addition of
methacrylic anhydride (~20-fold excess, Sigma) to a solution of 1 wt% HA (Lifecore, 64 kDa) in
deionized water adjusted to a pH of 8 with 5 N NaOH and reacted on ice for 24 hours[7,21]. For
purification, the macromer solution was dialyzed (MW cutoff 5-8kDa) against deionized water for
at least 48 hours and the final product was obtained by lyophilization.

1

H NMR was used to

determine the final functionality and purity of the MeHA. The reaction schematic for the synthesis
of MeHA can be found in chapter 4.

9.2.2 Methacrylated Lactic Acid HA (MeLAHA) Macromer Synthesis
The reaction schematic for MeLAHA is illustrated in Figure 9.1.

2-hydroxyethyl

methacrylate (HEMA) (Across organics) is reacted with dl-lactide (Polysciences) in a 1:1.5 molar
ratio via a ring opening polymerization (110ºC, 1 hour, under nitrogen) in the presence of a
catalytic amount of stannous octoate (tin 2-ethylhexanoate) (Sigma) to obtain MeLA-OH.
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Hydroquinone (Sigma) was added in trace amounts to the reaction mixture to inhibit free-radical
polymerization of the methacrylate groups. The number of lactic acid units was determined by 1H
NMR from the ratio of the integral area of the methacrylate peak and the methylene peak of the
lactic acid unit.
The hydroxyl end group was converted into a carboxylic acid via a 1:1 reaction of MeLAOH

with

succinic

anhydride

(Sigma)

in

the

presence

of

pyridine

(Sigma)

and

dimethylaminopyridine (DMAP) (Sigma) in anhydrous tetrahydrofuran (THF) at 50ºC for 24 hours
under nitrogen to obtain MeLA-COOH.

After cooling to room temperature, the solvent was

evaporated under vacuum and the residue was dissolved in dichloromethane followed by three
washes with a 0.1M HCL solution. The organic phase was dried over magnesium sulfate and
concentrated in a rotary evaporator, and kept at 4°C until used further.
The end group of the MeLA-COOH was functionalized by reacting with Nhydroxysuccinimidyl (NHS) (Sigma) and dicyclohexylcarbodiimide (DCC) (Acros organics) in a
1:1:1 molar ratio in anhydrous dichloromethane at 0ºC for 4 hours, followed by room temperature
for 24 hours under nitrogen to obtain MeLA-NHS. Insoluble N.N’-dicylcohexyl urea (DCU) was
removed by filtration and the filtrate was concentrated by rotary evaporation. In order to solubilize
HA in dimethyl sulfoxide (DMSO), the sodium salt of HA (Lifecore, 64 kDa) was converted to a
tetrabutylammonium (TBA) (Sigma) salt by acidic ion exchange at room temperature for 8 hours
with Dowex 50 W x 8-200 resin (Acros), filtered, and neutralized in aqueous TBA hydroxide. The
TBA-HA was then lyophilized and stored at -20ºC until further use.
TBA-HA was coupled with MeLA-NHS in anhydrous DMSO in the presence of
triethylamine at 40ºC for 24 hours. The reaction was cooled to room temperature and a 2.5 wt%
sodium chloride solution (20% (v/v)) was added to exchange the TBA salt with a sodium salt.
The resultant solution was purified through precipitation in acetone to obtain MeLAHA, which was
stored in acetone at -20ºC until use.
Each product was confirmed by 1H NMR (Bruker DMX 360 and 300 MHz spectrometer).
Diffusion-ordered NMR spectroscopy (DOSY) spectrum were recorded using stimulated echo
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pulse sequence using bipolar gradients with a longitudinal eddy current delay in Bruker DMX 600
MHz NMR spectrometer having z-gradient (maximum strength of 70 G/cm). The sine shaped
gradient pulse with 3.0 ms duration was logarithmically incremented in 32 steps, from 2% up to
95% of maximum gradient strength. Diffusion time was set to 300 ms and a longitudinal eddy
current delay of 5 ms was used. After Fourier transformation and base line correction, DOSY
spectrum was processed using Bruker Topspin software’s DOSY package.
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Figure 9.1 Reaction schematic for the synthesis of MeLAHA.
9.2.3 Methacrylated Caprolactone HA (MeCLHA) Macromer Synthesis
The synthesis of methacrylated caprolactone HA (MeCLHA) was based on that of
MeLAHA with slight modifications to simplify the reaction scheme (Figure 9.2). 2-hydroxyethyl
methacrylate (HEMA) (Acros organics) was reacted with ε-caprolactone (Sigma) via a ring
opening polymerization in the presence of stannous octoate (Sigma) at 130°C for 1hr to obtain
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MeCL-OH. The end group was then functionalized into a carboxylic acid (MeCL-COOH) via
reaction with succinic anhydride (Sigma) in the presence of N-methylimidazole at 65°C in
dichloroethane for 13 hrs. MeCL-COOH was washed three times in 0.1M HCL solution. The
organic phase was dried over magnesium sulfate, filtered, concentrated in the rotary evaporator,
and kept at 4°C until use.
Again, the sodium salt form of HA was converted to a TBA salt by acidic ion exchange
with Dowex 50 W x 8-200 resin for solubilization in DMSO. MeCL-COOH was coupled to TBAHA via an esterification reaction with di-t-butyl dicarbonate (BOC2O) as an activating agent with
DMAP[22] for 20 hrs at 45ºC in anhydrous DMSO. A 2.5 wt% sodium chloride solution (20%
(v/v)) was added to exchange the TBA salt with a sodium salt. The final product (MeCLHA) was
precipitated and washed in acetone, dissolved in DI water, dialyzed (MW cutoff 6-8k) for 24 hours
at 4ºC, lyophilized, and stored at -20ºC in powder form prior to use. The intermediate and final
macromer products were confirmed by 1H NMR.
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Figure 9.2 Reaction schematic for the synthesis of MeCLHA macromer.
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9.2.4 Hydroxyethyl Methacrylated HA (Hema-HA) Macromer Synthesis
Hydroxyethyl methacrylated HA was synthesized in the same manner as MeCLHA minus
the initial ring opening polymerization. 2-hydroxyethyl methacrylate was functionalized to HEMACOOH via reaction with succinic anhydride in a 1:1 molar ratio in the presence of Nmethylimidazole at 65°C in dichloroethane for 13 hrs, and then coupled to TBA-HA via an
esterification reaction with BOC2O with DMAP for 20 hrs at 45°C in anhydrous DMSO. The final
product (HEMA-HA) was precipitated and washed in acetone, dissolved in DI water, dialyzed
(MW cutoff 6-8k) for 4-6 hour, frozen, lyophilized, and stored in powder form at -20°C until use.
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9.2.5 Hydrogel Formation and Acellular Characterization
Hydrogels were synthesized by dissolving the HA macromers at various concentrations
and compositions in phosphate buffered saline (PBS), with 0.05 wt% photoinitiator, 2-methyl-1-[4174

hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959). The macromer solution was then
placed into a mold (5 mm diameter, 2 mm thick) and polymerized with ~ 2mW/cm2 ultraviolet light
(~365 nm, EIKO bulb) for 10 minutes. For degradation studies, hydrogels (n = 3 per composition)
were placed in separate wells of a 24-well plate containing 1 ml of PBS and placed on an orbital
shaker at 37°C. PBS solution was changed at every time point, and the amount of uronic acid (a
degradation component of HA) released during degradation was measured using a previously
established carbazole reaction technique[23,24] (Chapter 4, section 4.2).

9.2.6 Short-Term Cell Viability and Matrix Elaboration In Vitro
Mesenchymal stem cells (MSCs) (Lonza) were expanded to passage 4 in growth media
consisting

of

α-MEM

with

16.7%

FBS

and

1%

penicillin/streptomycin,

and

then

photoencapsulated (20 million cells/ml) in various MeHA: MeLAHA copolymer hydrogels (2:0,
1.5:0.5, 1:1, and 0.5:1.5 MeHA wt%: MeLAHA wt%).

Cell-laden hydrogels were cultured in

DMEM supplemented with 1% penicillin/streptomycin, 1% ITS+, 1mM sodium pyruvate, 40mg/ml
L-proline, 100nM dexamethasone, 50μg/ml ascorbic acid 2-phosphate, and 10 ng/ml of TGF-β3
(chondrogenic media, CM+) for up to 2 weeks in vitro. Cell viability was quantified using MTT
viability assay (ATCC) as measured by mitochondrial activity. Matrix distribution was visualized
by immunohistochemical staining for chondroitin sulfate (CS) after 2 weeks of culture. Samples
were fixed in 10% formalin for 24 hours, embedded in paraffin, and processed using standard
histological procedures. The histological sections (7 μm thick) were stained for CS using the
Vectastain ABC kit (Vector Labs) and the DAB Substrate kit for peroxidase (Vector Labs).
Sections were predigested in 0.5 mg/ml hyaluronidase for 30 min at 37ºC and incubated in 0.5N
acetic acid for 4 hours at 4ºC to swell the samples prior to overnight incubation with primary
antibody at 1:100 (mouse monoclonal anti-chondroitin sulfate, Sigma). Non-immune controls
underwent the same procedure without primary antibody incubation. Hematoxylin and eosin
(H&E) staining was also performed.
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9.3 Results & Discussion
The inclusion of hydrolytically degradable repeat units between the HA backbone and the
polymerizing moiety (e.g., methacrylate) yielded hydrolytically degradable HA macromers that
formed hydrolytically degradable hydrogels.

Since α-hydroxy esters (e.g., lactic acid,

caprolactone) are highly versatile in design, hydrolyzable, and approved by the FDA for several
biomedical applications[25,26], they were ideal groups to incorporate into the hydrogel.

By

changing the number and type of degradable repeat units, hydrogels could be tunable with
respect to degradation, structure, and mechanical properties.

9.3.1 Synthesis of MeLAHA Macromer
Lactic acid was polymerized off the hydroxy terminal group of HEMA using a ring opening
polymerization of lactide monomer in the bulk phase with stannous octoate as a catalyst to form a
hydroxyl terminated methacrylated poly(lactic acid) (MeLA-OH). The polymerization proceeds
through a coordination-insertion mechanism and the number of lactic acid repeat units is readily
controlled through the stoichiometric amount of lactide monomer to HEMA used in the reaction.
The 1H NMR spectrum of this polymer (Figure 9.4A) displayed characteristic resonances for the
methacrylate protons at δ 6.12 and 5.60 ppm and –CH and –CH3 protons of lactic acid at δ 5.19
and 1.52 ppm, respectively. From the integration ratio of the –CH proton corresponding to the
lactic acid units to the methylene protons of the methacrylate group, the number of lactic acid
repeat units was estimated (~3 for reported experiments). Importantly, the number of degradable
units can be used to control the hydrolysis rate of hydrogels incorporating lactic acid[27], with
more repeat units leading to more rapid degradation based on the probability of ester cleavage.
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A

MeLA-OH

B

MeLA-COOH

C

MeLA-NHS

Figure 9.4 1H NMR spectrum (CDCl3) of (A) MeLA-OH, (B) MeLA-COOH, and (C) MeLA-NHS.
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For coupling to HA, it was not possible to directly react the free hydroxyl group of MeLAOH with HA since HA possesses both carboxylic acid and hydroxyl groups that would interfere
with the reaction. Thus, the hydroxyl group of lactic acid was converted to a carboxylic acid
through an esterification reaction with succinic anhydride in the presence of pyridine and DMAP
as an esterification catalyst (Figure 9.1) to form a carboxyl terminated methacrylated poly(lactic
acid) (MeLA-COOH). The reaction was carried out in anhydrous THF since the acid anhydride is
subjected to hydrolysis in aqueous medium. The conversion of –OH to –COOH was confirmed by
1

H NMR (Figure 9.4B) with the δ 2.72 ppm resonance corresponding to the – (CH2)2 group of

succinic anhydride observed in the spectrum. The NHS ester derivative was formed for coupling
to HA through reaction of MeLA-COOH with NHS in the presence of DCC, where DCC promotes
esterification by reacting with the end carboxyl group through nucleophilic substitution. The final
product (MeLA-NHS) was obtained after filtering DCU as the byproduct and 1H NMR confirmed
successful modification (Figure 9.4C).
Since the solubility of the sodium salt of HA (Figure 9.5A) is limited to aqueous solutions
and the MeLA-NHS is not water-soluble, HA was converted to its TBA salt (Figure 9.5B) to make
it soluble in highly polar organic solvents.

After freeze-drying, HA-TBA was dissolved in

anhydrous DMSO and reacted with TEA and MeLA-NHS for coupling.

The product was

converted back to the sodium salt and precipitated in acetone to form MeLAHA.

The

derivatization reaction was confirmed by 1H NMR analysis (Figure 9.6) and exhibited distinct
resonances from the –CH3 protons of lactic acid at δ 1.58 ppm and the two protons of the
methacrylate at δ 6.18 and 5.80 ppm. The degree of modification (~10.5%) was determined by
the peak areas of the HA backbone and those of methacrylate groups.
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A

Na-HA

B

TBA-HA

Figure 9.5 1H NMR spectrum (D2O) of (A) sodium and (B) TBA salt of hyaluronic acid.

MeLAHA

Figure 9.6 1H NMR spectrum (D2O) of MeLAHA macromer (n=~3, 10.5% modification).
179

DOSY was used to analyze the purified MeLAHA product (Figure 9.7 B, D) to
discriminate between different components of the sample by their chemical shift and diffusion
behavior simultaneously. The separation in the diffusion dimension among various peaks is
based on the self-diffusion coefficient of different species present in the solution.

In DOSY

spectrum, molecules with lower molecular weights exhibit higher diffusion coefficients compared
to polymers. However, if the same small molecule is attached to the polymer chain, the selfdiffusion coefficient will be similar to the polymer.

A

C

B

D

Figure 9.7 DOSY spectrum of (A) a two component mixture of unmodified HA and MeLA-OH, (B)
unmodified HA, (C) HA-TBA, (D) and MeLAHA, which demonstrates successful coupling.
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Comparing DOSY spectra (Figure 9.7B and D), it is clear that peaks due to MeLA (1.03.0 ppm and > 5.0 ppm) shows similar diffusion coefficient as the HA peaks and confirms the
coupling of MeLA to HA. In contrast, physical mixing of MeLA and HA shows significantly higher
diffusion coefficient values for MeLA compared to HA (Figure 9.7 A and B). In addition, a slight
reduction in the overall diffusion coefficient of MeLAHA was observed after coupling, indicating a
higher molecular weight compared to unmodified HA.

9.3.2 Synthesis of MeCLHA and Hema-HA Macromers
With successful synthesis of the MeLAHA macromer, MeCLHA and Hema-HA
macromers were synthesized to further tailor hydrogel properties. Successful syntheses of these
macromers were verified by 1H NMR (Figure 9.8), displaying characteristic resonances for the
methacrylate protons at δ 6.12 and 5.60 ppm, –CH2 protons (labeled as 11, Figure 9.8A) of
caprolactone at δ 2.28 ppm, and –CH2 protons (labeled as 7 and 8, Figure 9.8B) of Hema-COOgroup at δ 2.65 ppm. The number of caprolactone repeats was estimated by integrating the ratio
of methacrylate protons and the –CH2 protons corresponding to caprolactone, and determined to
be ~3.8 repeat units for all experiments. From the integration ratio of methacrylate protons and
the 10 protons on the HA backbone between δ 3.2-4.1 ppm, the degree of modification was
determined to be 7.5% and 6.2% for MeCLHA and Hema-Ha, respectively.
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9.3.3 Characterization of Hydrolytically Degradable HA Hydrogels
In this system, a variety of parameters can be readily controlled. These include: the
molecular weight of the HA, the type (e.g., lactic acid, caprolactone), the number of hydrolytically
degradable repeat units, the extent of coupling (percent of HA repeat units modified), and the
concentration of macromer used for hydrogel formation.
For degradation studies, homopolymer hydrogels of varying type (MeLAHA, MeCLHA,
Hema-HA) and macromer concentrations (1 to 5 wt%) were incubated in PBS at 37°C and
monitored for HA release with time.

All hydrogels degraded in PBS without the addition of

exogenous hyaluronidase enzyme, whereas enzymatically degradable MeHA hydrogels required
exogenous enzyme for complete degradation (Chapter 4).

In addition, these hydrolytically

degradable hydrogels swell over time, suggesting a bulk degradation mechanism. Increases in
macromer concentration, i.e., increases in crosslinking density, result in increased degradation
time for all polymer types (Figure 9.9). However, notable differences among macromer types
were observed, with the fastest degradation seen in MeLAHA hydrogels and the slowest
degradation seen in MeCLHA hydrogels (2wt% hydrogels degraded in 2.5 days and 7 days,
respectively), where slight differences in local hydrophobicity surrounding the ester linkages can
result in the differences in degradation profiles of these hydrogels.

Though the number of

hydrolytically degradable units was not altered in this study, increases in the number of repeat
units would increase degradation rate as the probability of hydrolysis is increased in the hydrogel.
In addition, MeHA and hydrolytically degradable HA macromers can be copolymerized to
further fine tune hydrogel degradation profiles (Figure 9.10). These differential degradation
profiles can be utilized, as others have done with purely synthetic hydrogels [28,29], to enhance
matrix distribution within the hydrogel, which will discussed in further detail in the following
chapter.
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9.3.4 Cell Viability and Matrix Elaboration
To assess the utility of hydrolysis in copolymer hydrogels for matrix elaboration, MSCs
were encapsulated in hydrogels and cultured in chondrogenic media. Viability (Figure 9.11A) as
measured by mitochondrial activity after 7 days showed no statistical difference between all
groups, indicating that the addition of MeLAHA did not compromise the viability of the
encapsulated cells. The insignificant decrease in mitochondrial activity in the 0.5:1.5 hydrogels
may have resulted from a loss of cells to culture media, as this composition contained the
greatest portion of MeLAHA which is mostly degraded by 2 weeks. Overall, by increasing the
MeLAHA content within the copolymer hydrogels, an increase in chondroitin sulfate deposition
and distribution was observed (Figure 9.11B), where the 2:0 hydrogels exhibited pericellular
staining compared to more homogeneous distribution of ECM in the 0.5:1.5 hydrogels .
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9.4 Conclusions
In summary, the synthesis of hydrolytically degradable HA macromers and formation of
HA hydrogels capable of both hydrolytic and enzymatic degradation was achieved. The tunable
degradative component of this system provides enhanced control over hydrogel properties.
Others have shown that hydrogel chemistry and hydrogel properties (e.g., mechanics and
degradation) may play a role in the differentiation of stem cells and matrix distribution[30-32].
Therefore, this HA system can be optimized to tailor the stem cell microenvironment, control stem
cell differentiation, and enhance the deposition and distribution of cartilaginous matrix proteins.
The next chapter (chapter 10) will explore the long-term effects of temporal degradation in HAbased hydrogels on neocartilage formation.
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CHAPTER 10
Influence of Temporal Degradation on
Matrix Deposition in Hyaluronic Acid Hydrogels
(Adapted from: C Chung, M Beecham, RL Mauck, JA Burdick, “Tailored Hydrogel Crosslinking and
Degradation to Enhance Neocartilage Formation by Mesenchymal Stem Cells,” Biomaterials, 2009, in
press)

10.1 Introduction
In efforts to develop clinically translatable approaches for cartilage repair, mesenchymal
stem cells (MSCs) have been shown to undergo chondrogenesis and deposit neocartilage in a
variety of tissue engineering scaffolds[1].
properties of native tissues.

However, we are still limited in recapitulating the

For example, Mauck et al[2] showed that the biochemical and

mechanical properties of matured MSC-laden agarose scaffolds are lower than those containing
donor matched chondrocytes. The diminished ability of MSCs to produce functional cartilage
tissue is troubling, as the quality of tissue they produce determines their success as a viable cell
source for cartilage repair and regeneration. Beyond the amount and type of matrix produced,
the distribution of this matrix is essential for the optimization of tissue properties (e.g.,
mechanics). Thus, the design of biomaterials that support the distribution of formed tissue is
crucial for the optimization of neocartilage formation by MSCs.
Hyaluronic acid (HA) hydrogels are formed by the simple addition of a reactive group to
the HA backbone and subsequent crosslinking[3]. These hydrogels are tunable, where hydrogel
parameters can be varied by degree of methacrylation, macromer molecular weight, and
macromer concentration, providing a wide range of hydrogel properties (e.g., volumetric swelling
ratios, mechanical properties)[4], and undergo enzymatic degradation via hyaluronidases. For
applications in cartilage repair, we have shown that these HA hydrogels not only support and
maintain chondrocyte viability and phenotype when cultured in vitro and in vivo [5,6], but also that
HA hydrogel chemistry supports and promotes the chondrogenic differentiation of MSCs[7,8].
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However, ECM distribution is limited without adequate space for diffusion in these slow
enzymatically degrading hydrogels and techniques to better control network evolution with culture
are needed.
Ideally, scaffold degradation should coincide with ECM deposition and accumulation. In
engineered hydrogel scaffolds, degradation can alter the diffusion of nutrients and waste, cellscaffold interactions, and the distribution and retention of ECM proteins. Therefore, to tailor
temporal degradation of a scaffold, others have introduced hydrolytically degradable
components[9], matrix metalloproteinase (MMP)-sensitive peptides[10,11], and/or exogenous
enzymes[12,13] into scaffold designs.

In the previous chapter, we engineered hydrolytically

degradable HA macromers with the inclusion of poly(caprolactone) between the HA backbone
and the polymerizing moiety (e.g., methacrylate). In this study, the long-term effects of temporal
network structure on neocartilage formation by MSCs in vitro were investigated. We present a
system that exploits both the advantages of HA in cartilage regeneration, as well as tunable
degradation for the optimization of engineered tissue properties.

10.2 Materials & Methodology
10.2.1 Macromer Syntheses
Methacrylated HA (MeHA) was synthesized as reported in previous chapters [3]. Briefly,
methacrylic anhydride (Sigma) was added to a solution of 1 wt% HA (Lifecore, MW = 74 kDa) in
deionized water, adjusted to a pH of 8 with 5 N NaOH, and reacted on ice for 24 hours. The
macromer solution was purified via dialysis (MW cutoff 6-8k) against deionized water for a
minimum of 48 hours with repeated changes of water.

The final product was obtained by

lyophilization and stored at -20ºC in powder form prior to use.
Methacrylated caprolactone HA (MeCLHA) was synthesized as reported in Chapter 9.
Briefly, 2-hydroxyethyl methacrylate (HEMA) (Acros organics) was reacted with ε-caprolactone
(Sigma) via a ring opening polymerization in the presence of stannous octoate (Sigma) at 130°C
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for 1hr. The end group was then functionalized into a carboxylic acid (MeCL-COOH) via reaction
with succinic anhydride (Sigma) in the presence of N-methylimidazole at 65°C in dichloroethane
for 13 hrs. The sodium salt form of HA was converted to a tetrabutylammonium (TBA) salt by
acidic ion exchange with Dowex 50 W x 8-200 resin, followed by resin filtration and neutralization
with aqueous TBA hydroxide for solubilization in dimethyl sulfoxide (DMSO). MeCL-COOH was
coupled to TBA-HA via an esterification reaction with di-t-butyl dicarbonate (BOC2O) as an
activating agent with dimethylaminopyridine (DMAP)[14] for 20 hrs at 45ºC. The final product
(MeCLHA) was precipitated and washed in acetone, dissolved in DI water, dialyzed (MW cutoff 68k) for 24 hours at 4ºC, lyophilized, and stored at -20ºC in powder form prior to use. The
intermediate and final macromer products were confirmed by 1H NMR. Lyophilized macromers
were dissolved in phosphate buffered saline (PBS) containing 0.05 wt% 2-methyl-1-[4(hydroxyethoxy)phenyl]-2-methyl-1-propanone (I2959, Ciba) for photopolymerization.

10.2.2 Acellular Characterization
To monitor swelling and mechanical properties over time, acellular copolymer hydrogels
of MeHA and MeCLHA were formed at various wt% ratios (5:0, 4:1, 3:2, 2:3, 2:0, 1.5:0.5, 1:1, 1:0)
and incubated in PBS at 37°C. Wet and dry (after lyophilization) weights were recorded at each
time point to determine volumetric swelling ratio, as described in chapter 4. The mechanical
properties of the hydrogels were analyzed at various time points for up to 8 weeks in unconfined
compression (Dynamic Mechanical Analyzer Q800, TA Instruments) in a PBS bath. Hydrogels
were compressed at a rate of 10%/min until 60% of the initial thickness was reached. The
modulus was determined as the slope of the stress versus strain profile at low strains (<20%).

10.2.3 MSC Photoencapsulation and Culture
For cell encapsulation, macromers were sterilized using a germicidal lamp in a laminar
flow hood for 30 minutes prior to dissolving in a sterile solution of PBS containing 0.05 wt% I2959
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for polymerization.

Human MSCs (Lonza) were expanded to passage 4 in growth media

consisting of α-MEM with 16.7% FBS and 1% penicillin/streptomycin.

MSCs were

photoencapsulated (20 million cells/mL) in hydrogels (50 μl) of varying macromer concentration
(e.g., 5, 2, and 1 wt%) and type (e.g., MeHA, MeCLHA). Hydrogels consisting of 5:0, 4:1, 3:2,
2:3, 2:0, 1.5:0.5, 1:1, and 1:0 MeHA wt%: MeCLHA wt% (Table 10.1) were cultured in DMEM
supplemented with 1% penicillin/streptomycin, 1% ITS+, 1mM sodium pyruvate, 40mg/ml Lproline, 100nM dexamethasone, 50μg/ml ascorbic acid 2-phosphate, and 10 ng/ml of TGF-β3
(chondrogenic media) for up to 8 weeks in vitro.
Table 10.1 MeHA:MeCLHA hydrogel compositions
Total Macromer wt%

5

2

1

MeHA wt%

MeCLHA wt%

5

0

4

1

3

2

2

3

2

0

1.5

0.5

1

1

1

0

10.2.4 Cellular Characterization
The viability of MSCs in HA hydrogels was assessed using a live/dead cytotoxicity kit
(Molecular Probes) at 1, 7 and 14 days and an Alamar Blue assay (Invitrogen) (n=3) at 7 and 14
days of in vitro culture according to manufacturer’s instructions.
For short term gene expression analysis (3 and 14 days of culture), samples were
homogenized in Trizol Reagent (Invitrogen) with a tissue grinder, RNA was extracted according to
the manufacturer’s instructions, and RNA concentration was determined using an ND-1000
spectrophotometer (Nanodrop Technologies). One microgram of RNA from each sample was
reverse transcribed into cDNA using reverse transcriptase (Superscript II, Invitrogen) and oligoDT
(Invitrogen). Polymerase chain reaction (PCR) was performed on an Applied Biosystems 7300
Real-Time PCR system using a 25μl reaction volume for Taqman (5’-nuclease) reactions.
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Primers and probes specific for glyceraldehydes 3-phosphate dehydrogenase (GAPDH,
housekeeping gene), type I and type II collagen, and aggrecan are listed in Chapter 8, Table 8.1.
Relative gene expression was calculated using the ΔΔCT method, where fold difference was
calculated using the expression 2-ΔΔCt.

Results (n=4-8) from two replicate experiments were

combined and samples with poor RNA quality were excluded.
Additional samples (n=5) were measured (diameter and height), weighed (wet weight)
and tested in unconfined compression on a custom mechanical tester[15,16] after 1, 14, 35, and
56 days of culture. The mechanical tester consists of a computer-controlled stepper motor, a
linear variable differential transformer to measure displacement, and a 250g load cell to measure
load. Labview software (National Instruments) was used for stepper motor control and data
acquisition. Samples were loaded between impermeable glass plates in creep with a 2g tare load
until equilibrium (~300s), followed by stress relaxation with a single ramp displacement of 10%
strain at a rate of 10%/minute. The samples were allowed to relax to equilibrium (~1200s), and
the equilibrium confined compression moduli were calculated by dividing the equilibrium load by
the area loaded and the % strain for each sample.
Mechanically tested samples were then lyophilized, weighed (dry weight), and digested in
a proteinase K solution (200 μg/ml proteinase K (Roche), 100mM ammonium acetate, pH 7.0)
overnight at 60ºC. Proteinase K was then inactivated at 100ºC for 5 min. Total DNA, GAG, and
collagen contents (n=5) were determined using the PicoGreen dsDNA Assay[17], the
dimethylmethylene blue dye method[18] with chondroitin sulfate as a standard, and the
hydroxyproline assay[19] using a collagen to hydroxyproline ratio of 7.25[20,21], respectively.
The proteinase K digestion solution was used as a negative control.
Samples for histological analysis were fixed in 10% formalin for 24 hours, embedded in
paraffin, and processed using standard histological procedures. The histological sections (7 μm
thick) were stained for chondroitin sulfate and collagen distributions using the Vectastain ABC kit
(Vector Labs) and the DAB Substrate kit for peroxidase (Vector Labs).

Sections were

predigested in 0.5 mg/ml hyaluronidase for 30 min at 37ºC and incubated in 0.5 N acetic acid for
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4 hours at 4ºC to swell the samples prior to overnight incubation with primary antibodies at
dilutions of 1:100, 1:200, and 1:3 for chondroitin sulfate (mouse monoclonal anti-chondroitin
sulfate, Sigma), and type I (mouse monoclonal anti-collagen type 1, Sigma) and type II collagen
antibodies (mouse monoclonal anti-collagen type II, Developmental Studies Hybridoma Bank),
respectively.

Non-immune controls underwent the same procedure without primary antibody

incubation.

10.2.5 Statistical Analysis
ANOVA with Tukey’s post-hoc test was used to determine significant differences (p <
0.05). All values are represented as the mean ± standard deviation.

10.3 Results & Discussion
The use of MSCs as a cell source for cartilage repair depends on the ability to form
adequate neocartilage with the use of engineered materials. Due to the avascular nature of
cartilage, native cartilage tissue and engineered constructs rely mainly on diffusion for nutrient
supply and metabolic waste removal. With hydrogels, both the initial and temporal crosslinking
densities control the diffusion of nutrients, wastes, and newly synthesized ECM proteins[4,22].
Thus, by developing techniques to better control network evolution with time, we may be able to
improve overall tissue formation by encapsulated MSCs.

In the previous chapter, we

demonstrated the tunable degradation of the HA hydrogel system by the inclusion of hydrolytically
degradable moieties. In this study, we investigated the effects of network evolution on in vitro
neocartilage formation by encapsulated human MSCs in HA hydrogels.

10.3.1 Acellular Characterization
Coupled to changes in hydrogel degradation, the swelling and mechanical properties of
the hydrogel change with time in these copolymer hydrogels. The use of copolymer hydrogels
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were chosen to provide network stability while incorporating temporal degradation.

Macromer

concentrations (1, 2, and 5 wt%) were chosen based on cell viability, which was compromised at
high crosslinking densities (Chapter 4), and the formation of a stable scaffold after
photopolymerization, where concentrations lower than 1 wt% did not form a hydrogel.

The

solubility of MeCLHA dictated an upper limit to the various ratios of MeHA to MeCLHA. As both
2wt% MeLAHA and Hema-HA degraded rapidly, MeCLHA was chosen for further studies.
The elastic moduli of acellular hydrogels are dictated by total macromer concentration,
macromer composition, and hydrogel degradation. Initial moduli (1 day after polymerization)
significantly decreased with decreasing macromer wt% and decreases in moduli were observed
over time coinciding with increased hydrogel degradation (Figure 10.1). The differences in elastic
moduli within wt% groups (5, 2, and 1 wt%) between homopolymer and copolymer hydrogels can
be attributed to different degrees of HA macromer modification, where MeHA modification was ~3
times greater than that of MeCLHA, or from degradation differences within the first 24 hours,
which would both result in decreased crosslinking densities.

In addition, slight temporal

decreases in the elastic moduli of MeHA only (5:0, 2:0, 1:0) hydrogels were also observed.
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Figure 10.1 Elastic moduli of

Elastic M odulus (kPa)

40

MeHA:MeCLHA

35
30

hydrogels at various wt% ratios

≠

25

copolymer

20

for 1 (white), 7 (gray), and 14

15

(shaded)

days.

Significant

10

difference (p<0.05) in moduli

5
0
5:0

4:1

3:2
5 wt%

2:3

2:0

1.5:0.5
2 wt%

1:1

1:0
1 wt%

over time within each group is
denoted by ≠.

The volumetric swelling ratios (Qv) were calculated from wet and dry weights of the
hydrogel at specific time points and were found to be inversely related to total macromer
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concentration and increased with incubation time ranging from 32.5 ± 2.5 to 68.5 ± 3.6 at day 1
and increasing to 40.8 ± 3.3 to 70.1 ± 8.2 by day 56 (Table 10.2). Initial volumetric swelling ratios
within each wt% groups were insignificantly different, suggesting that macromer wt% plays a
more prominent role in swelling than crosslinking density, where higher concentrations of the
negatively charged HA macromer result in the greater retention of water within the hydrogel.
However, as HA is released from the hydrogel via hydrolytic degradation, swelling ratios increase
with the increased mesh size.

Table 10.2 Volumetric swelling ratios (n=3). Values are reported as mean ± standard deviation.
[Macromer]

wt% MeHA: wt% MeCLHA

5 wt%

2 wt%

1 wt%

Qv, t = 1 day

Qv, t = 56 day

5:0

36 ± 2

41 ± 3

4:1

37 ± 4

42 ± 5

3:2

33 ± 3

47 ± 4

2:3

36 ± 2

52 ± 2

2:0

51 ± 14

63 ± 6

1.5:0.5

47 ± 5

68 ± 9

1:1

67 ± 3

67 ± 2

1:0

68 ± 4

70 ± 8

10.3.2 Cellular Characterization
The photoencapsulated MSCs retained rounded cell morphologies in all hydrogels.
Viability assessed by live/dead staining indicated greater than 90% viability in hydrogels for
cultures up to 14 days in vitro with only a slight increase in the fraction of dead cells for 5:0
hydrogels at day 14 (Figure 10.2). This slight decrease in viability in the 5:0 hydrogels (the most
densely crosslinked of the hydrogels investigated) may have resulted from nutrient and waste
diffusion limitations or increased radical concentrations during crosslinking, while the inclusion of
a hydrolytically degradable component in copolymer counterparts allowed for the maintenance of
cell viability. All groups showed comparable metabolic activity as measured by the Alamar blue
assay up to 14 days of in vitro culture with the exception of a decrease in metabolic activity in 1:0
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hydrogels from day 7 to day 14 (Figure 10.3). There were no significant increases or decreases
in metabolic activity between day 7 and day 14 in all hydrogels, suggesting limited proliferation in
these environments.

Day 1

Day 14

5:0

3:2

2:0

1:0

1:1

5 wt%

2 wt%

1 wt%

Figure 10.2 Representative Live (green)/ Dead (red) stains of MeHA:MeCLHA copolymer
hydrogels after 1 and 14 days of culture. Scale bar = 200μm.
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5 wt%

2 wt%

1:1

1:0
1 wt%

Figure 10.3 Metabolic activity (n=3), as measured by Alamar blue assay, of MSC-laden HA
constructs at 7 (black) and 14 (white) days of in vitro culture.
199

10.3.3 Gene Expression Analysis
Short-term gene expression for type I and type II collagen and aggrecan was assessed
after 3 and 14 days of in vitro culture. Type II collagen and aggrecan are positive markers for
chondrogenic differentiation, while type I collagen indicates transformation to a more
fibrochondrocytic phenotype. Each sample was internally normalized to GAPDH, and each group
was normalized to expression of MSCs isolated at the time of encapsulation (i.e., after expansion
and before differentiation); thus, relative expression greater than 1 represents up-regulation with
culture, while relative expression less than 1 represents down-regulation of that gene compared
to that of initially encapsulated MSCs. No significant differences between groups were observed
for type I collagen at either of the two time points, and overall expression of type I collagen was
not significantly different compared to initially encapsulated MSCs (Figure 10.4A). Up-regulation
of type II collagen (note that the plot is on a log-scale) and aggrecan expression was indicative of
chondrogenic differentiation in all hydrogels and was found to be statistically higher at day 3 for
the 1:1 and 1:0 hydrogels compared to all other groups (Figure 10.4). At day 14, an increasing
trend of aggrecan expression in 2 wt% hydrogels was observed with increased MeCLHA content.
Furthermore, the 1:1 hydrogels exhibited significantly higher type II collagen and aggrecan
expression over both 2:0 and 1:0 hydrogels. Relative gene expression of type II collagen for 5, 2,
and 1 wt% MeHA only hydrogels were also all significantly different from each other at day 14.
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Figure 10.4 Relative gene expression of (A) type I collagen, (B) type II collagen, and (C)
aggrecan for all HA hydrogel formulations after 3 (white) and 14 (black) days of culture.
Statistical analysis of relevant comparisons: * denotes significant difference between starred
groups and all other groups for the specified time point and # denotes significant difference
between bracketed groups.
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10.3.4 Long-Term In Vitro Culture
With longer culture, samples demonstrated varying degrees of neocartilage formation;
macroscopically, 2 and 1 wt% hydrogels were more opaque in appearance after 8 weeks of in
vitro culture compared to higher wt% hydrogels (Figure 10.5 top).

Significant differences in

hydrogel diameters were observed among groups at various time points and within individual
formulations with culture time. The initial hydrogel diameters were dependent on total macromer
concentration, with significant decreases in diameter with decreased macromer wt%.

As

mentioned in the previous chapter, macromer wt% may play a more prominent role in initial
hydrogel swelling and size than crosslinking density, where the higher concentrations of the
negatively charged HA macromer result in the greater retention of water within the hydrogel.
Though no significant differences in diameter were found within each 5, 2 and 1 wt% groups
initially, regardless of the formulation; at later time points, a general trend of increased diameter
was noticed in 5 wt% hydrogels with increased MeCLHA content (Figure 10.5A). Increased
hydrogel diameters in 5 and 2 wt% groups over time reflect hydrogel degradation, as temporal
decreases in crosslinking density allow for increased volumetric swelling, as well as ECM
elaboration and neocartilage formation.

Changes in height were less noticeable as height

dimensions were smaller than corresponding diameter measurements and may have been limited
by the measuring technique.

With culture, all 5 and 2 wt% hydrogel diameters increased with

culture time, while slight but insignificant increases in height for some compositions were also
observed (Figure 10.5B). Overall, the most notable difference in hydrogels dimensions was seen
with 1:0 hydrogels, as these hydrogels were significantly smaller in diameter and height
compared to all other groups at every time point (Figure 10.5A and B). These differences in
hydrogel dimensions may result from cell-scaffold interactions, where MSCs are able to undergo
cellular condensation in the less crosslinked and weaker 1 wt% MeHA hydrogels.
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Trends in hydrogel dimensions were also correlated to hydrogel wet weight (Figure
10.5C). Again, wet weights of 1:0 hydrogels were significantly lower than all other groups at all
time points. Also, a general trend in 5 wt% hydrogels of increased wet weight with increased
MeCLHA content was observed, where at day 35 the wet weight of 5:0 hydrogels were
significantly lower than that of all other 5 wt% hydrogels.

10.3.5 Mechanical Properties
When mechanically tested in uniaxial, unconfined compression, changes in the
compressive equilibrium modulus (Figure 10.6A) and the peak stress (Figure 10.6B) were
observed among groups at each time point and within specific formulations over time. While
initial moduli (day 1) was dictated by macromer concentration (similar to acellular hydrogels),
moduli at day 35 and 56 was dictated by ECM production. 2 and 1 wt% samples exhibited an
increase in moduli over time with significant increases at days 35 and 56. At day 35, 2 wt%
hydrogels containing MeCLHA content (i.e., 1.5:0.5 and 1:1) exhibited moduli (30.4 ± 2.3 kPa and
32.3 ± 7.4 kPa, respectively) that were both significantly higher than that of the MeHA only (i.e.,
2:0 had moduli of 14.4 ± 2.3 kPa) samples. By day 56, moduli of 1:1 (49 ± 7 kPa) and 1:0 (57 ±
10 kPa) samples were significantly greater than all other groups.

However, there was little

change in the mechanics among the 5 wt% formulations and the 4:1 hydrogels had the highest
moduli of 27 ± 8 kPa after 56 days. Furthermore, decreases in moduli for the 3:2 and 2:3
hydrogels were observed from day 35 to day 56. Peak stresses obtained during mechanical
testing indicated similar trends as the compressive equilibrium moduli. Peak stress reflects water
retention within the sample, and is usually an earlier indicator of functional matrix development.
Again, peak stress increased with increased MeCLHA content in 2 wt% hydrogels. Peak stress
obtained in 1:1 and 1:0 hydrogels were significantly greater than all other groups at days 35 and
56.
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Figure 10.6 Compressive equilibrium moduli (A) and peak stresses (B) of constructs at 1 (white),
14 (dotted), 35 (striped), and 56 (black) days of in vitro culture. Statistical analysis or relevant
comparisons: * denotes significant difference between starred groups and all other groups for the
specified time point and # denotes significant differences between bracketed groups. Significant
increases in both moduli and peak stresses over time within each formulation were also observed
for all 2 and 1 wt% groups (not denoted). Significant decrease in moduli for 2:3 constructs from
day 35 to day 56 was also observed (not denoted).
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10.3.6 DNA and Biochemical Content
Mechanically tested samples were digested to determine DNA, sGAG, and collagen
contents. DNA content remained relatively constant among all groups at each time point and
within groups over time (Figure 10.7A).

The only significant changes in DNA content were

observed at day 56 with a decrease in DNA content for 3:2 and 2:3 groups. When normalized to
DNA content, the GAG content in the samples showed significant changes between groups at
each time point and within formulations over time (Figure 10.7B).

Generally, GAG content

increased within wt% formulations with increased MeCLHA content, with trends seen as early as
14 days. By day 35, MeHA only (5:0 and 2:0) hydrogels had significantly lower GAG content
compared to their copolymer counterparts. By the end of the 8 week culture, the 1:1 hydrogels
had the greatest GAG content and was significantly higher in GAG/DNA content (201 ± 4.3
mg/mg) than both 2:0 (169 ± 22 mg/mg) and 1:0 hydrogels (137 ± 4.3 mg/mg). No significant
differences in collagen content were observed between groups at each time point. However,
collagen content increased with culture time in all formulations, with 1.5:0.5 hydrogels attaining
the highest collagen content (654 ± 189 μg/sample) after 56 days.

206

10

DNA (μ g) per Sample

9

≠

≠

3:2
3:2

2:3
2:3

A

8
7
6
5
4
3
2
1
0

5:0
5:0

4:1
4:1

2:0
2:0 1.5:0.5
1.5:0.5 1:1
1:1

250

#

sGAG/DNA (mg/mg)

B

1:0
1:0

#

200
150

÷

100

×
50
0
5:0
5:0

4:1

3:2
3:2

2:3
2:3

2:0 1.5:0.5
1.5:0.5 1:1
1:1
2:0

1:0
1:0

4:1
4:1

3:2
3:2

2:3
2:3

2:0 1.5:0.5
1.5:0.5 1:1
1:1
2:0

1:0
1:0

Collagen/DNA (mg/mg)

120
100

C

80
60
40
20
0

5:0

5 wt%

2 wt%

1 wt%

Figure 10.7 DNA (A), sulfated GAG/DNA (B), and collagen/DNA (C) contents of constructs at 14
(dotted), 35 (striped), and 56 (black) days of in vitro culture. Statistical analysis of relevant
comparisons: * denotes significant difference between starred groups and all other groups for the
specified time point, # denotes significant difference between bracketed groups, ≠ denotes
significant difference over time between bracketed groups, ÷ denotes significant difference
between marked group and all other 2wt% groups, and × denotes significant difference between
marked group an all other 5 wt% groups. Significant increases in collagen/DNA content over time
were observed for all groups (not denoted).
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10.3.7 Immunohistochemical Analysis
Immunohistochemical staining of type I and type II collagen and chondroitin sulfate was
performed on all groups at 14 and 56 days of culture.

At day 14, pericellular staining of

chondroitin sulfate was observed for MeHA only (5:0 and 2:0) hydrogels while greater distribution
of staining was observed for their copolymer counterparts with increased distribution in hydrogels
with increased MeCLHA content (Figure 10.8). By 56 days of culture, chondroitin sulfate was
evenly distributed throughout the hydrogels for all groups. Hydrogels also stained positive for
type II collagen in varying degrees for all groups with 5:0 hydrogels showing the least amount of
staining compared to copolymer hydrogels showing the most staining (Figure 10.8). In general,
type II collagen staining increased from 14 days to 56 days in all constructs. Clustering of type II
collagen in copolymers was also observed. Little to no staining of type I collagen was present in
all hydrogels and non-immune controls also stained negative.

2 weeks
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5:0

4:1
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2:0

5 wt%

1.5:0.5
2 wt%

1:1
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Figure 10.8 Immunohistochemical staining of chondroitin sulfate (CS) and type II collagen (C2) of
constructs after 2 and 8 weeks of culture. Scale bar = 100μm.
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10.3.8 Importance of Degradation Rate
In this study, it is important to note that the timing and rate of degradation is crucial for
functional tissue development. If the degradation rate is faster than ECM deposition, large void
spaces created by degradation can result in the loss of cells and ECM proteins into the culture
medium. Specifically, the loss of GAGs from the hydrogel can result in compromised mechanical
properties, as GAG content is highly correlated to the compressive modulus of native and
engineered cartilage tissues[23]. In the case of the 5 wt% hydrogels, the compressive equilibrium
moduli decreased in hydrogels with increased MeCLHA content (3:2 and 2:3 hydrogels) and there
is no increased GAG accumulation within the hydrogels from day 35 to day 56 that is seen for all
other groups. However, when degradation rate compliments the rate of ECM deposition and
allows for the distribution of cartilaginous proteins within the hydrogel, compressive moduli
increase, as observed in the 2 wt% hydrogels that show an increasing trend in moduli with
increased MeCLHA content.

Increased distribution of ECM proteins is visualized with

immunohistochemical staining.

Specifically, at 14 days of culture, staining clearly depicts

increased distribution and quantity of chondroitin sulfate in hydrogels with increased MeCLHA
content, and at 56 days of culture, increased type II collagen distribution reflects diffusion of
larger ECM proteins. Faster and increased distribution of chondroitin sulfate over type II collagen
reflect differences in protein size, where the smaller chondroitin sulfate diffuses with greater ease
compared to the larger type II collagen fibers[24]. The decrease in acellular elastic moduli and
the increase in biochemical content, equilibrium compressive moduli, and ECM distribution in the
2wt% copolymer hydrogels reflect a cooperative match in hydrogel degradation rate and ECM
deposition.

10.3.9 Importance of a Dynamic Hydrogel
Furthermore, this study emphasizes the importance of network evolution, where a
hydrogel that starts at a higher wt% and decreases to a lower wt% is not equivalent to static
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hydrogels that start at the higher or lower wt%. Specifically, the 1:1 hydrogels were shown to
express up-regulation of type II collagen and aggrecan over the 2:0 and 1:0 hydrogels. Also of
importance is hydrogel size and shape throughout culture time. Unlike the dramatic decreases in
height and diameter of 1:0 hydrogels, which can pose problems in translation to clinical
applications, the 1:1 hydrogels more closely retain their size and shape.

With increased

GAG/DNA content and size retention, the 1:1 hydrogels show greater promise as an MSC-laden
scaffold for cartilage repair compared to 2:0 and 1:0 hydrogels. In addition, although matrix
distribution is fairly consistent across groups by 8 weeks, early changes in gel structure are
obviously important with respect to final construct properties.
To increase ECM deposition and distribution, others have tailored the degradation of
engineered scaffolds. Poly(ethylene glycol) dimethacrylate (PEGDM) has been copolymerized
with poly(lactic acid)-b-poly(ethylene glycol)-b-poly(lactic acid) end capped with acrylate groups
(PEG-LA-DA) to form degradable PEG hydrogels. These chondrocyte-laden constructs showed
increased collagen content and distribution in hydrogels with greater degradable content[9]. In
addition, cell-dictated degradation via MMP-based matrix remodeling has been shown to upregulate expression of type II collagen and aggrecan in MMP-sensitive PEG hydrogels with
encapsulated bovine chondrocytes[11].

More recently, degradation triggered by exogenous

addition of enzyme has also been explored. In a study by Ng et al, enzyme (agarase) treatment
applied to agarose hydrogels resulted in elevated collagen content and dynamic compressive
modulus after an initial loss of scaffold properties immediately after enzyme treatment[12].
Furthermore, Rice et al[13] showed that the timing and duration of enzyme (lipase) addition to
PEG hydrogels with caprolactone blocks greatly affected cartilaginous matrix properties.
Like others, we showed that the inclusion of hydrolytically degradable linkages in
crosslinked hydrogels results in increased ECM deposition and distribution by encapsulated cells.
However, this study focuses specifically on the use of MSCs, rather than isolated chondrocytes.
We showed clear increasing trends in sGAG/DNA content with degradable content for the 2 wt%
groups compared to trends in collagen/DNA content. While sGAG and collagen content still pale
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in comparison to native cartilage tissue (composed of 2-10% sGAG/wet weight and 5-30%
collagen/wet weight[25]), we showed improvements in sGAG content/wet weight and increasing
equilibrium moduli in the 2wt% hydrogels with increasing MeCLHA content. In addition, the
properties of the 2wt% hydrogels continued to improve (increased biochemical content and
moduli) during the course of this study rather than reaching a plateau that had been seen in
MSC-laden agarose hydrogels[2]. This could suggest that the dynamic HA hydrogel environment
may enhance the potential of neocartilage maturation.
By developing dynamic hydrogels based on HA, a linear polysaccharide found natively in
cartilage, we also capitalize on the biological advantages of this molecule. During development,
HA regulates a variety of cellular functions (e.g., gene expression, signaling, proliferation, motility,
adhesion, and morphogenesis)[26], where HA interactions are MW dependent and mediated
through cell surface receptors (e.g., CD44, ICAM-1, and RHAMM)[27,28].

Thus, HA-based

hydrogels have the potential to interact with encapsulated cells via cell surface receptors, and HA
macromers released from the hydrogel can serve as biological cues that have the potential to
initiate cell signaling pathways or sequester proteoglycan aggregates. The ability to tailor HA
macromer release through controlled hydrogel degradation during cartilage repair may play an
important role in mimicking the natural time course of cartilage formation and maturation. In
native cartilage, HA turns over rapidly with a half-life of 1-3 weeks[29,30]. Primarily degraded by
hyaluronidases (HYAL1, HYAL2, and HYAL3), HA macromers are broken down into HA
fragments, which can also induce the expression of MMP-3[31] and nitric oxide synthase[32],
synergizing the breakdown and remodeling process. With HA-based hydrogels, these enzymes
and other cell-generated reactive oxygen species can assist in the complete breakdown and
remodeling of the scaffold over time. Though the degradation products of these hydrogels yield
HA fragments with kinetic chain fragments, we believe that some HA biological cues are imparted
on encapsulated MSCs, as Chapter 8 has previously shown that HA chemistry can enhance
chondrogenesis[7]. The soluble delivery of HA from these hydrogels would be an added benefit,
but was not explored within the scope of this study. However, in this study, we do show that
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temporal network structure can influence neocartilage formation within HA hydrogels in vitro.
Thus, a photocrosslinkable scaffold with a dynamic network structure, biological relevance, and
the ability to support MSC chondrogenesis, as a potential candidate for cartilage repair, was
developed.

10.4 Conclusions
This study indicates that the tuning of temporal scaffold properties can be used to control
neocartilage production by MSCs in HA hydrogels. The faster degrading MeCLHA component of
the hydrogel increases the mesh size and creates void spaces, allowing for the deposition and
enhanced distribution of newly synthesized ECM proteins, while the MeHA component provides
structural support, maintaining the size and shape of the scaffold, until it is eventually degraded
and remodeled by the encapsulated cells. The timing of hydrogel degradation is important since
rapid degradation may result in the reduced retention of ECM proteins, whereas hydrogels that
degrade too slowly can inhibit tissue formation and distribution. Thus, a careful balance of slow
and fast degrading components is needed for optimal growth. Here, the 1:1 hydrogels, with
increased mechanical properties and biochemical content over time, while retaining construct
size, show great potential as a scaffold to support the production of functional cartilage tissue by
MSCs.
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CHAPTER 11
Conclusions, Limitations, and Future Directions

11.1 Conclusions
Aim 1: Synthesize and characterize photocrosslinked methacrylated hyaluronic acid hydrogels.
A cartilage tissue engineering (TE) scaffold was developed based on a natural
polysaccharide found natively in cartilage tissue, called hyaluronic acid (HA).

To form a

covalently crosslinked network, hydroxyl groups on the HA backbone were methacrylated,
yielding double bonds that could participate in photoinitiated polymerization, creating stable, yet
enzymatically degradable HA (MeHA) hydrogels. Properties of the hydrogel could then be tuned
by varying molecular weight, macromer concentration, and degree of modification. Increases in
molecular weight decreased the efficiency of the methacrylation reaction and increased the
viscosity of the prepolymer solution, while effects of molecular weight on swelling, mechanics,
and degradation were insignificant. Increases in macromer concentration, however, had more
profound effects on hydrogel properties, resulting in increased elastic moduli and degradation
times (in the presence of hyaluronidase), and decreased volumetric swelling ratios, which can be
correlated to crosslinking density and hydrogel mesh size. Therefore, with tunable properties,
MeHA hydrogels could be tailored and applied to a variety of applications.
In particular, for application in cartilage TE, these hydrogel properties affected
chondrocyte viability and neocartilage formation. Hydrogels with increased HA molecular weight
yielded inhomogeneities in cell and extracellular matrix (ECM) distribution within the hydrogel due
to the viscosity of the prepolymer solution, while increased macromer concentration resulted in
cell death due to limitations in nutrient and waste diffusion and greater radical concentrations
during photopolymerization. The greatest cell viability and ECM deposition was observed in the 2
wt% MeHA hydrogels; and in particular, the 50 kDa group had the most homogenous distribution
of both chondrocytes and ECM. Within these hydrogels, chondrocytes maintained a rounded
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morphology and continued to deposit cartilage specific matrix proteins when cultured
subcutaneously in vivo.

Aim 2: Investigate cellular response and neocartilage formation of encapsulated chondrocyte and
mesenchymal stem cells in photocrosslinked HA hydrogels.
What a cell senses from its surrounding can dictate its behavior and response. Once
removed from their native environment, harvested cells are exposed to stimulation from a variety
of environments. This may include: growth on tissue culture polystyrene (TCPS) in 2D during cell
expansion, culture in a cell pellet at high densities with high cell-cell contact, and encapsulation in
3D scaffolds where cell-scaffold interactions can also impart different cellular cues. This change
from their native environment can negatively or positively influence cell phenotype, growth, and
biosynthesis.
Due to the limited availability of cartilage tissue for cell isolation and the small percentage
of the tissue comprised by chondrocytes, the need to expand chondrocytes in vitro is indisputable
if chondrocytes are to be considered as a viable cell source in strategies for cartilage repair.
However, for harvested chondrocytes, expansion in 2D on TCPS can result in dedifferentiation,
characterized by a loss in cell morphology and the increased expression and production of type I
collagen [1,2]. The encapsulation of in vitro-expanded chondrocytes in MeHA hydrogels led to
compromised neocartilage formation (i.e., biochemical content and biomechanical properties) in
vivo (in subcutaneous culture) as early as the second passage, i.e. chondrocytes that had been
expanded twice in 2D on TCPS after the initial harvest.
In addition, chondrocyte behavior in MeHA hydrogels was highly dependent on the tissue
source of the chondrocyte. Various types of cartilage (elastic, hyaline, and fibrocartilage) are
found in different parts of the body, and chondrocytes isolated from each region serve specific
functions and differ in their response to stimuli. This was demonstrated as auricular (from the
ear) and articular (from the knee) chondrocyte behavior differed when cultured in MeHA
hydrogels exposed to different culture conditions (static in vitro culture, subcutaneous in vivo
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culture, and exposure to cyclic compression in vitro).

Though both auricular and articular

chondrocytes demonstrated good viability in MeHA hydrogels, they exhibited differences in
metabolic activity and phenotype retention as illustrated by the temporal changes in the
expression of cartilage specific genes in vitro. In subcutaneous culture, encapsulated auricular
chondrocyte succeeded in producing more functional matrix, with mechanical properties of the
constructs increasing over time, compared to the articular chondrocyte group. However, when
mechanically stimulated in MeHA gels in vitro, to more closely simulate the loaded environment of
the knee joint, articular chondrocytes exhibited greater up-regulation of type II collagen and
aggrecan compared to auricular chondrocytes. Thus, similar to what others have observed [3-9],
differences in cartilage tissue source yield diverse chondrocytes that respond differently to
specific environments. While this aim only investigated the differential response of chondrocyte
type in MeHA hydrogels, it is important to remember that the TE scaffold itself can play a large
role in the success of each chondrocyte type[10].
As the use of chondrocytes in cartilage TE is limited clinically, many investigators have
turned to exploring the potential of mesenchymal stem cells (MSCs). During embryogenesis,
MSCs are surrounded by a dynamic matrix in which HA of varying molecular weights play specific
roles in limb development[11,14]. In vitro, substrate bonded HA has been shown to stimulate
MSC chondrogenic differentiation. HA can interact directly with cells via surface receptors or
indirectly through the binding of other matrix proteins or structuring water for cell exclusion to
encourage cell aggregation. Given the presence of HA in MSC chondrogenic differentiation, the
developed HA-based hydrogel was hypothesized to provide an advantageous environment for
MSC chondrogenic differentiation. In vitro culture of MSC-laden MeHA hydrogels demonstrated
that these hydrogels supported MSC chondrogenesis with the addition of soluble TGF-β3.
Comparisons with an inert, photocrosslinked PEG hydrogel implied that HA hydrogel chemistry
can enhance chondrogenesis, and microarray data suggests that the HA chemistry can lead to
up-regulation of matrix stabilizers (e.g. collagens, HA link protein, matrilins) to improve and
sustain chondrogenic differentiation.
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Aim 3: Develop hydrolytically degradable HA macromers to enhance ECM deposition and
distribution.
Despite the ability of MeHA hydrogels to permit and promote MSC chondrogenesis, ECM
accumulation was predominantly limited to pericellular regions. This pericellular localization of
ECM can result from diffusional limitations of the large proteins in the hydrogel and delay
construct maturation.

By incorporating faster, hydrolytically degradable moieties into the

hydrogel, pores created during hydrogel degradation can improve the distribution of deposited
ECM, resulting in improved construct properties[12,13].
To this end, hydrolytically cleavable ester linkages were added between the HA
backbone and the reactive methacrylate group to form methacrylated lactic acid (MeLA),
methacrylated caprolactone (MeCL) and hydroxyethyl methacrylate (HEMA) HA. By altering the
chemistry and the number of repeat units of the hydrolytically degradable group, the degradation
rate of the hydrogel could be controlled. The inclusion of more ester linkages resulted in faster
degradation (but lower solubility), while the addition of a more hydrophobic group (e.g., CL versus
LA) resulted in slower degradation. Hydrogels made entirely of these hydrolytically degradable
HA macromers completely degraded in phosphate buffered saline (PBS) without the addition of
hyaluronidase enzyme over a period of days to weeks. Similar to the MeHA hydrogels, increases
in macromer concentration increased the time for complete degradation, as more crosslinks
created during the polymerization need to be broken.

With time, ester linkages within the

hydrogel are cleaved, resulting in larger mesh sizes, swelling of the hydrogel, and a loss of
mechanical properties.
When seeded with MSCs, the inclusion of hydrolytically degradable units improved the
ECM distribution within the hydrogels, but the stability of the hydrogel was compromised when
the ratio of hydrolytically degradable HA (MeLAHA, MeCLHA, HEMA-HA) to enzymatically
degradable HA (MeHA) was too high. In addition, rapid hydrolytic degradation can result in the
loss of cells and sulfated glycosaminoglycans (GAGs), which leads to compromised mechanical
properties, as in the case of MeHA:MeCLHA copolymer hydrogels of 3:2 and 2:3 compositions.
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However, when temporal degradation is appropriately timed, increases in the mechanical
properties of the constructs reflect the increased deposition of GAGs and the increased
distribution of ECM within the hydrogel; and indicate the development of functional tissue.
Importantly, the development of a “dynamic” hydrogel, or a hydrogel whose mesh size
changes over time as a result of degradation, can be superior to a “static” hydrogel, or pure
MeHA hydrogels that are stable and slow degrading. This is demonstrated by the up-regulation
of cartilage specific genes and subsequent increased deposition of cartilage specific ECM
proteins in the 1:1 MeHA:MeCLHA hydrogels over the 2:0 and 1:0 MeHA only hydrogels. These
1:1 hydrogels allowed for the diffusion of ECM proteins within the construct over time and
provided structural stability to prevent the contraction of the hydrogel by MSCs. After 8 weeks of
in vitro culture, mechanical properties of the 1:1 hydrogel continued to improve without signs of
plateau. Thus, the material design of the hydrogel was vital in the transformation of MSCs to
chondrocytes and in the production of functional matrix.

11.2 Limitations
While this dissertation explores the development and characterization of HA hydrogels for
cartilage regeneration, several limitations to these studies must also be considered. Though
lightly touched upon, the biological significance of HA was not explored in detail, as only the tip of
the surface was grazed on its interaction with cells and its potential role in MSC chondrogenesis.
Additionally, the release of HA (alone or with kinetic chain fragments) from the hydrogels may
initiate cell signaling pathways, as molecular weight-dependent HA fragments dictate varied
cellular processes in embryogenesis and natural wound healing [14,15]. However, the effects of
the attached kinetic fragments (be it stimulatory, inhibitory, or insignificant) in the MeHA
components on the HA-cell interaction remains unexplored. Also, the complete degradation and
remodeling of HA-based hydrogels was not fully characterized in vivo. As HA degradation can
occur by free radicals generated in a number of chemical and enzymatic reactions [16] and is
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also managed by hyaluronidases that reside within the cell [15], the degradation of these
hydrogels can be dictated by both encapsulated cells and the local environment surrounding the
hydrogel. Thus, the in vitro degradation of the hydrogels in PBS with and without exogenous
hyaluronidase at 37°C served primarily as a material characterization parameter rather than a
discrete timeline for hydrogel degradation.
Secondly, the delivery of transforming growth factor-β (TGF-β3) needs attention as we
look towards the desired in situ polymerization of these HA-based hydrogels or implantation of
immature constructs for clinical application, particularly with MSCs. With a shift from in vitro
culture (the primary culture method used in this dissertation for MSCs) to an in vivo environment
(for clinical application), controlled delivery of soluble TGF-β3 to the encapsulated MSCs provides
a challenge that needs to be solved, and was not addressed in this research. While the water
swollen network provides a good medium for the passive diffusion of nutrients and growth factors
during in vitro culture, the facile diffusion of directly encapsulated molecules out of the hydrogel
diminishes the availability and influence of these molecules on encapsulated cells in vivo.
Various methods and ideas for growth factor delivery are addressed and discussed in future
directions (Section 11.3). Here, concentration, availability, and activity of the growth factor must
be sufficient to induce chondrogenic differentiation of MSCs, promote their continued maturation
into chondrocytes, and induce matrix formation into a functional tissue.
A final limitation to this work is the lack of assessment of the cell-laden HA hydrogels in a
clinically relevant defect model. Subcutaneous culture in nude mice was used to gauge the ability
of chondrocytes and MSCs to produce neocartilage tissue in an in vivo environment, but this fails
to mimic the mechanical loads and inflammatory molecules (e.g. cytokines) that are present in an
injured or diseased cartilage defect site of the knee or hip. Local stimuli (mechanical or soluble)
can alter cell response and tissue formation. In addition, without a defect model, integration of
the scaffold with the surrounding native cartilage during repair in vivo was not examined. Without
adequate integration of the scaffold with the surrounding native cartilage, complete repair can be
compromised as the hydrogel may not be secure in the defect site. However, it would have been
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premature to initiate this analysis until questions regarding growth factor delivery were addressed
for this system.

11.3 Future Directions
11.3.1 TGF-β3 Delivery
As mentioned in the previous section (11.2), the delivery of TGF-β in vivo remains a
challenge. Members of the TGF- β superfamily of growth factors play a major role in bone and
cartilage development. In a study by Heine et al., immunohistochemical staining for TGF-β in
developing mouse embryos demonstrated localization of TGF-β in tissues derived from the
mesenchyme. Intense staining was observed during the remodeling of these tissues, as during
the formation of digits from limb buds [17].

This demonstrated TGF-β’s importance in

mesenchyme cell differentiation and its regulation of ECM synthesis. Accordingly, since then,
TGF-βs have been shown to induce a chondrogenic response in a variety of cells (chondrocytes
[18-20], MSCs [21-23], fibroblasts [24]), resulting in the up-regulation of chondrocytic markers and
subsequent deposition of sulfated glycosaminoglycan (sGAG) and collagen.
Three different isoforms of TGF-β (TGF-β1, TGF-β2, and TGF-β3) have been discovered
in mammalian species, and these isoforms can differ in their effects on chondroprogenitor cells
[25-28]. TGF-β1 is responsible for initial cell-cell interaction between condensing progenitor cells,
and stimulates new matrix synthesis by chondrocytes [28].

TGF-β2 regulates hypertropic

differentiation of chondrocytes via Indian hedgehog (Ihh) and parathyroid growth hormone
peptide (PTHrP) expression[25].

While all isoforms of TGF-β can induce chondrogenesis in

human bone marrow derived MSCs, a study by Barry et al. showed that TGF-β2 and –β3 are able
to produce more rapid accumulations of proteoglycan and type II collagen compared to TGF-β1
[29].

223

In chapter 8, human MSCs were shown to undergo chondrogenesis in HA hydrogels in
vitro with the addition of soluble TGF-β3 delivered via the culture media. For in vivo studies,
TGF-β3 was encapsulated directly in the hydrogels during photopolymerization, where the high
water content of the hydrogel can mimic the environment of native soft tissue, providing a suitable
means to deliver bioactive molecules. While short-term gene expression showed up-regulation of
cartilage specific markers, immunohistochemical staining demonstrated lesser degrees of matrix
accumulation compared to in vitro cultured hydrogels. With direct encapsulation, growth factor
release is controlled by diffusion; and the highly permissible nature of the hydrogel can lead to its
rapid initial release, which decreases the concentration of growth factor seen by the encapsulated
cells. Additionally, in vivo culture with direct growth factor encapsulation lacks the luxury of
growth factor delivery at a constant concentration over an extended period of time, which can
compromise chondrogenesis.
As a result, a variety of growth factor delivery methods have been investigated. These
include the use of microspheres[30-33], covalent tethers [34], affinity ligands[35], biomimetic
peptides[36] and adenoviruses[37]. Growth factor-loaded microspheres can provide additional
control over TGF-β release and have been delivered in both hydrogels[19] and pellet cultures[32].
Previous work by Mann et al. has shown the ability to tether TGF-β1 to stimulate ECM production
in poly(ethylene glycol) (PEG) hydrogels[34]. Furthermore, the incorporation of degradable linkers
between the tether and the bioactive molecule allow for pre-determined liberation and controlled
release rates[38,39]. Although covalent tethering provides an effective means to control the
availability of the growth factor, covalent conjugation may also reduce growth factor bioactivity, as
presentation of the protein to the cell can be altered. Recently, ligands that reversibly bind TGF-β
have been targeted as a means to sequester growth factors. One such ligand is heparin [35],
which binds to a broad variety of growth factors via non-specific electrostatic interactions.
However, its potential immunogenicity and binding of numerous proteins may complicate release
in vivo; thus, the incorporation of biomimetic peptides have been explored as another alternative
method of growth factor delivery. In a study by Hao et al, rat bone marrow derived MSCs
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transfected with a recombinant adenovirus encoding TGF-β3 were encapsulated in agarose
hydrogels, and were shown to express type II collagen on days 2 and 3 post infection[37].
A pilot study was completed to address growth factoring sequestering in HA hydrogels.
In Chapter 10, the inclusion of degradable HA was shown to increase functional matrix deposition
and distribution in vitro. However, in vivo, temporal degradation can accelerate the diffusion of
encapsulated TGF-β3 in vivo and compromise the benefits of the dynamic hydrogel.

When

hydrogels of 2:0, 1:1 and 1:0 MeHA wt%: MeCLHA wt% were used to encapsulate MSCs and
TGF-β3 (10ng/gel), the 2:0 hydrogels, with the highest crosslinking density of the three groups,
exhibited the greatest up-regulation of type II collagen, suggesting that higher crosslinking density
may yield better retention of TGF-β3 within the hydrogel.
Additionally, various concentrations of TGF-β3 (0, 200 and 2000ng/ml) were
encapsulated in 1:1 hydrogels to investigate the effects of TGF-β3 concentration delivered via
direct encapsulation. Others have shown that the differentiation pathway can dictate the amount
of TGF-β that is required, where 10ng/ml is optimal for chondrogenesis while 2ng/ml is adequate
for neurogenesis in vitro [40-42]. However, for in vivo culture, the optimized TGF-β dosage and
delivery protocol have not been established. In the pilot study, a 2-fold increase in aggrecan
expression was observed for the 2000ng/ml group. However, no differences in gene expression
for types I and II collagen were seen between TGF-β3 groups. The rate of TGF-β3 diffusion from
the hydrogel may be rapid, resulting in low effective growth factor concentrations as seen by the
encapsulated cells for both TGF-β3 concentrations. In subsequent studies, conjugation of a
Cy5.5 fluorophore to TGF-β3 [35] can be used to visualize the diffusion of the growth factor in
vivo via transdermal fluorescent imaging of implants cultured subcutaneously in the dorsum of
nude mice.
Additionally, the bolus dosage delivery method for TGF-β3 can be compromised by the
short half life and consumption of the growth factor.

When 1:1 hydrogels with 200ng/ml of

encapsulated TGF-β3 were cultured in chondrogenic minus (CM-) media (without the continuous
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addition of soluble TGF-β3), constructs were less opaque than those cultured with continuous
growth factor supplementation. Macroscopically, those lacking TGF-β3 supplementation were
opaque in the center and translucent on the periphery of the construct after 2 weeks, suggesting
that growth factor quickly diffused from the exposed surfaces of the hydrogel, and was unable to
induce chondrogenesis and matrix deposition in those regions.
Lastly, the pilot study explored the use of a thrombospondin-1 (TSP-1) based peptide as
an affinity ligand for the retention of TGF-β3 within the hydrogel [43]. In native tissue, the ECM
serves as a reservoir for growth factors, where these signaling molecules can be bound in latent
or active form by ECM proteins. By synthesizing an acrylated TGF-β binding peptide (AcryGGKGGWSHW), the affinity ligand could be covalently bound within the hydrogel network. To
investigate the effects of peptide addition, 10μM of TGF-β binding or missense peptides were
incorporated into 1:1 hydrogels with directly encapsulated TGF-β3 (200ng/ml).

Hydrogels

cultured in CM- media in vitro and subcutaneously in vivo in nude mice, showed no significant
differences in gene expression with or without binding or missense peptides.
The lack of improved chondrogenesis may have resulted from a number of reasons. In a
study by Lin et al [44], linear spacers of glycine (G2, G7, and G12) were shown to improve the
availability of the growth factor binding site to the cells within poly(ethylene glycol) diacrylate
hydrogels with increased spacer length. Thus, the availability of the TGF-β binding site may have
been sterically hindered by the HA network. In future affinity binding peptide designs, a longer
spacer for the pendant binding peptide should be taken into consideration as it may be more
effective in growth factor retention.

Additionally, the use of fluorescence resonance energy

transfer can be use to visualize and quantify the binding of the growth factor to the peptide.
In addition, the binding affinity of the peptide to the growth factor may not be optimal.
Protein binding is typically weak and low binding affinities may not be sufficient for growth factor
retention within the hydrogel.

However, if binding is too strong, the growth factor can be

sequestered and unavailable to the encapsulated cells.

Furthermore, the specificity of the

binding can also affect the success of the affinity peptide. Non-specific binding of the peptide
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may result in competitive binding, decreasing the percentage of bound growth factor. Thus, a
careful balance of binding and specificity must be satisfied for successful use of a biomimetic
affinity peptide for growth factor retention. With this in mind, additional TGF-β3 specific binding
proteins should be investigated and binding assays should be performed to screen differences in
binding affinity in subsequent studies.
Another approach that can be taken for sustained TGF-β3 delivery to encapsulated cells
is the incorporation of biomimetic peptides that are able to activate latent TGF-β3. MSCs, along
with several other cell types, produce and secrete latent TGF-β3 [45-48]. The secretion of latent
growth factor during MSC chondrogenesis should first be examined to determine the feasibility of
this approach. If they are found to secrete adequate quantities of TGF-β3, this approach could
provide a cell-driven positive feed back loop. The peptide sequence that is responsible for TGF-β
activation on TSP-1 has already been determined. Again, spacers, multivalency design, and
conformational presentation of the peptide must be examined and considered in the development
of a bioactive peptide for growth factor delivery.

11.3.2 In Vivo Defect Model
Once an effective growth factor delivery method has been optimized in subcutaneous in
vivo culture, the next step is to investigate repair in an in vivo defect model. While in vitro and
non-weight bearing subcutaneous models provided a means to characterize, develop, and
optimize HA tissue engineered constructs, they fail to mimic the native joint environment where
cartilage repair is most needed for clinical application, as mentioned in Section 11.2.
Unfortunately, due to the physiological and anatomical differences between the human joint and
those of experimental animals, no animal defect model is directly applicable to humans.
However, small animal models such as rabbits may be used for initial evaluation of
developed constructs since they provide a practical approach to investigate scaffold integration
and the quality/functionality of the repaired tissue in a dynamically loaded environment, before
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performing more costly studies in larger animals (e.g., swine, goat, sheep).

Additionally,

procedural complications in the injection and photopolymerization of the scaffold within the defect
site can also be examined. Importantly, careful choice of the animal and the defect site, size, and
type must be taken into consideration. Initial pilot studies in full-thickness swine articular defects
demonstrated that partial polymerization would be needed to localize the injection of the cellladen scaffold due to low viscosity of the cell/macromer solution. Developing a facile injection
protocol would illustrate the feasibility of performing in situ photopolymerization for HA hydrogel
based cartilage repair in a minimally invasive manner, as desired clinically.
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